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Abstract 
There is an increasing and serious problem of antimicrobial resistance emerging where 
previously useful antibiotics are no longer effective. This causes a significant monetary 
and human cost in the healthcare system, and is a direct result of the misuse and over 
prescription of antibiotics. The development and implementation of rapid point of care 
diagnostics to conclusively identify problem pathogens such as Staphylococcus aureus 
could slow the emergence of antibiotic resistance by correctly targeted antibiotic therapy. 
The rapid and sensitive protease detecting LGX probe is an example of such a diagnostic 
test. The synthesis of this rhodamine based fluorogenic probe and the investigation of 
other fluorescence motifs for protease detection has been the focus of this project. Scale 
up and optimisation of the synthetic route to the previously produced LGX probe was 
achieved, allowing further testing in a healthcare environment. Previous work has failed to 
address the complexities associated with the use of conventional fluorescence motifs for 
probe generation, as well as the ways in which their fluorescence may be modulated. 
Herein we address these problems, and those encountered with the scale up of the ‘LGX’ 
probe. The lessons learned from the LGX synthesis provided the basis for development of 
a number of novel analogues of the orphan fluorophore class Singapore Green. A library 
of nine simplified and highly active fluorescent Singapore Greens were generated. These 
were exhaustively investigated and it was determined how structural variations effect both 
their spectral and fluorescence properties including quantum yield and extinction 
coefficient. The spectral characteristics of Singapore Green fluorescent motifs were found 
to be highly favourable allowing them to provide the central core of future probes. This 
work has also provided the synthetic methodology required to produce ‘LGX’ in the 
quantities required for eventual utilisation in healthcare environments. Furthermore it has 
provided the several novel platforms for the development of future probes. This is of 
potentially considerable value as it may not only contribute to the reduction of the problem 
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pathogen S. aureus as well as slow the emergence of resistance, but also facilitate 
generation of other important protease detection systems. 
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Abbreviations 
ACE  angiotensin-converting enzyme 
Arg  arginine 
BIOPEP bioactive peptides 
Boc  tertiary butoxycarbonyl 
BODIPY borondipyrrolmethine 
br  broad 
CA  coupling agent 
Cbz  benzyloxycarbonyl 
COMU (1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-
carbeniumhexafluorophosphate 
d  doublet 
DCM  dichloromethane 
δ  chemical shift in parts per million 
dd  doublet of doublets 
DDAO  7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) 
DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DIEA  diisopropyl ethylamine 
DMF  dimethyl formamide 
DMSO  dimethyl sulfoxide 
DPP-4  dipeptidyl peptidase-4 
EDCI  1-(3-dimethylaminopropyl)-3-ethylycarbodiimide hydrochloride 
EEDQ  N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline 
eq  equivalent 
ESBL  extended spectrum β - lactamases 
EtOAc  ethyl acetate 
FP-2  Falcipain-2 
HABP  hospital acquired bacterial pneumonia 
HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium-3-oxid 
hexafluorophosphate 
HPLC  high performance liquid chromatography 
HR MS  high resolution mass spectrometry 
IR  infra-red 
m  multiplet 
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MAPKK  mitogen-activated protein kinase kinase 
MDAP  mass directed auto purification 
Me  methyl 
MeOH  methanol 
MRSA  methicillin resistant Staphylococcus aureus 
MSSA  methicillin sensitive Staphylococcus aureus 
m/z  mass to charge ratio 
NMR  nuclear magnetic resonance 
PCR  polymerase chain reaction 
ppm  parts per million 
Pro  proline 
PRSP  penicillin resistant Streptococcus pneumoniae 
PSMA  prostate specific membrane antigen 
PyBOP  (benzotriazole-1-ylxoy)tris(pyrrolidino)phosphonium hexafluorophosphate 
q  quartet 
Rf  retention factor 
Rho  Rhodamine 110 
ROI  return on investment 
rt  room temperature 
SNAP  soluble N-ethylmaleimide-sensitive factor attachment protein 
SNARE  soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
VABP  ventilator acquired bacterial pneumonia 
Val  valine 
VRE  vancomycin resistant enterococci 
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1.1 Introduction to Proteases 
1.1.1 Definition and Function 
The term protease and proteinase are often used interchangeably in literature, by 
definition however, a protease refers to either an endo or exopeptidase, while proteinases 
refer specifically to endopeptidases.1 They are simply enzymes that function to induce 
proteolysis. Proteolysis is achieved through catalysing the cleavage of an amide bond 
between two amino acids of the peptide chain. This can occur in either the main body of a 
peptide, in which case the are denoted endopeptidases, or at the final amino acid at the 
carboxyl (C-) or amino (N-) terminus, denoting them as exopeptidases.2 The proteolysis 
produces two shorter peptide chains from the original larger single chain. Countless 
biological functions are reliant upon this process, including protein digestion, wound 
healing, cell division and immune system activation to name but a few.3  
 
Figure 1. The action of an endo and exopeptidase on a peptide. 
Substrate selectivity is extremely important to the function of a protease, as lack of 
discrimination between substrates may lead to unwanted cleavage and detrimental 
downstream effects. In light of this, many proteases exhibit high specificity and recognise 
only a very limited number of peptide sequences. Conversely, some exhibit a surprisingly 
broad selectivity, enabling them to cleave a wide variety of substrates. These variations in 
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selectivity are attributed to the precise shape, size and orientation of the catalytic site in 
question. The catalytic properties and specificity of a protease are determined by the 
order of its primary amino acid sequence. The variable mechanisms associated with 
these, as well as regulation of substrate and proteolytic access have been, and continue 
to be, the subject of much research.4,5,6,7  
 
Figure 2. General representation of peptide cleavage through protease activity. Protease enzyme 
active site is regenerated following cleavage. 
Interest in proteases arises from but is not limited to the fact that abnormal protease 
activities are linked to an array of diseases. In humans, around 1.7 % of genes code for 
proteases, which corresponds to approximately 400 individuals, of which at least 14 % are 
under investigation as therapeutic targets for diseases, including cancers, Alzheimer’s 
disease, thrombosis, diabetes, and HIV.8,9,10,11,12 In view of the compelling reasons for the 
study of proteases their mechanisms and inhibitors, it is clear why this field of research is 
important and justifies the extensive investigation which continues to be devoted to the 
development of sensitive, selective and robust assays for their detection and 
quantification.  
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1.1.2 Organisation 
There are seven well defined families of proteases, named after residues important to 
their catalysis, these are: Aspartic, Cysteine, Glutamic, Metallo, Asparagine, Serine and 
Threonine. In addition to this, there are two further members consisting of mixed catalytic 
family or unknown catalytic mechanism. Of the seven main families, four are large and of 
major therapeutic interest (Aspartic, Cysteine, Serine and Metallo), with the remaining 
three which are either less-well understood, have few members, or possess little apparent 
therapeutic application. The well-defined families and the year they were first 
characterised are as follows in Table 1.13 
Protease Year of discovery Catalytic residue nature 
Aspartic- 1993 Aspartamate carboxylic acid 
Cysteine- 1993 Cysteine thiol 
Serine- 1993 Serine alcohol 
Metallo- 1993 Metal based, often Zinc 
Threonine- 1997 Threonine alcohol 
Glutamic- 2004 Glutamate Carboxylic acid 
Asparagine- 2010 Asparagine 
 
Table 1. Types of protease and their year of discovery. 
 
1.1.3 Aspartic proteases 
Aspartic Proteases are classed as such due to the two aspartic acid residues housed 
within their active site which are largely responsible for their activity. It has been deduced 
and generally accepted that an acid-base mechanism is responsible for their catalytic 
activity. This arises through the two active site aspartate residues playing the part of acid-
base proton shuttles. They work together to activate a water molecule which is in turn 
responsible for the proteolysis, this is believed to be initially localised between the two 
aforementioned aspartates and commences the proteolytic activity.14  
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1.1.4 Cysteine proteases 
Like the others, the cysteine family of proteases are named after the important residue in 
their active site. Their catalytic activity is made possible by the presence of this 
nucleophilic residue, along with a basic histidine in close proximity. In addition, an 
aspartate residue usually accompanies the two others in order to form a catalytic triad. 
The aspartate residue is important for orientation and polarisation of the histidine residue 
in order to facilitate proteolysis via enabling efficient proton transfer between them, 
forming the initial Cys-S-/His-NH+ ion pair which commences the proteolysis leading to an 
oxyanioic transition state. Collapse of the transition state results in elimination of the 
carboxyl end of the substrate. Repetition of the catalytic steps then lead to elimination of 
the NH2 side of the substrate along with regeneration of the catalytic site.15,16,17,18  
1.1.5 Serine proteases 
The active site of the serine protease again contains the catalytic triad charge relay 
system, consisting of the nucleophilic serine (after which these proteases are named), a 
basic histidine, and aspartate residues which in combination are responsible for their 
activity.19 The generally accepted catalytic mechanism for serine proteases is similar to 
cysteine proteases and proceeds via two steps. The initial step involves acylation of the 
serine residue. This leads to a tetrahedral oxyanion intermediate following deprotonation 
of serine by histidine. The intermediate then collapses expelling the NH2 side of the 
substrate, assisted by proton transfer. The second catalytic step involves elimination of 
the carboxyl side of the substrate via de-acylation to regenerate the catalytic site for 
further catalysis.19  
1.1.6 Metalloproteases 
Metalloproteases are a wide-ranging family of protease enzymes in which a metal ion is 
central to their catalytic activity. Within the active site, the metal ion is coordinated to the 
surrounding protein via three amino acid residues which consist of aspartate, glutamate, 
and either histidine or lysine. A vast majority of the metalloproteases contain zinc as the 
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active metal. However, others containing cobalt or calcium are known but the metal ion 
always appears as a divalent cation.20,21  
Their catalysis in general relies on the coordination of a water molecule to the cationic 
metal centre (in this case zinc) imparting polarisational activation. A tetrahedral oxyanionic 
transition state is formed, stabilised by the Lewis acidity of the zinc centre. Other steps 
precede proton transfer between the enzyme’s active carboxylic acid group and the 
terminal carboxylate group of the substrate which completes proteolysis regenerating the 
enzymes active site.20,21,22  
 
1.2 Protease Activity 
1.2.1 Accurate Antimicrobial Targeting via Protease Activity 
There is an ongoing problem of antimicrobial resistance emerging for previously treatable 
illnesses. This is a result of the lack of new antibiotics coming to market as well as poor 
management and use of those currently available. This is a well-established problem that 
has appeared at a time when both antibacterial research and productivity has dropped to 
an all-time low, with few new agents on the horizon.23  
Balancing the system to facilitate the supply of new antibiotics while improving the 
effectiveness of those currently available in order to suppress the rise of resistance has 
become difficult. The lack of new antibiotics being released leads to a steady increase in 
resistance to those currently available, at great cost.24 
Two main factors have contributed to the crisis of emerging antibiotic resistance. Firstly, 
the reduction in the number of pharmaceutical companies over the years since modern 
antibiotics were initially developed. Where there once were many individual competing 
companies, mergers and acquisitions have reduced the number of companies with the 
capacity to develop such agents. This has led not only to a decrease in competition 
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(contentious in itself), but also to a decrease in the number of individual antibiotic 
compounds in development.25 This, coupled with those same companies developing other 
pharmaceutical agents with higher chances of success and return on investment (ROI), 
gives an indication as to why so many have abandoned antibiotic research altogether.26  
Secondly, but equally important, is the long term misuse of the currently available 
antibiotics. This facet of the developing antibiotic resistance problem could be attributed to 
both convenience and ignorance in relation to antibiotic use. Currently, antibiotic therapy 
is based upon the empiric model. This could be likened to an “educated guess”, whereby 
a healthcare professional will prescribe a particular course of antibiotics based upon 
various signs and symptoms. The caveat is that there is rarely a definitive diagnosis as to 
the identity of the problem pathogen (if one is even present), and this often leads to less 
than ideal antibiotic use.27 That is not to say that this model of antibiotic therapy has not 
been effective in the past, with many lives saved and significant societal advances as a 
consequence. However, the downside of antibiotic use directed by the empiric model is 
the high costs paid by the misprescribed patients, whether they be human or otherwise. 
Unnecessary courses of antibiotics prescribed for uninfected patients leads to needless 
side effects, damage to the human microbiome, and most importantly, antibiotic 
resistance.27 This erroneous use could be reduced, or even eradicated if testing for 
pathogen identity were undertaken before antibiotic therapy commenced. Unfortunately 
this is often unfeasible, as testing is generally slow, too expensive, or impractical in many 
cases.27 
There are a number of particular bacterial strains which have been shown to pose the 
greatest threat in terms of antibiotic resistance. Studies on the impact of said resistance in 
terms of mortality and length of hospitalisation have highlighted these bacteria as: 
methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus 
pneumoniae (PRSP), extended spectrum β – lactamases (ESBLs) in Escherichia coli and 
Klebsiella pneumoniae, vancomycin-resistant Enterococci (VRE) and carbapenem-
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resistant Pseudomonas aeruginosa.28 These studies concentrated on a range of common 
problem infection sites including urinary tract, soft tissue, blood, respiratory and skin. The 
results quantified the additional burden caused by these to be approximately 25,000 
deaths, 400,000 infections and 2 - 5 million extra hospital days per year in the EU alone. 
The monetary cost was estimated to total approximately € 900 million per year, with a 
concurrent loss of 600 million days of productivity.29 The WHO has placed infections 
resulting from antibiotic resistant bacteria at the top of their preliminary ranking of 
pharmaceutical gaps, above cardiovascular disease, diabetes types I and II, and even 
cancer.30 Furthermore, lower respiratory infections caused by bacterial pathogenesis are 
ranked first on the list of global burden of disease.31 The two most common healthcare 
associated infections in the United States are hospital acquired bacterial pneumonia 
(HABP) and ventilator acquired bacterial pneumonia (VABP), with the leading cause of 
these complications being Staphylococcus aureus.32,33 Adverse outcomes related to these 
infections can be lessened or avoided altogether via the swift administration of correctly 
targeted and dosed antibiotic therapy.34,35,36 
With this in mind it is not surprising that a general agreement has arisen that a 
transformational effect in the use and effectiveness of antibiotics would be seen if superior 
methods of detection of problem pathogens were employed. These would have to be 
equally accurate, but much faster and cost effective than those currently utilised. 
Therefore, the answer is adoption of rapid point of care tests to improve decision making 
in the treatment of bacterial infections. This is particularly important in the early stages of 
treatment where conclusive identification of the pathogen is crucial to avoid the use of the 
empiric method of antibiotic prescription. Therefore, the change in practice from empiric to 
accurate and appropriately targeted antibiotic use following a conclusive identification 
could achieve the aforementioned transformational effect, suppressing the rise of 
resistance.37 This point is reflected in the WHO’s report stating that “Governments and 
partners need to work closely with industry to encourage greater investment in research 
and development of new diagnostics that can improve decision making”.38 
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The message is therefore clear, the continued development of simple, cheap, efficient and 
accurate point of care tests is the key solution for addressing the emergence of antibiotic 
resistance. These tests provide the opportunity to break the current cycle of inaccurate 
antibiotic therapy by allowing rapid and accurate identification of problem pathogens. This 
would then allow antibiotic therapy to commence only after positive identification and 
determination of antibiotic susceptibility. These tests can operate via targeting a specific 
protease enzyme expressed by the problem pathogen, providing conclusive results many 
times faster than traditional culture or polymerase chain reaction (PCR) methods. 
Furthermore, these rapid diagnostics could also expedite the development of new 
antibiotic classes, addressing the other major problem faced by the healthcare industry. 
This could be achieved by improving the cost effectiveness of clinical trials by identifying 
only the correct patient populations to be tested, ruling out those carrying several bacterial 
infections treatable by currently available antibiotics.39,27 
It is therefore clear that development of rapid diagnostics for identification of common 
healthcare infections for which resistance is emerging is of paramount importance. These 
bacterial protease targeting probes could form the basis of a modern antibiotic 
stewardship strategy, optimising clinical outcomes while minimising harmful 
consequences of antibiotic use. If this strategy is not implemented, along with the lack of 
new antibiotics in development, multidrug resistant bacterial infections will become more 
and more commonplace. The final result of this being, in the not too distant future, 
traditional antibiotic therapy will have been confined to the pages of history, and the ‘post 
antibiotic era’ will have begun. If the human race is to remain resident on planet earth for 
generations to come, this must be avoided at any cost. 
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1.3 Protease Detection 
1.3.1 Detection Methods 
The detection of protease activity has been crucial to the understanding of their function 
and importance in physiology. Quantification of their activity has profoundly deepened the 
understanding of these proteins as the driving force behind not only important biological 
functions, but also numerous diseases. Therefore, protease detection methods must be 
constantly developed and improved so as to be able to fully understand them in a clinical 
and biological context; more specifically, to allow their exploitation as therapeutic targets 
for the treatment of diseases. To address this, significant research is ongoing in this area. 
The ability of a protease to distinguish its proper substrate from among many candidates 
is very important in maintaining the biological function for which it is designed. The 
selection of the enzyme’s substrate is regulated by various factors, including the location 
and timing of expression, enzyme and substrate concentrations, and the requirement of 
cofactors. However, the dominant principle in determining protease specificity is the 
structure of its active site which is dictated by its specific amino acid sequence. This in 
turn determines its shape, size, polarity and consequently which substrates it has affinity 
for, as a result of their complimentary properties. The area of the active site which dictates 
the affinity may be referred to as the specificity pocket. The properties of which are heavily 
based upon the side chains of the substrate and enzyme residues, as well as the steric 
and electronic interactions between them. 
Determination of the substrate specificity of a protease and characterisation of its active 
site is of paramount importance in understanding the role that protease plays in a complex 
biological pathway. In defining the specificity of a protease for a particular substrate, the 
initial basis for design of selective inhibitors for that enzyme is provided. This enables 
study of the action of the protease in its biological context, which may then allow its 
manipulation for medicinal or other purposes through activity modulation.40 
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Protease activity may be detected through a myriad of different techniques; though they 
may be broadly grouped into one of three categories based upon the method of 
monitoring said activity. The three categories consist of: Natural substrate turnover, 
Substrate based probes and Activity based probes, each of which has its own advantages 
and disadvantages.40 
The most direct method of detection is via natural substrate turnover, in which an active 
protease may be detected via cleavage of its natural substrate. It is then possible to 
directly measure protease cleavage events via quantification of the peptide fragments 
produced by proteolysis of the substrate. However, in this case the substrate fragments 
must be isolated, purified and quantified from the complex mixture of products produced.41 
On the other hand, substrate based probes are able to generate a signal directly following 
a proteolytic event, simplifying the detection of activity.42 Activity based probes, the third 
category, are able to monitor protease activity indirectly by using a substrate like region 
which binds covalently instead of being cleaved by the protease. Therefore, quantification 
of binding reveals protease activity.43,44  
1.3.2 Natural Substrate Turnover 
Protein substrates are cleaved by active protease enzymes, a simple example of this 
would be autoproteolysis, in which a protease cleaves an inactive form of itself to produce 
its active form.45,46 A common way of measuring the proteolysis of individual substrates is 
via resolution of the substrate fragments through electrophoresis, using sodium 
dodecylsulphate polyacrylamide gel (SDS-PAGE). This is then followed by immunoblotting 
or Coomassie staining to visualise the individual substrate fragments. A prominent 
limitation of this procedure is that substantial prior knowledge of the substrates to be 
measured is required. Changes in migration of the substrate fragments through the gel 
indicate proteolysis of the substrate. As an alternative to visualisation techniques, mass 
spectrometry may be used in tandem with SDS-PAGE, to simultaneously measure 
substrate turnover of all fragments; monitoring of several proteases at the same time is 
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therefore made possible.47 Furthermore, gel-free techniques have been developed in 
order to separate proteolysis fragments from several different proteases at the same time. 
This then facilitates identification and quantification of most fragments from the sample 
through exploitation of the unique α-amino group liberated from the substrate.48 
Commonly cleaved substrate sequences suggest catalytic recognition motifs, while the 
pathways into which the substrates fall may indicate the function of the protease in 
question. A schematic of the steps involved in these techniques is shown in Figure 3.49 
Both gel-based and gel-free methods have proved effective in separating closely related 
physiological functions of proteases, assisting in the design of selective activity and 
substrate based probes.  
 
Figure 3. Protease detection through natural substrate turn over. 
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1.3.3 Substrate Based Probes 
As mentioned before, quantification of proteolytic cleavage of natural substrates requires 
isolation and identification of the resulting peptide fragments. This is a significant limitation 
if the function of the protease is thus far unknown. However, substrate-based probes are 
able to measure protease hydrolysis activity without the need for complex isolation and 
characterisation procedures. These probes generally consist of two parts, the recognition 
sequence which binds to the active site of the protease in question, and a reporter which 
provides a detectable signal upon cleavage of the probe. The selectivity and sensitivity of 
the probe is critically dependent upon the design and identity of the recognition sequence, 
as this is the part of the probe which confers specificity and is cleaved by the target 
protease.50 The recognition sequence is usually identified and synthesised based on one 
of two ways. Either through prior knowledge of the natural protease substrate and its 
reproduction, or identification of a specific sequence through cleavage patterns obtained 
from synthetic peptide libraries screened against the protease in question.42 Following 
identification of the correct recognition sequence, it is coupled to the reporter to form the 
active protease probe. Countless examples of substrate-based probes exist, particularly 
the fluorogenic variety which are simple, robust and used frequently to reflect this. An 
example of which combines a fluorophore such as 7-hydroxy-4-methylcoumarin (AMC, 1) 
or 7-amino-4-carbamoylmethylcoumarin/4-methylumbiliferone (ACC/4-MU, 2), with an 
amino acid recognition sequence targeted by the protease of interest. The fluorescence of 
the probe is minimal when the recognition sequence is attached, and upon cleavage a 
large increase in fluorescence is observed as the free fluorophore is released, Figure 4.40  
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Figure 4. AMC/ACC substrate based probes produce a large fluorescence increase upon 
proteolysis. 
The design of fluorogenic probes is relatively simple in principle but their selectivity can be 
limited as the recognition sequence binds to the active site at the non-prime side. 
However, this limitation is not common to all fluorogenic substrate based probes as some 
have recognition sequences which bind across both prime and non-prime sides of the 
active site. Fluorescence resonance energy transfer (FRET) probes are an example of 
this, these contain a fluorophore and quencher attached to either end of a recognition 
sequence.42 Cleavage of the recognition sequence releases the quencher, which diffuses 
away from the fluorophore leading to a measurable change in fluorescence. Changes in 
fluorescence observed when using these probes are detected and quantified by plate 
reader, fluorescence microscopy or in vivo imaging, (Figure 5).40 
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Figure 5. Substrate based protease detection via FRET. 
Examples of Bioluminescence resonance energy transfer (BRET) probes using similar 
recognition sequence arrangements have also been demonstrated, as well as colour 
changing gold nanoparticle-based probes.51,52 Substrate based probes are not only limited 
to detection by fluorescence, other detection methods have also been demonstrated. For 
example, clinical varieties have been developed, an example of which is a probe 
containing a 19F trifluoromethoxybenzylamide with an accompanying Gd3+ chelator has 
been used for magnetic resonance imaging (MRI). The probe acts as an MRI contrast 
agent, in which the signal is minimal when intact due to quenching by the paramagnetic 
Gd3+ cation, but when cleaved this effect is lost and a strong MRI signal is observed.53 
Many other types of substrate-based probes also exist, but their general design 
characteristics are analogous to that of the discussed examples.  
The study of proteases using substrate-based probes benefits from several advantages 
over the use of other probe types. Their properties allow a diverse library of designs to be 
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created with few limitations. Any chemical group that can be bonded to an amide or 
carboxylic acid can be included in the structure allowing a near limitless range of 
possibilities. There have even been examples of genetically engineered substrate-based 
probes in which a FRET donor-acceptor fluorescent protein pair are attached to each end 
of the recognition sequence.54 Further advantages include the high signal to noise ratio 
achieved by substrate-based probes, in part due to the rapid signal increase produced as 
each enzyme is able to rapidly cleave multiple probes. This is in addition to their 
applicability to high throughput screening. With these advantages in mind, it is not 
surprising that fluorogenic probes of this type are frequently used for substrate specificity 
and inhibitor screening. This enables the design of selective inhibitors, activity-based 
probes, and the discovery of novel recognition sequences.55 Of course substrate-based 
probes are not without their limitations, the most prominent of which is the difficulty in 
distinguishing which specific protease is responsible for substrate cleavage. This 
information can only be deduced using some prior knowledge of substrate specificity of 
the protease in question. Another minor disadvantage is that after cleavage, diffusion of 
the reporter leads to a blurred signal, which complicates location or isolation of the 
protease of interest, if indeed this is required.49 The simplicity and flexibility of substrate-
based probes lends itself to ever more ingenious designs limited only by the ever-
expanding synthetic toolkit available, and the imagination of the designer.  
1.3.4 Activity Based Probes 
The third form of protease detectors are the so-called activity-based probes. These differ 
from the other two in that when activated, they bond covalently and irreversibly to the 
target protease. This covalent bond is the result of either electrophilic attack from a 
nucleophilic residue housed within the enzyme’s active site, or in some cases the action of 
a photoactivatable crosslinker which can bond to a non-catalytic residue in the active site. 
Activity based probes are composed of three parts, the reactive functional group from 
which the covalent bond to the enzyme is formed, the recognition sequence, and a 
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reporter which produces a signal to indicate activity. As with the other probe types, a 
recognition sequence is used to confer protease specificity so only catalytically active 
proteases are detected. Like substrate based probes, commonly a fluorophore is attached 
to the recognition sequence as the reporter, so as to produce a signal from which to 
gather activity information.43,44 Various detection methods have been utilised for activity-
based probes. These include the time consuming SDS-PAGE methodology, which may or 
may not be complimented with mass spectrometry, fluorescence microscopy and in vivo 
imaging techniques, as detailed in Figure 6. The covalent linkage between the probe and 
the target protease is considered an advantage of activity-based probes as it indicates the 
protease location and can aid isolation if this is required. Additionally, it may be able to 
indicate potential incorrect drug targeting as well as highlighting ancillary proteases in 
physiological processes.40,49 
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Figure 6. Fluorescently tagged activity-based probe, using an acyloxymethyketone electrophile for 
in vivo imaging and identification of target protease. 
 It should be well noted that the design of such probes would be near impossible without 
the prior knowledge gained through the use substrate-based probes (initial identification of 
individual proteases themselves, identification of their catalytic recognition sequences 
etc). Another disadvantage of activity-based probes is their requirement for the 
incorporation of a reactive electrophile or photo-crosslinker which, even with careful 
design produces significant/notable cross reactivity.56,57 This along with the total 
inactivation of the target protease upon binding could affect the physiological process in 
question and lead to non-representative results. In order to minimise the alteration of the 
studied biological process and their downstream compensatory mechanisms, only a small 
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percentage of the active enzyme is usually modified, which of course leads to weak 
signal.49,58 
1.4 Fluorescence 
1.4.1 The Fluorescence Process 
The process of fluorescence results from three stages which can occur in certain types of 
molecules that possess certain characteristics. These include but are not limited to poly-
aromatic hydrocarbons, heterocycles and mixed molecules which show extended 
conjugation. Some form of extended conjugation is generally a requirement for a molecule 
to exhibit fluorescence. This is due to the electrons occupying the extended molecular 
orbitals being of similar energy to the photon energy associated with that particular 
fluorescence process. Molecules which exhibit fluorescence are known as fluorophores, 
and often share similar characteristics to coloured molecules known as chromophores. 
Fluorescent probes often consist of a fluorophore linked to another moiety, designed to 
show varying fluorescence characteristics which respond to specific stimulus, or localise 
to a particular area of interest in an analytical sample.59 
The three key stages of fluorescence and the associated electronic transitions of the 
fluorophore may be explained with the aid of a Jablonski diagram, Figure 7.59 
 
Figure 7. A simplified Jablonski diagram showing the stages of the fluorescence process. 
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A fluorophore absorbs a photon of energy hνex, the energy of this incident photon matches 
the gap between the ground singlet electronic state (So) and the excited singlet electronic 
state (S1’) to which the electron is promoted. This photon is usually provided by either an 
incandescent lamp or laser of the correct wavelength. Following excitation, the electron 
remains in the (S1’) state for a finite period or lifetime (τ), usually in the region of 1-10 ns. 
In this time energy is lost through conformational changes taking in place in the 
fluorophore as well as rapid reorganisation of solvent molecules and other interactions 
around the modified dipole of the conformationally changed fluorophore. This result of this 
energy loss is the reversion of the fluorophore to a relaxed singlet excited state (S1), it is 
this state from which emission of a photon of hνem and fluorescence occurs. An important 
point to note is that not all the excited molecules relax back to their ground state by 
emission of a photon, several other competing processes also act to depopulate the S1 
state. These other processes allow the fluorophore to return to its ground state through 
non-radiative means such as collisional quenching, bond rotation, photoinduced electron 
transfer (PeT) or Fluorescence resonance energy transfer (FRET) to an acceptor 
molecule. An additional possibility is intersystem crossing achieved via a spin inversion of 
the excited electron to yield an excited triplet state (T1). Photon emission is also possible 
from the T1 state, however the lifetime of this excited state tends to be significantly longer 
and the emission wavelength also longer, as a result of this emission from T1 is termed 
phosphorescence.  
Upon emission of a photon hνem through fluorescence or phosphorescence, the 
fluorophore returns to its ground electronic state (So) and the sequence may begin again. 
As a result of the energy dissipated during the lifetime of the exited state, the energy of 
the photon hνem is lower than that of the incident photon hνex and consequently of longer 
wavelength. The difference between the energy of the incident and emitted photon (hνex - 
hνem) is known as the Stokes shift. This shift is significant for the sensitivity and 
subsequent usefulness of the fluorophore as it defines the gap between excitation and 
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emission photons. This is important for the ease of detection of the emitted photon against 
a low background and in isolation from the excitation photon. 
A number of key properties of a fluorophore arise from the aforementioned sequence. The 
Stokes shift mentioned previously denotes the difference between energy of excitation 
(hνex) and emission (hνem), a general rule states hνex > hνem under normal circumstances. 
Multiphoton absorption is however possible, whereby two or more photons are absorbed 
simultaneously leading to hνex < hνem. The fluorescence quantum yield (Φ), is a measure 
of the quotient of photons absorbed to those re-emitted as fluorescence and is a direct 
indication of the efficiency of the fluorescence process. In addition to these the extinction 
coefficient (ε) is a measure of how strongly the molecule absorbs light of a particular 
wavelength, per unit concentration. Excited state lifetime (τ), is the average time between 
absorption and emission and is an important property, it is dependent on the relative rates 
of fluorescence and other competing non-radiative processes. Finally, a useful measure of 
fluorophore brightness is derived from the product of ε and Φ, this provides a relative 
comparison of photon yield between differing fluorophores under the same incident light 
intensity.59,60  
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1.5 Key Fluorophores 
The study of fluorescence has been ongoing for more than 100 years, and to date a huge 
number of fluorophores have been classified. However, a large proportion of these are 
derivatives of but a few main classes which have enjoyed the most widespread use. 
These broadly fall into six important classes, which are most commonly used as probes 
for chemical or biological detection. The six main classes, along with their prototypical 
structures and corresponding optical properties are shown in Table 2, and will be 
discussed briefly below. 
 
Table 2. The key fluorophore structures, classes and spectral properties.60,61,62,63,64,65,66,67,68,69,70 
 
Structure Name λabs (nm) λem (nm) ε (M-1/cm-1) Φ Ref
Coumarins 360 450 1.7 x 104 0.63 154
BODIPYs 505 516 9.1 x 104 0.80 153
155
156
Phenoxazines 572 585 5.6 x 104 0.74 157
Cyanines 554 568 1.3 x 105 0.14 158
159
160
Fluoresceins 491 510 9.0 x 104 0.86 161
Rhodamines 498 521 6.8 x 104 0.98 162
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1.5.1 Coumarins 
Coumarin is one of the most common and widely used fluorescent molecules seen in 
organic chemistry. The unsubstituted parent coumarin structure is traditionally modified at 
the 7-position (Figure 8 arrowed) with electron donating heteroatoms in order to produce 
molecules showing strong fluorescence. The most common modifications include addition 
of a hydroxyl or amine group to yield 7-hydroxy-4-methyl-coumarin (4-
methylumbelliferone, 4-MU, 2) or 7-amino-4-methyl-coumarin (7-aminomethylcoumarin, 
AMC, 1), as per Figure 8. 
 
Figure 8. 7-Aminomethylcoumarin (AMC, 1) and 4-Methylumbeliferone (4-MU, 2). 
Due to the ease with which coumarins may be chemically bonded to other molecules via 
either their hydroxyl or amine groups, many fluorogenic probes, labels and enzyme 
substrates exist, some dating back many decades.71 The fluorescence properties of 
hydroxy coumarins are moderately sensitive to pH due to the relatively low pKa of 7.8 of 
their hydroxyl group. This property may be modified via attachment of electron 
withdrawing groups such as halogens, these act to decrease delocalised electron density 
and lower the pKa of the hydroxyl group, thus reducing pH sensitivity.72 Amino coumarin 
conjugates see frequent use as enzyme substrates, especially proteases enzymes as a 
result of their ability to form amide bonds to peptides. They do not suffer from the same 
pH sensitivity as their hydroxy analogues which broadens their usability. Amino coumarin 
derivatives such as compound 14 (Figure 10) (λex/λem = 380/444 nm, ε = 1.8 x 104 M-1cm-1) 
which contains a carboxyl linker, grants it the ability to act as a substrate for lipoic acid 
ligase. This then further enables the molecule to fluorescently label specific proteins which 
contain the corresponding short peptide recognition sequence.73  
ONH2 O OOH O
AMC 4-MU
1 2 
7 7 
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Acylation of the amino group of the amino coumarins results in a hypsochromic shift and 
drop in quantum yield. This comes about due to lowering of conjugated electron density 
and the increased possibility of shedding excess energy through non-radiative means. 
This property grants the fluorophore the useful ability to act as a fluorogenic enzyme 
substrate.74 Conversely, alkylation of the amine group results in a bathochromic shift due 
to the increase in electron density from the positive inductive effect of the alkyl group. 
Molecule 17 (Figure 11) shows comparatively long absorption and emission maxima for a 
probe of this type (λex/λem = 444/514 nm).75  
 
Figure 9. The Pechmann condensation to produce the core fluorescent coumarins. 
The synthesis of coumarins commonly proceeds via a Pechmann condensation of a 
phenol with a β-carbonyl ester under acid catalysis.76 Synthesis of the typical coumarin, 4-
MU 2, involves the addition of resorcinol 8 to ethyl acetoacetate 9, (Figure 9).  The 
reaction gives high yields when producing 7-hydroxy coumarins or N-acylated 7-amino 
coumarins. However, synthesis of unprotected amino coumarins is difficult and usually 
requires protection of the aniline group for good yields, acylation is often used for this 
purpose.77 A more up to date route to 7-aminocoumarins utilises palladium catalysed 
Buchwald-Hartwig cross coupling to convert 7-hydroxy coumarins into the analogous 
amino coumarin. In this reaction the coumarin is converted into the triflate, coupled with 
an imine, and then  subjected to acid catalysed hydrolysis to yield the required 7-
aminocoumarin in reputedly good yield.78  
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Figure 10. Conversion of a triflate functionalised hydroxy coumarin 12 to the corresponding amino 
coumarin 14. 
In addition to this, the coumarin core may be produced through a Knoevenagel 
condensation of a 2-formylphenol and a β-substituted carboxylic acid or ester of choice. 
This route has the advantage that it may be used on multi functionalised molecules 
without experiencing significant side reactivity.79  
 
Figure 11. Preparation of functionalised coumarin 17 via a Knoevenagel condensation. 
It is clear that the utility of coumarins as fluorescent labels, probes and fluorogenic 
substrates cannot be overstated. In light of the ability to modify their spectral properties 
via structural changes they have enjoyed wide use in synthetic chemistry and chemical 
biology; they are not however, without their drawbacks. The relatively low quantum yields, 
and predominantly short wavelengths of excitation and emission reduce their usefulness 
in live imaging and when probing deeper into samples. This is, in part, due to the 
damaging effects of shorter wavelength irradiation as well as autofluorescence, coupled 
with the relatively high intensity of light required to produce good signal to background 
ratios. 
1.5.2 BODIPYs 
This fluorophore class consists of a boron dipyrrolmethene core skeleton from which the 
abbreviated name is derived, although the full IUPAC name of the core is 4,4-difluoro-4-
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bora-3a,4a-diaza-s-indacene 18. Again, these enjoy widespread use in synthetic 
chemistry and are noted for their versatility, as a result of their favourable spectral 
properties: They have an exceptionally short Stokes shift, a net neutral charge, very high 
quantum yield in a wide range of solvents including water, sharp excitation and emission 
maxima and show little sensitivity to environmental changes. The insensitivity of their 
spectral characteristics to polarity changes is mainly attributed to their mutually orthogonal 
dipole moment and transition dipole.80,81 The simplest unfunctionalized BODIPY 18 
decomposes above -30 to -40 oC and consequently wasn’t synthesised until 2009. On the 
other hand, the tetramethyl BODIPY 3 and more complex versions are stable at room 
temperature and therefore readily available.82,83  
  
Figure 12. The simplest BODIPY core structure 18 and its stable tetramethyl analogue 3. 
The tetramethyl compound 3 and its derivatives exhibit a notably higher photostability than 
fluorescein.84 The BODIPY class has no exocyclic donor or acceptor groups, which is 
quite unusual for a useful fluorophore. This however endows it with the possibility of 
modification at almost any position in order to tailor its spectral characteristics. An 
example in which conjugation has been extended via addition of four aromatic groups, as 
well as replacement of the bridging carbon with a nitrogen is 22, (Figure 14). This 
compound is known as an aza-BODIPY due to replacement of the bridging carbon with 
nitrogen, it shows a large bathochromic shift in comparison with the parent compound, as 
well as a dramatic drop in quantum yield (λex/λem = 642/688 nm, Φ = 0.07).85 The 
extension of conjugation acts to lower the energy of the HOMO, and the extra substituents 
allow the depopulation of the excited electronic state via non radiative means. 
Furthermore, even the boron ligands may be substituted, another example of which 
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bridges and incorporates the previously added phenol substituents of 23. This further 
extends conjugation leading to an additional bathochromic shift, while the added 
rigidification significantly increases the quantum yield (λex/λem = 728/746 nm, Φ = 0.51).85  
The historic synthesis of the tetramethyl BODIPY core 3 relied on an analogue of the 
Vilsmeier-Haack reaction. It is initiated by condensation of dimethyl-pyrrole 20 with 2-
formyl-3,5-dimethylpyrrole 19 followed by BF3 treatment to complete the synthesis, (Figure 
13).62 The flexibility of this synthetic route invited the of production of numerous 
unsymmetrical BODIPY derivatives.  
 
Figure 13. The traditional Vilsmeier-Haack route to produce BODIPY dyes. 
Symmetrical versions of the dye are also obtainable through condensation of an aldehyde 
with two pyrrole equivalents. Through substitution of the aldehyde, the functionality of the 
bridging carbon may be modified for additional variation in spectral characteristics.86 
Furthermore, the so called nitrogen bridging aza-BODIPY dyes may also be created via in 
situ generation of the pyrrole rings.87 The aforementioned BODIPYs 22 and 23 may be 
synthesised from diarylpropanone starting material 21 through treatment with ammonium 
acetate, followed by BF3. Demethylation and incorporation of the phenol substituent into 
the boron system is achieved through treatment with BBr3 to produce 38.85  
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Figure 14.  Preparation of an aza-BODIPY dye 22, followed by ligand substitution of the boron 
centre to produce 23. 
The exceptional flexibility of the BODIPY core for modification and spectral tailoring has 
earned it significant interest from the synthetic community. Unsurprisingly, this has led to 
the production of numerous BODIPY based fluorophores with many and varied uses. 
BODIPYs have been used effective bioluminescence/fluorescence energy transfer 
(BRET/FRET) donors, reactive labels for certain species, as well as fluorogenic 
probes.88,89,90 However, some problems may occur due to the very small Stokes shift, 
which can lead to spectral overlap and self-absorbance. 
1.5.3 Phenoxazines 
Phenoxazines are an old class of fluorescent dye and possess a long and varied history in 
stains, laser dyes, and fluorescent probes.91,92 They exhibit high sensitivity to polarity and 
their surrounding environment, in light of this a derivative thereof comprises the core 
component of the pH indicator litmus.92 The phenoxazines possess a similar core to that 
of the xanthene based fluoresceins and rhodamines, albeit with a relative bathochromic 
spectral shift as a result of the oxazine nitrogen.  
The archetypal phenoxazine dye is known as resorufin 4 (Figure 15) and this compound 
shows favourable spectral characteristics when existing in its anionic form (λex/λem = 
572/585 nm, ε = 5.6 x 10-4 M-1cm-1 Φ = 0.74). The sensitivity to pH exhibited by this 
molecule is a factor to be taken into account however, as the pKa of the hydroxyl group is 
5.8.64 Resorufin 4 and other variants of this core structure show strong fluorescence 
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quenching effects when the hydroxyl group is either alkylated or acylated, this effect is 
also accompanied by a moderate hypsochromic shift. This property makes resorufin 4 and 
its analogues a useful core for fluorogenic enzyme substrates and labels.93,94 Resorufin 4 
also shows redox active spectral properties, which allow it to act as a redox probe for 
peroxidases as a result of the lack of fluorescence of its oxidised and reduced forms.95  
Spectral characteristics of this class may be further modified through incorporation of 
other groups into the core, such as fused benzo rings or exocyclic alkyl amino groups 
which extend conjugation. Also, replacement of the oxazine oxygen with other atoms 
elicits further spectral changes. An exemplar of the changes such modifications produces 
results in the Nile red fluorophore 27 (Figure 15). The extended conjugation of this 
molecule causes a bathochromic shift compared to the parent compound when in 
aqueous solution (λex/λem = 523/565 nm). It is however sensitive to polarity, and a 
hypsochromic shift is observed when in non-polar solvents such as xylene, and this is 
accompanied by a 100 fold increase in fluorescence quantum yield. This polarity 
dependent spectral shift allows the molecule to be utilised as a lipid stain for live cell 
imaging, or visualisation of cell membranes in microscopy.96,97 Replacement of the 
phenoxazine oxygen with a geminal-dimethyl group and addition of two chlorine atoms to 
the quinone ring system produces the compound 7-hydroxy-9H-(1,3-dichloro-9,9-
dimethylacridin-2-one) known as DDAO 30 (λex/λem = 646/659 nm, ε = 5.6 x104 M-1cm-1, 
pKa = 5.0) (Figure 16). Derivatives of this compound have been demonstrated as 
substrates for aryl sulfatases, β-galactosidases, and as a caged fluorophore system.98,99 
As before, alkylation of the phenolic hydroxyl produces a dramatic change in fluorescence 
which lends itself to these applications. 
Traditionally, the synthesis of phenoxazines proceeds through the acidic condensation of 
phenols with nitrosylated aromatics. The prototypical phenoxazine resorufin 4 is produced 
in this way, via condensation of resorcinol 8 with 4-nitrosoresorcinol 24 in H2SO4.100 Nile 
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red 27 is produced in the same way, via reaction of 1-naphthol 26 and  substituted 3-
aminophenol 25.91  
 
Figure 15. Acid mediated condensation route to the phenoxazines: resorufin 4 and Nile red 27. 
Other routes are however possible, DDAO 30 is synthesised by treatment of phenol 28 
and chloramine 29 with base, reduced, condensed with acid and finally oxidised to yield 
the product 30, (Figure 16).98 
 
Figure 16. Synthesis of phenoxazine analogue DDAO 30 via an alternative route. 
The number of steps required in this synthesis somewhat limits its applicability and 
therefore lends itself to further innovation to simplify its production. 
1.5.4 Cyanines 
The cyanines are a class of fluorescent dye that conform to the general structure R2N-
(CH=CH)n-CH=NR2+ and as such are a diverse group. They generally exhibit a large 
extinction coefficient, are resistant to photobleaching and enjoy good absorption and 
emission tunability through structural modification. They have only relatively recently 
Figure 32. Acid mediated synthesis of the simple phenoxazines resorufin and Nile red 
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(1993) had their usability expanded significantly, through development of structural 
hybrids. This development has led to advances in their utility as a result of the invention of 
the so called CyDyes. These are indocarbocyanine sulfonates, an example of which is 
Cy3 5 (λex/λem = 554/568 nm, ε = 1.3 x105 M-1cm-1 Φ =0.14). The sulfonate group imparts 
greater solubility to the dye, this along with further functionalisation has provided handles 
for bioconjugation and labelling of proteins and nucleic acids.66,101 As well as their 
somewhat limited applications as stains for cell membranes and DNA.102,103 The 
practicality of the CyDyes stems from the fact the excitation and emission maxima may be 
tailored simply by extension of the central polymethine chain. Extension of this chain 
produces a bathochromic in both excitation and emission wavelengths. The numerical 
suffix of the CyDye nomenclature corresponds to the number of carbon atoms in the 
central chain (Figure 17).67 
 
Figure 17. CyDyes, notable for their increase in λex/λem with central chain length. 
Not unlike the BODIPY class’s core structure, the cyanines contain no exocyclic donor or 
acceptor groups, this somewhat limits their usefulness as strategies for modifying the 
spectral characteristics seen in other fluorophores are not applicable. Methods have 
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however been developed to partially overcome this limitation and these involve the fusion 
of the cyanine with another class of fluorophore such as rhodamine. An example of this 
fusion is 37 (Figure 19) and the joining of the two leads to an excitation maximum at 
longer wavelength with decent fluorescence properties (λex/λem = 720/750 nm, ε = 1.25 
x105 M-1cm-1 Φ = 0.30). Other combinations of fluorophore also exist such as cyanine-
fluorescein and cyanine-coumarin both of which allow modification of their spectral 
properties through functionalisation of the non-cyanine structure.104,105,106  
Generally the synthetic route used to produce the cyanines involves addition of an 
aldehyde equivalent to an activated carbon species like a 2-alkylindolinium salt.107 For 
example the Cy3 dye 5 is produced in this manner through condensation of the indolinium 
salt 33 with triethyl orthoformate 34, to yield the product (Figure 18).101 
 
Figure 18. Synthetic route to cyanine 5 from an alkylindolinium salt 33 combined with triethyl 
orthoformate 34. 
Chromenylium compound 35 may also be fused with aldehydic cyanine precursor 36 in an 
analogous manner to form a hybrid fluorophore 37 with enhanced tunability (Figure 19). 
Substitution of the chromenylium portion enables generation of various hybrid structures 
with properties tailorable for desirability.108 
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Figure 19. Fusion of cyanines with other fluorophores results in enhanced tunability of spectral 
characteristics. 
Most commonly the cyanine fluorophores are used as fluorogenic labels or stains for 
targeting nucleic acids or proteins, showing a large fluorescence increase upon binding.63 
They have also been found to be useful in several other applications including pH sensing 
fluorescent indicators, and as FRET donor-acceptor pairs wherein two different cyanine 
dyes are bound together by a targeted cleavable linker.109,110  
1.5.5 Fluoresceins 
Fluorescein 6 is one of the oldest synthetic fluorophores, having been first synthesised in 
1871 by Adolf von Bayer.111 It does however remain one of the most commonly used 
fluorophores with countless applications in medicine, industry and science. The phenolic 
hydroxyl of fluorescein is moderately acidic with a pKa of 6.4. The compound is most 
fluorescent in its dianionic form and is commonly used for fluorescence detection (λex/λem 
= 491/510 nm, ε = 9.0 x 104 M-1cm-1 Φ = 0.86).112 The fluorescence profile of fluorescein is 
pH sensitive because of its relatively low pKa, however, addition of electron withdrawing 
substituents such as halogens to the phenolic rings lowers its pKa decreasing its pH 
sensitivity and enhancing photostability.113 Fluorescein 6 exists in an equilibrium between 
a non-fluorescent closed lactone form and an open highly fluorescent form, Figure 20.  
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Figure 20. Fluorescein 6 exists in equilibrium between a non-fluorescent (left) and several 
fluorescent forms (right, far right). 
This equilibrium may be modified through functionalisation of the phenolic hydroxyl 
groups. This acts to lock the molecule into the non-fluorescent closed lactone form. The 
ability to lock the molecule into the non-fluorescent through functionalisation allows useful 
fluorogenic enzyme probes to be produced.114 These develop a large increase in 
fluorescence upon enzymic cleavage and release of the fluorophore which contributes to 
an excellent signal to background ratio. 
The brightness of fluorescein is relatively easy to modify through simple changes to its 
structure, however the excitation and emission maxima are more difficult to adjust without 
subsequent loss in fluorescence intensity. Rose Bengal 38 is an example of this drop in 
intensity after modification. The molecule also shows a bathochromic shift compared to 
the parent compound, most tellingly this shift is accompanied by a large decrease in 
quantum yield (λex/λem = 548/566 nm, Φ = 0.018).115 Bathochromically shifted fluoresceins 
have, however, been produced for use as labels, achieved through the fusion of additional 
rings and extension of the lower phenolic ring systems (Figure 21).116 These extended 
molecules were coined seminaphtho- 39 and naphthofluoresceins 40, and have found 
application as fluorescent indicators and cellular stains.117,118,119,120  
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Figure 21. Addition of substituents and extension of conjugation produces bathochromic shifts, as 
well as variation in fluorescence quantum yield. 
In addition to this, modification to the core xanthene moiety of fluorescein 6 has been 
shown to effectively change the spectral characteristics, Figure 24. For example, 
replacement of the xanthene oxygen with a geminal dimethyl group produces a 
carbofluorescein 45 which shows a bathochromic shift compared to the parent compound 
(λex/λem = 544/567 nm, ε = 1.08 x 105 M-1cm-1 Φ = 0.62), along with a pKa of 7.4.68 
Furthermore, replacement of the aforementioned oxygen with a dimethylsilyl group 
produces silafluorescein 47, which exhibit an even larger bathochromic shift (λex/λem = 
582/598 nm, ε = 1.1 x 105 M-1cm-1 Φ = 0.42).121  
Historically, the synthesis of fluorescein has involved the condensation of resorcinol 8 with 
phthalic anhydride 41 in a melt of ZnCl2 at 180 oC, or in a neat acid such as CH3SO3H at 
lower temperatures around 85 oC, Figure 22.111,112,113 
 
Figure 22. Traditional condensation routes to fluorescein 6 require harsh conditions. 
The use of nitro or carboxy substituted phthalic anhydrides results in the production of 
fluoresceins substituted on the upper ring. These substitutions are useful as 
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bioconjugation handles, however a mixture of isomers is formed (Figure 23) and these 
require separation. This is usually attempted via derivatisation and subsequent 
crystallisation.112,113  
 
Figure 23. Substituted phthalic anhydrides produce a difficult to separate mixture of substituted 
fluorescein isomers. 
The carbo- 44 and silafluorescein 47 (Figure 24) cannot be produced through the same 
acid mediated method as the parent compound. They are instead synthesised through the 
addition of an organometallic aryl group to a benzophenone derivative. For example 
carbofluorescein 44 is produced through the addition of a Grignard reagent 43 to a 
protected anthracene derivative 42, which upon deprotection yields the required 
compound.68 Similarly, silafluorescein 47 is produced through the addition of an aryl 
lithium 46 to protected silanone 45.121 These reactions produce only single isomers 
(Figure 24), however the protection of ancillary groups must be robust and this can be a 
limiting factor. 
 
O
O O
R
OH
OH
OOH O
CO2H
R
+
OOH O
CO2H
R
+
Figure 40. Substituted phthalic anhydrides produce a difficult to separate mixture of isomers.
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Figure 24. Carbo- 44 and silafluoresceins 47 may be produced as single isomers from addition of 
organometallics, as long as suitable protection of other functionality is available. 
The usefulness of the fluoresceins stems from the augmentation of the open-closed 
equilibrium through simple functionalisation of the phenolic oxygens via alkyl- or acylation. 
As the removal of these groups via enzymic or other cleavage results in a large increase 
in fluorescence, a broad variety of possibilities for fluorogenic enzyme probes, sensors, 
and photoactivatable dyes exists. 122,123,124  
It is unsurprising that fluorescein continues to be the subject of extensive research with 
further structural modifications yielding new and useful compounds for a myriad of 
applications. The production of bathochromically shifted fluoresceins with good brightness 
has provided the basis for a number of new and useful ion indicators and enzyme 
substrates.121,125 There is, as always, scope for further development and no doubt many 
more improvements and advances will be seen as research continues.60 
1.5.6 Rhodamines 
Rhodamines are another older class of fluorophore similar to fluorescein 6, the first 
synthesis of which was recorded as far back as the 1880s. These fluorophores are 
essentially the amino analogue of fluorescein 6, they do however have a number of 
advantages over fluorescein 6, including lower pH sensitivity, better photostability and 
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improved tunability. The prototypical rhodamine, suforhodamine B 50 (Figure 25), was first 
described in a patent dating back to 1887.126 This fluorophore strongly absorbs in the 
green region with a strong emission in the yellow region (λex/λem = 565/586 nm, ε = 8.4 x 
104 M-1cm-1 Φ = 0.45).63 Rhodamine 50 has frequently been used as a laser dye, and its 
sufonyl chloride counterparts are commonly used to label amino containing molecules. 
Tetramethyl rhodamines 53 (Figure 25) are another example of conjugatable rhodamines, 
which are attached by the second carboxyl group of the upper ring system to 
biomolecules or ion sensing groups.127 The structural change from sulfonate to 
carboxylate produces a weak hypsochromic shift in both the excitation and emission 
maxima (λex/λem = 548/572 nm, ε = 7.8 x 104 M-1cm-1).68  
 
Figure 25 Synthesis of sulforhodamine B 50 and tetramethylrhodamine 53. 
Variation of the amine substituents in rhodamines also produces variations in the spectral 
properties of the dye. A hypsochromic shift is observed from the non-alkylated rhodamine 
110 7 when compared to its tetramethyl counterpart 53, rendering it spectrally similar to 
fluorescein (λex/λem = 496/517 nm, ε = 7.4 x 104 M-1cm-1 Φ = 0.88).68,69,70,128 The ability to 
conjugate peptides and other biomolecules to the available amine groups of rhodamine 
110 7 has led to its common use as a fluorescent label.129 Rhodamine 110 7 is also widely 
used as a core for fluorogenic probes and detectors. Similarly to fluorescein 6, the 
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molecule exists in equilibrium between a non-fluorescent closed lactone form and several 
highly fluorescent quinoid forms. This equilibrium may be forced towards the closed and 
non-fluorescent form via acylation of the amine groups. Subsequent removal of the acyl 
groups via enzymic cleavage or other means produces a large increase in fluorescence. 
This highly exploitable property has led to many fluorogenic derivatives which have 
proven useful for the detection of enzymic activity, as well as activity measurement labels 
in fluorescence microscopy.122,130,131  
 
Figure 26. Rhodamine 110 7 exists in equilibrium between a closed, non-fluorescent lactone form 
(left), and fluorescent quinoid forms (centre, right). 
Further modification of the rhodamine core through substitution of the xanthene oxygen 
with atoms such as carbon, silicon, germanium and tellurium has also been shown to vary 
its spectral properties.68,132,133 Substitution for carbon yields carborhodamines, the 
simplest of which exhibits a bathochromic shift compared to the parent compound (λex/λem 
= 552/577 nm, ε = 6.5 x 104 M-1cm-1 Φ = 0.64).68 Larger bathochromic shifts may be 
produced through substitution of the xanthene oxygen with silicon, to produce 
silarhodamine 60 (λex/λem = 691/712 nm, ε = 1.0 x 105 M-1cm-1 Φ = 0.12) (Figure 28). This 
shift brings the excitation and emission maxima close to the infrared region and creates a 
useful core for the production of compounds for in vivo imaging.134  
The initial synthesis of sulforhodamine 50 involved an acid catalysed condensation of  
benzaldehyde 49 with aminophenol 48, followed by FeCl3 mediated oxidation (Figure 
25).126 The standard carboxy rhodamines, bearing an additional o-carboxyl group on their 
upper ring may be produced through condensation of a phthalic anhydride with two 
equivalents of a substituted 3-aminophenol. An example is the production of 53 which is 
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generated as an isomeric mix of the 5/6-carboxy- analogue by condensation of two 
equivalents 3-(dimethylamino)phenol 52 with trimellitic anhydride 51 in ZnCl2 (Figure 
25).127 An alternative set of conditions which have proved successful involves dissolution 
of the two starting materials in propionic acid with a catalytic quantity of TsOH.122  
Production of rhodamines through the aforementioned condensation route has a number 
of notable disadvantages. The use of substituted phthalic anhydrides leads to the 
production of a mixture of difficult to separate isomers, which require complex and time-
consuming separation to yield any single isomer. Although single isomers are 
commercially available, they are prohibitively expensive for most applications. In addition, 
the limited availability of 3-aminophenol derivatives can also prove problematic. 
Furthermore, the strongly acidic conditions used for the condensation are not well 
tolerated by many functional groups, and this further limits the applicability of this route. 
An example of some of the problems encountered is shown when using the condensation 
route for the synthesis of 5-carboxyrhodamine 110 53. Although its production is possible 
via this route, not only a mixture of isomers is formed but hydrolysis of the product to 
rhodols and fluoresceins is also observed, significantly complicating the purification.135  
After much research into the synthesis of rhodamines a number of alternatives to the 
condensation have proven viable. One such strategy converts fluoresceins into 
rhodamines via conversion to triflates, followed by a Buchwald-Hartwig cross coupling to 
yield the corresponding rhodamine. For example, the single isomer 5-carboxyrhodamine 
110 53 may be generated from the t-butyl protected 5-carboxyfluorescein triflate 55 
followed by deprotection (Figure 27). This approach simplifies the production of such 
single isomers and even allows the synthesis of N-aryl and N-acyl rhodamines. This 
useful transformation also circumvents the difficulty of acylating rhodamines in light of the 
low reactivity of the aniline nitrogen of rhodamine.136 Carbofluoresceins have been 
successfully converted into carborhodamines using this same method, giving rise a 
diverse collection of bathochromically shifted rhodamines.68 
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Figure 27. Buckwald-Hartwig cross coupling of a triflate functionalised carboxy fluorescein 55 
produces a single isomer of carboxy rhodamine 53. 
One other successful method has applied organometallic compounds to add to N-tetra 
alkylated xanthones, to generate a variety of other rhodamines.137,138 Silarhodamine 60 
was successfully synthesised from addition of organolithium 59 to the xanthone analogue 
diaminosilanone 58, yielding the product 60 after amine deprotection (Figure 28).60 
 
Figure 28. Production of silarhodamine 60 from addition of an organolithium. 
As a result of the improved customisability of the rhodamine core over its counterparts, it 
is not surprising that rhodamines remain the most useful of all the fluorophores. Their 
application for the production of fluorescent probes and labels is unrivalled, with the 
implementation of carbo and silarhodamines significantly advancing probe and label 
based imaging capabilities in vivo.68,133,134,138 Combinatorial libraries are now accessible 
and enable tuning of probes to specific biological targets.139 Along with this, 
photoactivatable rhodamines have also been developed, and the carborhodamines have 
proven useful in super-resolution microscopy.122 
As the understanding of the factors controlling the open/closed equilibrium of rhodamine 
has deepened, as has their usefulness and applicability to new and improved applications. 
The carbo- and silarhodamines shift this equilibrium towards the closed form which 
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reduces their overall brightness. There is however a concurrent increase in cell 
permeability as a result of the higher contribution from the reduced polarity closed 
form.68,138 Alongside this it has been found that modification of the upper ortho substituent 
also effects the equilibrium. Substitutions of this group have allowed production of lactam 
based photoactivatable fluorophores as well as various sensors.140,141,142 There is still 
room for advancement of the properties of this class of fluorophore, and as research 
continues it is inevitable that these will be made. 
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1.6 Aims 
This research project set out to re-synthesis the S. aureus probe LGX for further testing 
both in-house at Kingston University and externally as part of its development as a next 
generation point of care test for the microorganism. Following this the synthesis was to be 
re-examined and improved upon in order to facilitate the synthetic scale up required in 
order to be produced on a larger scale industrially. Having achieved this, further down the 
line it was the responsibility of the writer to investigate routes to new fluorophores. This 
investigation would allow not only allow the production of novel fluorophores of value to 
the synthetic community, but facilitate the development of new protease probes. Having 
synthesised a small library of novel fluorophores, the most promising candidate would be 
put forward for production of a next generation S. aureus probe with desirable features 
such as a simplified synthesis and improved sensitivity. 
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2.1 LGX Synthesis and Scale Up 
2.1.1 Construction of the Boc-Val-Pro-OH Section of the Biomimetic Peptide 
LGX was a Staphylococcus aureus probe previously developed by the Le Gresley lab with 
high sensitivity and proven efficacy in detection of the bacteria. Its effectiveness was 
based upon targeting a bacterial protease expressed by 95 % of the bacteria in 
question.70 Previous syntheses of the compound were met with difficulty and its 
production was notably of low yield (~1.8 %). 
 
Figure 29. The active compound in the fluorogenic S. aureus probe LGX 61. 
The exploratory synthesis and scale up of LGX 61 commenced with the coupling of 
protected amino acid Boc-NH-Val-OH 62 with HN-Pro-OMe 63 for production of part of the 
biomimetic tripeptide Boc-NH-Val-Pro-OMe 64. Commercially available protected amino 
acids 62 and 63 were obtained, and solution phase peptide coupling undertaken. A range 
of conditions were tested in order to ascertain the most effective route to the dipeptide. 
The dipeptide Boc-NH-Val-Pro-OMe 64 would later be required in significant quantities to 
allow optimisation of the synthetic route.  
 
Figure 30. Generation of the dipeptide Boc-Val-Pro-OMe 64 using COMU 67. 
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Previous work had produced the dipeptide in moderate yields using solution phase 
peptide coupling techniques with the coupling agent 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDCI) 65, and the additive ethyl 
cyanohydroxyiminoacetate (Oxyma) 66 to suppress racemisation in the presence of 
triethylamine (TEA) base.70  
 
Figure 31. Coupling agent EDCI 65, additive Oxyma 66, and coupling agent COMU 67. 
This route was found to produce yields of around 50 %; improvements were achieved by 
substitution of EDCI 65 with (1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-
morpholino-carbeniumhexafluorophosphate (COMU 67) which improved yields to a 
consistent 60 - 70 %.  
2.1.2 Attachment of Boc-Arg(Cbz)2-OH to Rhodamine 110 
Having improved the synthetic route and produced sufficient quantities of the protected 
dipeptide, attention was directed toward the coupling of rhodamine 110 7 with the 
protected arginine, HO-(Arg(Cbz)2-NHBoc)2 68.  
 
Figure 32.  Coupling of protected arginine 68 with rhodamine 110 7 using coupling agent (CA) to 
form the rhodamine bis-acylate, Rho-(Arg(Cbz)2-NHBoc)2 69. 
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Both rhodamine 110 7 and the protected arginine 68 were obtained commercially; 
rhodamine as the HCl salt and arginine with NH t-butoxycarbamate (Boc-) protection and 
double side chain carboxybenzyl (Cbz-) protection, (Figure 32). Initial coupling attempts 
followed that of previous work: solution phase peptide synthesis with EDCI 65 in 
combination with Oxyma 66 in the presence of TEA base. These coupling conditions 
proved ineffective, producing complex intractable mixtures in all instances. Numerous 
variations in the number of coupling agent and base equivalents were tested, along with 
both DMF and DCM as solvent choices. Other solvents were unable to dissolve the 
reagents and only the activated amino acid was found to dissolve in DCM. Numerous 
workup conditions were also tested in tandem on each reaction in order to ascertain the 
most effective. These test workups included copper sulphate washes for removal of 
uncoupled amine, as well as standard acid and base workup steps. Traditional flash 
column chromatography was employed for purification, using both gradient and isocratic 
mobile phases. After many trials of the aforementioned coupling conditions, they were 
ruled out as too inefficient with remarkably poor yields of only moderate purity. The 
quantities produced using these methods precluded continuation of the synthesis and so a 
more effective route was sought. 
Following the lack of success of the previous EDCI 65 based coupling route, attention was 
turned toward the previously successful coupling agent COMU 67 This reagent had 
recently garnered significant attention from the synthetic community due to its high 
efficiency in coupling hindered and bulky amino acids.143 In addition to the success 
reported by other researchers, it was rationalised that the improved water solubility of the 
COMU 67 by products may simplify workup. This would be advantageous as purification 
had been problematic when using EDCI 65 coupling route.  
The general coupling procedure optimised by the inventors of COMU 67 for solution 
phase was initially employed for synthesis.143 A similarly complex reaction mixture was 
observed upon TLC analysis, this was inferred to be a selection of mono, bis and other 
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variations of coupled products. It is worthy of note that as rhodamine 110 7 exists in 
equilibrium between at least three forms in solution, coupling is capricious. As a further 
complication each of these forms suffer from an intrinsic lack of NH2 nucleophilicity.144 The 
equilibrium consists of a colourless closed lactone form containing two anilino type NH2 
groups (Figure 33, left), a coloured open quinone form in which one of the amine groups 
exists as a zwitterionic iminium species (Figure 33, centre), and an open and coloured 
form in which one amine exists as an imine, (Figure 33, right). 
 
Figure 33. Solution equilibrium of rhodamine 110 7 and the effect on ring bound NH2 groups. 
Both open forms are significantly less reactive towards acylation as the nucleophilic 
electron pair is far less available. This effect is introduced not only due to a contraction of 
the outer orbital through rehybridization from sp3 to sp2, significantly increasing in s 
character, but also the reduction of availability through initial cationic iminium formation 
when converting from the anilino form. It is therefore likely that only the aniline form would 
possess the nucleophilicity required to undergo acylation to any appreciable extent. 
Furthermore, as the open forms are favoured in polar solvents, these effects, when 
combined with the low nucleophilicity of aniline groups especially when heavily 
conjugated, goes some way to explain the difficulty in bis acylation of rhodamine 110 7. A 
further noteworthy observation is that, in polar solvents such as those employed herein 
the solution is strongly fluorescent. 
Yet another complication associated with acylation of rhodamine 110 7, is that when the 
upper carboxylic acid group is exposed in the open forms, it is possible for it also to be 
activated by the coupling agent. This therefore enables rhodamine-rhodamine homo-
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coupling and polymerisation to compete with the intended coupling, as shown in Figure 
34. 
 
Figure 34. Possible side products through coupling agent activation of the upper carboxyl group of 
rhodamine, accessible from its open fluorescent forms. 
After consideration of the potential issues the nature of rhodamine 110 7 contributed to 
the synthesis of the bis-arginine intermediate, the complexities associated with arginine 
itself were also considered. It is common knowledge that arginine is one of the most 
problematic amino acids, not only due to its steric bulk, but also because of the guanidine 
group at the distal end of the side chain. As the guanidine moiety is reactive to both 
nucleophiles and electrophiles it is usually protected in peptide synthesis to avoid such 
side reactions. However, exhaustive Cbz- protection of the guanidine group of arginine is 
very difficult, and so double protection is usually the most robust available. Two main side 
reactions are associated with arginine, de-guanidination and δ-lactam formation.145,146  
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Figure 35. De-guanidination occurs following an Nω-acylation side reaction of a non-exhaustively 
protected guanidine group. The following deprotection step results in both de-guanidination of 
arginine to form ornithine and simultaneous liberation of the corresponding substituted imidazolone.  
 
Figure 36. δ – lactam formation from an activated arginine residue. Cyclisation forms the δ – 
lactam as a result of the latent nucleophilicity of the un-protected guanidyl δ – NH group. 
These side reactions (Figure 35 and 36) may be suppressed, but are rarely eliminated 
through side chain protection. One of the most effective protecting groups for minimisation 
of these side reactions has been found to be the carboxybenzyl group (Cbz).145 This 
protection was selected in light of this and a number of other factors. These included its 
high stability to both acid and basic conditions, permitting the orthogonal and acid labile 
Boc- protecting group to be removed without affecting it. Moreover, the simplicity of its 
removal via hydrogenation was the deciding factor, leading to its selection over others. 
This was because later in the synthesis when the molecule is large and complex, 
deprotection could be achieved very simply without further purification, vastly simplifying 
the final synthetic step. 
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Again, significant time was devoted to investigating COMU 67 as a coupling agent to 
produce Rho-(Arg(Cbz)2-NHBoc)2, 69. Initially the standard optimised procedure was 
adopted as with generation of the aforementioned dipeptide.143 Several small scale test 
reactions were initiated, with increasing numbers of arginine equivalents to investigate 
saturation effects on coupling efficiency. Careful TLC analysis revealed that as the 
number of arginine equivalents increased, as did reaction mixture complexity. This 
indicated a concurrent increase in side reactivity with arginine saturation. It was found that 
using only a slight excess in the region of 1.1 arginine equivalents per reaction site was 
the most effective reaction stoichiometry. This appeared to minimise the number of side 
reactions and facilitated the effective removal of unreacted arginine in reaction workup. 
Extension of reaction time up to 168 hours was also tested, however above 48 hours 
provided no advantage and in fact led to a more complex crude mixture. Modest 
recovered yields of around 8 % were achieved with COMU 67, consequently it was 
deemed necessary to continue investigation of the coupling procedure.  
 
Figure 37. Coupling agents EEDQ 71, PPh3Cl2 72, PyBOP 73 and HATU 74. 
Several other coupling agents were employed in order to enhance the efficiency of the 
coupling procedure. These were investigated through a selection of tandem reactions to 
screen the for applicability to this difficult coupling. The selection of coupling agents was 
influenced by their reported effectiveness in the promotion of difficult couplings.147 They 
included N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) 71, 
Dichlorotriphenylphosphorane (PPh2Cl2) 72 (benzotriazole-1-
ylxoy)tris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP) 73, and (1-
[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium-3-oxid 
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hexafluorophosphate (HATU) 74. Their effectiveness in promoting the coupling is shown 
in Table 3. 
 
 
 
 
 
 
Table 3. Coupling agents and their best isolated yields of Rho-(Arg(Cbz)2-NHBoc)2, 69. 
Notably, most coupling agents performed worse than COMU 67 in coupling arginine to 
rhodamine 110, with only PyBOP 73 approximately equalling the efficiency of COMU 67. 
However, HATU 74 was found to vastly increase the efficiency of coupling with a 
concurrent improvement in isolated yield. Moreover, the crude reaction mixture was found 
to contain fewer by products than that obtained with COMU 67 coupling, likely as a 
consequence of the higher reactivity of HATU 74 over COMU 67. Like most peptide 
coupling agents, the reaction pathway of both COMU 67 and HATU 74 is thought to 
essentially pass through the same stages. However, the final stage in the case of HATU 
74, in which the activated ester is attacked by the nucleophile, benefits from a 
neighbouring group effect not seen in COMU 67. This neighbouring group effect is 
brought about by the nitrogen lone pair of the azotriazole ester formed in the HATU 74 
coupling pathway as shown in Figure 38. The result is improvement of orientation of the 
incoming amine providing an improved and faster reaction pathway, leaving less time for 
side reactions to take place. It is believed that the improvement in yields and reduction of 
side reactions observed was a result of this effect. 
Coupling Reagent Isolated yield 
EEDQ 71 - 
PPh3Cl2 72 - 
EDCI 65 5 % 
PyBOP 73 8 % 
COMU 67 8 % 
HATU 74 25 % 
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Figure 38. Peptide coupling mechanism of HATU 74 and its improved efficiency facilitated by the 
neighbouring group effect. 
With a more effective coupling agent in hand, optimisation of the coupling procedure was 
undertaken. Varying quantities of coupling agent and amino acid were tested, again under 
the pretence that saturation of rhodamine with increasing numbers of arginine equivalents 
would increase efficiency. The rationale behind this was that increasing saturation with 
arginine would concurrently increase the probability of collision of mono-acylated 
rhodamine with the amino acid while in the minor anilino form, forming the bis-acyl. Once 
again this was found to be largely ineffective with increasingly complex mixtures observed 
via TLC as ratios of amino acid to rhodamine increased. Eventually it was determined that 
only a slight excess of amino acid, in the region of 1.1 - 1.2 equivalents per reaction site 
was most effective, similar to COMU 67.  
Attention was now directed at its purification, predictably this provided its own challenges. 
Flash column chromatography was employed, with a broad selection of mobile phases 
tested. These ranged from ethyl acetate/petroleum either to acetonitrile/DCM in an 
attempt to take full advantage of the eluotropic series. Perturbations in the order of elution 
N
N
N
N
O N
N
+
PF6
- O
–
O
NH-BocR
1
O
O
NH-Boc
R
1
N
N
+
N
N
N
N
O
–
O
O
NH-Boc
R
1
N
N
N
N
N
R
2
R
3
O
H
H
O
NN
H
+
+
OH
N
N
N N
O
NH-Boc
R
1
N
H
R
2
R
3
O
+
Stage 1. Initial activation of Amino acid Stage 2. Attack by –OAt to form active ester
Stage 3. Neighbouring group effect orientates 
incoming Amino acid facilitating its attack
Stage 4. Peptide chain is extended efficiently
Chapter 2 – Results and Discussion 
 
72 
 
of fractions of interest were observed upon substitution of mobile phase. Nevertheless, the 
complexity of the crude reaction mixture even after optimisation of workup precluded any 
noteworthy improvement to isolable yield.  
An explanation as to the problems encountered in purification is that compound of interest 
appeared to be unstable on silica. Decomposition from colourless, with only a 254 nm 
absorbance, to fluorescent yellow under both 254 and 365 nm irradiation was observed in 
only minutes via TLC. This was initially attributed to the moderate acidity of silica, which, 
in the presence of a nucleophilic solvent such as methanol may promote hydrolysis. As 
this effect appeared most swiftly in the presence of methanol, this solvent was substituted 
for one less nucleophilic. The decomposition was however also noted when using other 
non-nucleophilic solvent combinations such as ethyl acetate/hexane, albeit more slowly. 
To address the apparent silica facilitated de-acylation of rhodamine, TEA treated silica 
and both neutral and basic alumina were employed. Confoundingly, all of these appeared 
to produce the same effect to a more or less of an extent. Reverse phase techniques were 
then tested, but even these proved no more effective at quelling the apparent 
decomposition. After much investigation it was found that only mild degradation was seen 
when using a 3:7 ethyl acetate:chloroform mobile phase on untreated silica. These 
conditions allowed sufficient time for isolation, while providing a favourable loading 
capacity.  
Having optimised the coupling procedure and purification, isolated yields rose to 25 %, a 
more than three-fold improvement over those previously reported. As a result of this 
improvement, sufficient quantities for continuation of synthesis could now be produced, 
therefore the next synthetic step was addressed. 
2.1.3 Completing Attachment of the Biomimetic Tripeptide 
With sufficient quantities of Rho-(Arg(Cbz)2-NHBoc)2 69 in hand, Boc- deprotection of the 
parent compound was undertaken. This provided the di-amine Rho-(Arg(Cbz)2-NH2)2 75 
for the next stage of synthesis, coupling of 75 to Boc-NH-Val-Pro-OH 76. HATU 74 was 
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utilised with the optimised solution phase coupling procedure to generate Rho-(Arg(Cbz)2-
Pro-Val-NH-Boc)2 77.  
 
Figure 39. Coupling of Rhodamine-(Arg(Cbz)2-NH2)2 75 to Boc-Val-Pro-OH 76 mediated by HATU 
74, to produce Rhodamine-(Arg(Cbz)2-Pro-Val-NHBoc)2 77. 
This was achieved in consistently good yields of around 67 %. It was once again noted 
that the compound decomposed on silica similar to that seen with the parent compound 
Rho-(Arg(Cbz)2-NHBoc)2 69. As the current intermediate was of large molecular weight, a 
high polarity mobile phase was required for purification. To address this, as well as 
provide sufficient resolution, methanol/DCM mixtures were initially employed. These were 
found to be of limited use due to significant and rapid decomposition. After a number of 
TLC trials, it was determined that a pure ethyl acetate mobile phase provided sufficient 
polarity for separation, while minimising said decomposition. Employment of this mobile 
phase allowed sufficient quantities of the product Rho-(Arg(Cbz)2-Pro-Val-NHBoc)2 77 to 
be isolated effectively. An optimised synthetic route to the precursor 77 of the active LGX 
compound 61 had now been established, with improvements to both simplicity of 
synthesis and isolated yields. These improvements would facilitate further up scaling of 
production of the protected LGX precursor 77 in a proposed future industrial setting. 
Quantities of said precursor 77 could therefore be produced and stored in the desirable 
inactive form. Then, in theory when required, the less stable active compound 61 may 
simply be generated through Cbz- deprotection, needing no further purification! 
Following the successful synthesis of the active compound precursor, efforts were turned 
toward an efficient deprotection strategy. Conditions for guanidine Cbz deprotection of the 
of Rho-(Arg(Cbz)2-Pro-Val-NHBoc)2 77 were employed in light of the near quantitative 
O
O
O
N
H
N
H
OO
NH2NH2
NH
NN
H
NH
N
H
N
CbzCbz CbzCbz
O
N
H
O
O
N
O
OH
+
HATU, DIEA
DMF O
O
O
N
H
N
H
OO
NHNH
NH
N N
H
BocHN
N
O
O
NHBoc
N
O
O
NH
N
H
N
Cbz Cbz Cbz Cbz
75 76 77 
Chapter 2 – Results and Discussion 
 
74 
 
yields previously reported.70 Initial tests used the same 5 % Pd/C under one atmosphere 
hydrogen pressure. Deprotection was indicated to have occurred over a 24 hour period 
through TLC analysis, the result of which was a baseline spot. Removal of the catalyst 
was achieved via filtration through a celite bed, leaving what appeared to be the pure 
compound in near quantitative yields. Analysis via 1H- NMR spectroscopy showed the 
disappearance of the Cbz- aromatic proton signals around 7.1 ppm as well as complete 
disappearance of the associated benzyl protons at 5.1 ppm. This provided good 
confirmation as to the successful Cbz- deprotection of guanidine’s side chains.   
The S. aureus probe LGX was then constituted in the manner previously reported, using 
the freshly synthesised Rho-(Arg-Pro-Val-NHBoc)2 61.70 It was then tested on coagulase 
positive S. aureus in order to ensure its activity and reproducibility when compared to 
previous studies.70 Bewilderingly, no fluorescence response was observed when these 
tests were carried out, even when the bacterial concentration was vastly increased in the 
test cultures. Further batches of the bacterial culture were tested as well as newly 
synthesised active compound, all of which yielded the same result. After eradication of the 
possibility of a problem with the bacteria, it became clear that there was a problem with 
the LGX. 
Exhaustive examination of 1H-NMR spectra of the newly synthesised batch of Rho-(Arg-
Pro-Val-NHBoc)2 61, and comparison to the active LGX reported by the Le Gresley lab 
showed one slight difference which had so far gone un-noticed. A singlet proton signal 
had appeared at around 6 ppm, this transformation had not been previously been 
observed and hence overlooked as a slight impurity picked up from celite or another 
source. Mass spectrometry was employed in order to further investigate what this new 
signal could correspond to. The result was a molecular ion peak two Daltons heavier than 
that expected from the active compound, once again easily overlooked and attributable to 
proton capture during ionisation in MS. This information when combined with the 
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additional proton peak observed at around 6 ppm, and the general downfield shift in the 
aromatic region signified a structural change previously unobserved.  
Considering the resonance region in the spectrum in which this new signal resided, it was 
rationalised to be unlikely to correspond to a shifted aromatic signal. The region in which it 
was found did however permit a strongly deshielded benzylic proton. Examination of the 
COSY spectrum also confirmed no short-range coupling, as would be expected of such a 
proton. It was subsequently inferred that hydrogenation had occurred simultaneously on 
the upper benzylic position while undergoing Cbz- deprotection. The two Dalton increase 
in mass was also explained by addition of two hydrogens, one at the benzyl position and 
one on the upper carboxylic acid. This was also the reason as to why when testing the 
newly made compound no fluorescence response was observed. It is well known that 
rhodamines, when reduced at the benzylic position are non-fluorescent due to breakdown 
of molecular conjugation. This further confirmed the credibility of the described structural 
change in the compound. Nevertheless, it did not explain why the exact same 
hydrogenation conditions previously used for Cbz- deprotection were now causing over 
hydrogenation and consequent inactivation of the compound. One further mystifying point 
was the exact same batch of Pd/C was used for deprotection, even coming from the same 
jar.  
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Figure 40. Proton NMR spectrum of the Cbz- protected LGX precursor 77 compared to the 
reduced LGX 78. Note the complete disappearance of the benzyl signals (A) signifying Cbz- 
deprotection along with the appearance of the benzyl proton signal (B) at around 6 ppm. 
2.1.4 The Hydrogenation Problem 
Following conclusive identification of the cause of inactivity of the newly synthesised 
compound 78, focus was directed toward overcoming it. Exhaustive testing of 
hydrogenation conditions were undertaken in an attempt to increase the selectivity of the 
hydrogenation. Attempts were made to remove only the Cbz- protection while leaving the 
upper benzylic lactone intact, as it is crucial for activity.  
Initial testing varied the stoichiometry of the catalyst as well as solvent choice. Monitoring 
via TLC and NMR proved this to be ineffective, with over hydrogenation of the crucial 
upper lactone ring prevailing in all instances. Subsequent variations in catalyst loadings 
were also tested, as well as reduction in hydrogen pressure from one atmosphere to 
simply charging the catalyst with hydrogen and running the reaction under nitrogen in an 
attempt to limit the available hydrogen. This was again met with similar results. The 
central lactone being reduced faster than global Cbz- deprotection was now becoming 
increasingly probable. With this in mind, coupled with the expense and tedious nature of 
preparing the LGX precursor 77 and then wasting it, the decision was made that material 
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must be conserved and a more thorough approach adopted. Employment of sensitive 
autoclave equipment was deemed the only realistic option as this could provide a 
stoichiometric quantity of hydrogen, just enough to deprotect the guanidine groups in 
theory leaving the crucial functionality untouched. In the absence of such equipment, 
Peakdale Molecular were instructed to exhaustively test hydrogenation conditions, which 
they did. 
Conditions Result 
Pd/C (Kingston) and PtO2, 1 atm H2, EtOH, 
16 h 
Complete conversion to 77 
PtO2, 1 atm H2, EtOH, 16 h 78+ intermediates with some Cbz intact 
Pd/C (Kingston), 1 atm H2, EtOH, 16 h 78 + intermediates with some Cbz intact 
Pd/C (Kingston), 1 atm H2, IPA, 16 h Mainly single Cbz removed + 77 
Pd/C (Kingston), 1 atm H2, MeOH, DIPEA, 16 
h 
78 + intermediates with some Cbz intact 
Pd/C (Peakdale), 1 atm H2, THF, 16 h Mainly single Cbz removed + 77 
Pd/C, 1 atm H2, MeOH, RT, 24 h Mainly 78 observed 
Pd/C 1 atm H2, IMS, RT, >5 days Mainly 78 observed 
Pd/C, 30 bar H2, MeOH, RT, 24 h Mainly 78 observed 
Pd/C, 30 bar H2, IMS, RT, >5 days Mainly 78 observed 
1 % Pd/C, 1 atm H2, MeOH, RT, 3 days Mainly 78 observed 
1 % Pd/C, 1 atm H2, 1:1 IMS-AcOH Incomplete after 2 days. Intermediates 
observed indicated ring opened material 
 
Table 4. Hydrogenation conditions tested for selective deprotection of LGX precursor 77. 
 
A multitude of deprotection conditions were screened as shown in Table 4. It was 
determined that LGX precursor Rho-(Arg(Cbz)2-Pro-Val-NHBoc)2 77 could not be 
selectively deprotected under standard or non-standard hydrogenation conditions as 
evidenced in their report, the results of which are included in Table 4. Indeed, the rate of 
hydrogenation of the central benzyl ester was proven to be greater for Rho-(Arg(Cbz)2-
Pro-Val-NHBoc)2 77 than the rate of loss of Cbz- protection.69 Moreover, analogous cyclic 
benzyl esters in the form of phthalides have been shown to be highly prone to reduction 
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under countless hydrogenation conditions, resulting in cleavage and saturation 
comparable to that observed.148  
 
Figure 41. Catalytic hydrogenation of the analogous phthalide ring system 79 results in cleavage to 
80, similar to that observed with our rhodamine 110 7 based probe. 
Production of the LGX 61 probe for use in both clinical and non-clinical environments 
relies on the specificity of the final Cbz- deprotection step. The same specificity is also 
required for generation of other rhodamine-based protease probes containing Cbz- 
protected functionality. This is because non-specific deprotection renders the probe 
inactive as the reduced rhodamine core is non-fluorescent, as was observed. Exposure to 
the target protease and subsequent cleavage therefore liberates a non-fluorescent 
molecule, rendering the probe ineffective. 
2.1.5 Overcoming the Hydrogenation Problem 
Despite exhaustive testing of hydrogenation conditions, it was not to be possible to 
preserve the upper lactone while removing the Cbz- protection during scale up. In view of 
this, an alternative approach was adopted. If loss of the lactone is unavoidable, would it 
be possible to selectively reform the required functionality through subsequent oxidation 
(Figure 42)?  
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Figure 42. Modified scheme adopted in order to produce LGX in its active form 61.  
Examination of the literature provided information on the ability of dihydro rhodamine 110 
81 (and others) to act as an intracellular oxidant sensors in tissues such as tumour cells. 
These dihydrorhodamines are, in their reduced form, both colourless and non-fluorescent. 
However, when exposed to intracellular reactive oxidant species, they are oxidised to their 
coloured fluorescent forms. This produces a fluorescence contrast change signalling a 
positive test result.149  
 
Figure 43. Non-fluorescent dihydro rhodamine 110 81 converts into fluorescent rhodamine 110 7 
upon exposure to reactive oxygen species to form a fluorogenic intercellular probe. 
With this transformation in mind, it was attempted to apply it to the reduced LGX probe 78 
in order to test if selective oxidation was achievable. Oxidation of our probe by peroxide or 
similar species commonly targeted by dihydro rhodamines was found to be ineffective. 
Additionally, such conditions had not been shown to reform the upper lactone ring, instead 
yielding the fluorescent open form.149 Hence, a more selective reagent was sought out. 
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Exhaustive testing of oxidants was now undertaken in an effort to restore the crucial 
functionality, these are listed in Table 5 below.69  
Conditions Result 
DBU, DMF, bubbling air, 3 h No reaction 
H2O2, 3 h No reaction 
PhI(OAc)2, KBr, DMF, 16 h No 78 or desired product observed. LCMS 
showed no significant mass. 
PhI(OAc)2, KBr, DCM, 16 h No 78 or desired product observed. LCMS 
showed no significant mass. 1H NMR showed 
slight shift in “benzylic proton” 
1 M NaOH, MeOH, 16 h 78 + more polar product with no significant 
mass associated with it 
PtO2, EtOH, 6 h No reaction 
Pd/C, IMS, 16 h No reaction 
DDQ, MeOH, 16 h No reaction, Tentative 61 at high excess 
DDQ, DMSO, 16 h Mainly 78 and DDQ by products. Possible 
product mass in LCMS, but peak associated 
comes off in wash 
DDQ, DMF, 16 h Mainly 78 and DDQ by products. Possible 
product mass in LCMS, but peak associated 
comes off in wash 
DDQ, DCM/H2O 9:1, 16 h No reaction – insoluble 
DDQ, MeCN/MeOH 9:1, 16 h No reaction 
MnO2, MeOH, 16 h No reaction 
                                                                                                                                        
Table 5. Oxidising conditions tested in order to re-form crucial functionality in LGX probe. 
After testing numerous oxidants and conditions, 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) appeared to show promise. It is noted for its oxidative coupling 
ability, and so a further test reaction was set up. Dissolution of the inactive product in 
MeOD with excess DDQ allowed reaction progress to be monitored by proton NMR at 60 
second intervals. Delightfully, regeneration of the lactone functionality was implied through 
disappearance of the offending benzylic proton signal at around 6 ppm. Optimisation of 
this oxidation method followed, it was then applied to the bulk of the reduced probe. 
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Restoration of the crucial functionality was found to be successful by application of this 
method. The result was completion of a successfully scaled up synthesis of LGX 61, using 
the optimised 8 equivalents of DDQ in methanol. Under these conditions it was possible to 
re-form the central lactone of the rhodamine core to yield the active compound while 
leaving the peptide side chains intact. The yield of this reaction was high (83 %) and the 
correct structure was verified by both NMR and HR MS, with successful cross referencing 
to previous data on the active compound.70  
Having successfully solved the LGX over hydrogenation problem via DDQ re-oxidation to 
restore the critical functionality, the synthesis of the LGX S. aureus probe could undergo 
scale up and further testing for use in healthcare and other environments. This may in 
future form part of an updated and ultra-fast first line of defence for the detection and 
control of troublesome bacterial strains, with an aim to reduce the morbidity rate of 
bacterial infection via accurately targeted antibiotic therapy. 
 
2.2 Routes to Novel Fluorophores 
2.2.1 Reconsidering the Order of Probe Construction 
Having considered the problems associated with the scale up of the LGX probe 61, it 
became apparent that the fundamental issues limiting the utility of rhodamines in this 
context has not been fully addressed thus far. These issues relate to the difficulty in using 
rhodamine-based fluorophores to generate probes. As was shown, they are not only 
unreactive towards derivatisation, but also prone to a multitude of side reactions resulting 
from their structural equilibria. This may go some way toward explaining why despite 
finding widespread use as fluorogenic probes, the chemistry of these is somewhat limited 
and has advanced little since the 1980’s.150 In order to improve upon and increase the 
usefulness of these xanthene based fluorophores, a modified approach is required. This 
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revised approach would attempt to reverse the order of probe construction in an effort to 
simplify synthesis. 
As mentioned before, rhodamine 110 7 exists in equilibrium between several forms in 
solution, with the conjugated lone pairs of the NH2 groups undergoing resonance, thus 
reducing their availability and subsequent nucleophilicity. It was rationalised that this 
limitation could be overcome through reduction of some of the conjugation through 
removal of the top lactone aromatic (phthalide). Removal of this system should reduce the 
number of possible canonical forms with a consequent increase in NH2 nucleophilicity. 
This would theoretically improve the efficiency of the amino acid coupling procedure, 
simplifying purification and improving yields. The upper lactone ring would be introduced 
at a later stage to complete the fluorophore core, after amino acid coupling was complete, 
Figure 44. 
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Figure 44. Modification to synthetic strategy to produce probes, amino acids (AA) will be added to 
a unfinished fluorophore core, after which the fluorophore will be completed. 
2.2.2 Samarium Iodide 
The method would commence with the synthesis of a parent xanthone such as 82 (Figure 
44), which, following addition of the amino acid chain would be modified to produce the 
desired rhodamine analogue. An advantage that building up the xanthone core first 
provides, is that access to unsymmetrical structures is possible. This would enable not 
only a selection of novel unsymmetrical rhodamine analogues to be constructed, but also 
the probes built upon them would possess simplified kinetic profiles. This is because the 
previously produced LGX probe 61 contained two biomimetic arms, cleavage of the first 
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arm yields only the moderately fluorescent compound 83. However, in order to display 
maximum fluorescence the second arm must also be cleaved to liberate rhodamine 110 7, 
(Figure 45). This leads to a more complex second order fluorescence profile with respect 
to the fluorophore, limiting the linear dynamic range of detection. This would complicate 
simple kinetic rate analysis being performed upon the microorganism of interest. However, 
if maximum fluorescence were achieved in but a single cleavage event, analysis could 
easily be performed upon the target of interest, directly correlating the rate of change of 
fluorescence with the rate of cleavage. This could potentially allow quantification of the 
microorganism, as opposed to mere detection. 
 
Figure 45. Symmetric 61 vs non-symmetric 84 fluorogenic probes. Symmetric varieties require two 
proteolysis events to achieve full brightness, non-symmetric probes require only one.  
Before undertaking the new route toward un-symmetric probes, a small set of un-
symmetric rhodamine analogues were prepared and tested for coupling efficiency. This 
was to confirm that the only logical option for improvement of coupling were to remove the 
aforementioned upper ring system. These were synthesised via the traditional route in 
which phthalic anhydride is condensed with various phenols in acid at high temperatures 
(140 oC) for extended periods (~2 days).151 This route, although aggressive and tedious, 
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did indeed allow production of various rhodamine analogues, albeit in low yields after long 
and difficult purifications.  
 
Figure 46. Traditional condensation route used for production of un-symmetric rhodamines for 
coupling test. 
 
Figure 47. Condensation mechanism between phenols 86, 87 and phthalic anhydride 41 to 
produce un-symmetrical rhodamine 85. 
The optimised coupling method used previously on rhodamine 110 7 was applied to the 
two newly synthesised rhodamine analogues. Several HATU 74 mediated test couplings 
were attempted, using both mono-amino rhodamine 85 and iodorhodamine 89. The crude 
reaction mixtures were examined via TLC and GC-MS for coupling effectiveness. The 
results were found to be similar to that of rhodamine 110 7 coupling, yielding complex 
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near intractable mixtures. With these results in mind, our newly proposed route in which 
the un-symmetrical fluorophore is built up last was confirmed as the next logical next step, 
with other possibilities effectively ruled out. 
Following the aforementioned confirmation, and with a general plan in mind, the literature 
was scoured for transformations that when applied to xanthone, would result in the 
required functionality. Before applying the new transformations to more complex 
xanthones, they were trialled on the simplest unfunctionalized and commercially available 
xanthone core 90. Testing of experimental conditions on this cheap an easily obtainable 
precursor allowed determination of transformations viable to the more complex xanthones 
later on.  
During our investigation, samarium diiodide (SmI2) appeared as an interesting possibility. 
It was reputed to induce reductive coupling between α, β – unsaturated esters and 
carbonyl compounds. This resulted in production of γ – lactones in a one pot reaction, with 
broad scope in applicable substrates. There are numerous examples of this reagent 
rapidly and efficiently forming 5 – member spirocyclic ring systems like that found in 
rhodamine.152,153,154  
 
Figure 48. General mechanism of reductive coupling of a ketone with an acrylate to form a γ – 
lactone. 
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Moreover, the rapidity of many of its reactions under surprisingly mild conditions allow it to 
be used with high selectively in polyfunctional systems similar those in question. 
  
Figure 49. Reductive coupling reactions of xanthone 90 with acrylates 91 or 93 in order to build the 
upper lactone ring to produce structures 92 or 94 respectively.  
The primary viability testing of SmI2 was undertaken on unfunctionalized xanthone using 
commercially available 0.1 M SmI2 solution obtained from Sigma-Aldrich. Initially the 
reaction was carried out at room temperature with a equimolar ratio of xanthone, ethyl 
acrylate, and the proton donor s-butanol, treated with 2.5 equivalents of SmI2. This 
followed the standard reductive coupling procedure.152 Reaction progress was monitored 
by TLC and it was noted that after four hours the reaction mixture appeared to have 
reached a steady state. In addition to this, a solution colour change had occurred from the 
deep blue indicative of SmI2, to the yellow of SmI3 signifying consumption of the reagent. 
TLC examination of the crude indicated that xanthone 90 and acrylate 91 starting 
materials had not been fully consumed. Gas Chromatography-Mass Spectrometry (GC-
MS) analysis of the crude reaction mixture revealed no trace of the target lactone 92. 1H-
NMR analysis also showed only starting materials, again with no trace of lactone 92 
formation for which two triplets were expected at around 2 and 2.7 ppm based on 
spectroscopic data obtained for similar spirolactones. With no evidence of the target 
molecule in four hours, reaction time was increase to 20 hours, hopefully sufficient to 
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produce the target. Conditions were held constant and progress was again monitored by 
TLC. Examination of the crude mixture after 20 hours yielded essentially the same results, 
tentative evidence however of a new but weak TLC spot at lower Rf was revealed after 
KMnO4 visualisation. Normal workup procedure was employed after which the new TLC 
spot was no longer visible. Examination of the crude via GC-MS, 1H, and COSY NMR 
provided no evidence of target molecule 92, with only starting materials 90 and 91 were 
observed. The tentative evidence given by the higher polarity TLC spot which curiously 
disappeared after workup may imply the reaction mixture contained an unstable organo-
samarium(III) compound, readily hydrolysed back to starting materials in the workup. 
Given that no solid evidence of the formation of desired lactone 92 was observed for the 
reactions at room temperature, it was decided that it be tested at reflux. This would 
hopefully provide sufficient energy to overcome whatever barrier was inhibiting formation 
of desired lactone 92. Even at reflux, TLC analysis after 20 hours showed incomplete 
consumption of the starting materials. However, in addition to the transient low Rf spot 
previously observed, a new higher Rf spot with strong absorption at 254 nm was seen. As 
target lactone 92 should be more polar than the starting materials, this new spot appeared 
inconsistent with the expected results, however, attention was nonetheless directed 
towards it. Examination of the 1H-NMR spectrum of the crude gave no indication of the 
desired product 92 once again, showing only starting materials 90 and 91 and a small 
amount of the reduction product, xanthene 95. It appeared that some xanthone had had 
the ketone group reduced to CH2. The condensing of the four characteristic aromatic 
peaks of xanthone 90 into two multiplets implied this, along with the appearance of a 
singlet resonance at 4 ppm courtesy of the aforementioned xanthene CH2. Cross 
reference with known data for the compound confirmed this.155 
As conducting the reductive coupling at reflux had still not promoted formation of the 
desired lactone, the number of SmI2 equivalents was doubled to five. This attempted to 
address the commercially obtained SmI2 solution being of lower concentration than that 
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stated, as this has been extensively stated and studied in the literature.156 After 20 hours 
and five SmI2 equivalents, analysis of the crude showed similar results to before, no 
evidence of target lactone 92. One notable difference however was that xanthone 90 had 
been consumed much more significantly, with a corresponding increase in production of 
the reduction product, xanthene 95.  
 
Figure 50. Samarium diiodide mediates reduction of xanthone 90 to xanthene 95 in the presence 
of an alcohol proton donor such as s-BuOH. 
A further attempt was made to produce the lactone of interest 92, on this occasion SmI2 
was freshly produced in house using Imamoto’s method, with standardisation against a 
volumetric solution of ultra-pure iodine in THF.157  
3 Sm    + 3 I2  2 SmI3     + Sm  
2 SmI3    + Sm  3 SmI2 
Figure 51. Imamoto’s method to prepare SmI2, using samarium metal and iodine.157 
Following standardisation to a high degree of accuracy, the fresh SmI2 solution was used 
immediately for two further reactions, both at room temperature and for 20 hours, using 
exactly 2.5 equivalents of SmI2. One was performed with the s-BuOH additive, and one 
without, so as to be directly comparable to previous results. This ruled out the possibility 
of reaction failure either due to inconsistent SmI2 stoichiometry, or inclusion of the alcohol 
proton donor usually required for coupling. Both reactions showed little change to that 
previously seen, with the crude 1H-NMRs of both showing predominantly starting 
materials. One final reaction with only xanthone 90 and SmI2 was undertaken to ascertain 
whether xanthone 90 showed any notable reactivity towards SmI2, this yielded only 
starting material 90.  
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Xanthone (eq) Acrylate (eq) SmI2 (eq) s-BuOH (eq) t (h) T (oC) 
1 1 2.5 1 4 20 
1 1 2.5 1 20 20 
1 1 2.5 1 20 reflux 
1 1 5.0 1 20 20 
1 1 2.5 0 20 20 
1 1 2.5 1 20 20 
1 0 2.5 0 20 20 
1 0 2.5 1 20 20 
1 1 2.5 1 20 20 
 
Table 6. Reductive coupling reactions performed with the stoichiometries of xanthone 90 and 
acrylate 91 and corresponding conditions.  
To ensure the reductive coupling procedure actually worked and did indeed furnish the 
intended product, a reaction between cyclohexanone 96 and ethyl acrylate 91 with the 
same stoichiometries was set up. This proceeded smoothly to yield the expected 
spirocyclic lactone 92 in good yield, the structure of which was confirmed via NMR and 
HR MS. The success of this reaction confirmed that the SmI2 mediated reductive coupling 
was incompatible with xanthone 90 and by extension the xanthone species in general. 
This was conceivably due to stabilisation and quenching of the ketyl radical species 
formed in the first step. This conjecture agreed with studies undertaken by Martinez et al. 
who’s findings demonstrated that numerous xanthones were able to efficiently deactivate 
free radicals. This occurred due to their high electron affinity and was shown to be 
especially efficient if the xanthone were in its neutral state.158 
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Figure 52. Samarium diiodide successfully forms the target lactone structure in the test reaction 
producing spirolactone 97. 
After successfully demonstrating the incompatibility of samarium induced reductive 
coupling with xanthone 90, this approach could be ruled out with confidence. The 
requirement for a new route was now apparent. Consequently, the literature was once 
again examined for transformations which would result in the required functionality.  
2.2.3 Directed Metalation 
The process of directed ortho metalation (Figure 53) was highlighted as one of the better-
known routes towards aryl containing scaffolds, and its investigation appeared to show 
promise.  
 
Figure 53. Metalation occurs adjacent to the Directed metalating group (DMG) due to a complex 
induced proximity effect. This results in coordination of the lithium species to the Lewis basic DMG 
producing regioselectivity in lithiation. Treatment with an electrophile E+ then results in substitution 
at the lithiated position. 
The Wuts group was found to have explored and successfully applied dialkyl hydrazides 
to directed lithiation.159 The rationale behind their investigations were that amides had 
seen traditional use as efficient ortho metalating agents. Their limitation was that strongly 
acidic conditions were often required to hydrolyse the amide, subsequently cleaving other 
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labile groups. This had limited the applicability of such agents, especially to more delicate 
substrates. Therefore, as dialkylhydrazides ‘look’ similar to primary amides, they ought to 
exhibit similar ortho metalating properties, but with the added benefit of being far more 
labile than their amide counterparts. This meant that hydrolysis could be achieved 
selectively in the presence of sensitive ancillary groups, under milder conditions.159  
It was shown that ortho lithiation of dimethyl hydrazide could be achieved with s-butyl 
lithium (s-BuLi), n-butyl lithium on the other hand had been insufficiently basic at below     
-10 oC. The lithiated product was then exposed to a number of standard electrophiles, 
generating the free acid ortho addition product after oxidation. This was consistent with 
previously demonstrated directed metalation chemistry differing only by the mild nature of 
the oxidants required, such as CuCl2 or H5IO6. Strikingly though, if the electrophile had 
aldehyde or ketone functionality, lactonization was often spontaneous during the workup 
procedure.159 This would lead to a spirocyclic phthalide or aromatic lactone in the case of 
addition to cyclohexanone, similar to the core structure of rhodamine. By extension, if this 
chemistry could be applied to xanthones, it may lead to a novel and cost-effective route to 
rhodamine conjugates. This could potentially facilitate the generation of novel rhodamine 
analogues and rhodamine-based probes. 
With the hypothesis in place, attention was directed to synthesis of the directed ‘lithiating’ 
agent N’,N’-dimethylbenzohydrazide 100. This was initially attempted through 
condensation of benzoyl chloride 98 and dimethyl hydrazine 99 in the presence of 
triethylamine. Recrystallisation then yielded both needle like, and hexagonal prismatic 
crystals, the majority of which were the prismatic variety. Examination by 1H-NMR 
confirmed formation of the target compound 100 as the needle like crystals, however the 
major product was determined to be the bis acylated compound N-benzoyl-N’,N’-
dimethylbenzohydrazide 101, which was confirmed by 1H-NMR and HR MS.  
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Figure 54. Benzoyl chloride 98 mediated acylation of dimethylhydrazine 99 produced both the 
target dimethylhydrazide product 100 and by-product 101. 
The synthesis was improved through utilisation of Schotten-Baumann conditions, 
employing a biphasic aqueous NaOH/diethyl ether mix at 0 oC with maintenance of a pH 
above 11. This method minimised the side reaction and furnished target compound 100 in 
vastly improved yield after a simple recrystallisation.  
 
Figure 55. Treatment of the DMG N’,N’-dimethylbenzohydrazide 100 with s-BuLi yielded lithium 
species 102. 
Next, lithiation of hydrazide 100 to produce lithium species 102 was achieved with s-BuLi 
in the presence of tetramethylethylenediamine (TMEDA), at -78 oC in 30 minutes. The 
resulting solution was stirred for a further 210 minutes, after which the cyclohexanone 96 
substrate was added, and stirred overnight. The standard quenching and workup 
procedure followed, after which the crude was examined by 1H-NMR for evidence of the 
target compound. NMR examination showed good evidence of the compound by 
examination of the aromatic region, the reaction having proceeded with satisfying 
efficiency. The pure compound 103 was then isolated via column chromatography in good 
yield. Further inspection showed that the spontaneous cyclisation had occurred, 
exclusively forming product 103. As expected, hydrolysis of the hydrazide intermediate 
had taken place in the workup procedure without the need for aggressive conditions. 
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Figure 56. The target spiro-lactone 103 formed spontaneously following exposure of 96 to lithium 
species 102 and workup. 
Having successfully confirmed that directed metalation can produce the core lactone in a 
single step, attention was directed towards its application to xanthone 90.  
Again, the hydrazide was generated in the same manner as before, after which xanthone 
105 was added, stirred for 210 minutes and allowed to rise to room temperature. The 
reaction was monitored by TLC which showed a complex mixture up to and after 16 
hours. The consumption of xanthone 90 was also found to be incomplete after this time. 
Purification of the intractable mixture was not possible using the standard workup which 
was previously successful. Several further attempts were made with little success, 
however, evidence of the product of interest was observed by LRMS. Reducing the 
number of xanthone 90 equivalents was found simplify the crude reaction mixture, 
however, the pure product remained elusive. Following confirmation of the presence of the 
target via MS, attention was turned toward the workup procedure. Eventually it was found 
that the target compound could be crystallised by acidification with concentrated HCl 
following the standard workup. Acidification appeared to have induced cyclisation of the 
product to produce needle like crystals of pure product. Cyclisation to form the target 
lactone was inferred to have probably occurred via a intramolecular Fischer type 
esterification.   
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Figure 57. Formation of target product 104 following exposure to lithium species 102 and 
subsequent acidification with concentrated HCl. 
Full spectral analysis of target compound 104 confirmed its identity, the unfunctionalized 
version of the rhodamine core. Examination of the literature revealed that this was a novel 
route to spiro[isobenzofuran-1(3H),9’-[9H]xanthen]-3-one 104, a previously uncategorised 
structure. This was the first verified synthesis of compound 104 backed by a full 
spectroscopic dataset, (Figure 58). 
 
Figure 58. 1H-NMR spectrum and proton assignments of spiro[isobenzofuran-1(3H),9’-
[9H]xanthen]-3-one 104, previously unreported. 
After the success of the directed metalation approach in generating the core rhodamine 
structure 104, the conditions would now be applied to functionalised xanthones to 
ascertain if the route was compatible. Synthesis of the functionalised xanthones was then 
commenced. 
The synthetic methodology adopted for production of the parent xanthone was adapted 
from that of Young-Hoon et al., the procedure was originally developed to produce a 
rosamine library through combinatorial synthesis.160 These conditions were employed to 
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produce the initial 3-amino-6-nitro-xanthen-9-one 108, which would later be modified 
aiming to form novel unsymmetrical rhodamine analogues. 
Production of 108 commenced with an Ullmann condensation of 2-chloro-4-nitrobenzoic 
acid 105 with N-(3-hydroxyphenyl)acetamide 106, requiring high temperatures and 
extended reaction times. The reaction pathway passes through biaryl ether 107 which was 
not isolated. Instead, workup in hot concentrated sulphuric acid induced secondary ring 
closure to yield 108 in consistent yields of 30 %. 
 
Figure 59. Synthesis of 3-amino-6-nitro-xanthen-9-one 108 via modification of A. Young-Hoon et 
al’s method. 
Multiple attempts at functionalisation of the ketone group of unsymmetrical xanthone 108 
were undertaken, using lithium species 102. These all resulted in intractable mixtures. 
Conceivably this was due to incompatibility with the nitro amino arrangement alongside 
the highly basic nature of the organo-lithium nucleophile. Further examination yielded no 
evidence to the formation of the target compound via LRMS. 
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2.2.4 The Grignard Approach 
Following determination that functionalised xanthone 108 was incompatible with the 
organo-lithium reagent 102, its less aggressive organo-magnesium Grignard counterparts 
were tested. If this approach were successful, acylation of the NH2 of 108 with an 
appropriately protected amino acid such as BocNH-Arg(Cbz)2-OH 68 to give an acylated 
rhodamine precursor would be the next step. An attempt at introduction of the lactone to 
the acylated xanthone would follow this, which, if successful would signal an initial 
success of this route. 
In order to determine compatibility of Grignard reagents with the xanthones, a test 
reaction of phenylmagnesium bromide 109 on xanthone 90 was carried out with success, 
to yield tertiary alcohol 110, confirmed by MS. 
 
Figure 60. Successful formation of tertiary alcohol 9-phenyl-9H-xanthen-9-ol 110 through exposure 
of xanthone 90 to phenylmagnesium bromide 109. 
Following the success, the conjecture that acetal protected Grignard reagent 111 could be 
exposed to xanthone 108 to produce alcohol 112 was tested. Acid hydrolysis would then 
follow to produce 113, followed by oxidation to complete the upper lactone, yielding 
product 114, Figure 61. 
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Figure 61. Proposed incorporation of upper ring by Grignard addition, followed by mild oxidation. 
Several attempts at the first step of incorporation of the upper lactone to form intermediate 
112 by Grignard addition of 111 to 108 were met with little success. Examination of the 
crude mixtures showed no evidence of the product via NMR or MS. A complex intractable 
mixture which rapidly became purple was instead produced in all cases. The synthetic 
attempts and their associated stoichiometries are included below (Table 7). 
Grignard (eq) Xanthone (eq) Reaction time (h) 
1.1 1 4 
2 1 4 
3 1 4 
4 1 4 
5 1 4 
1.1 1 20 
2 1 20 
3 1 20 
4 1 20 
5 1 20 
 
Table 7. Reaction timings and equivalencies of Grignard 111 exposed to xanthone 108. 
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The surprising lack of success of the Grignard reaction, alongside the striking colour 
change warranted further investigation. Upon which the Bartoli indole synthesis reaction 
was uncovered.161 This synthesis described the reaction of Grignard reagents with aryl 
nitro compounds to yield indoles, thus demonstrating the reactivity of these toward such 
reagents. It was inferred that Indole formation via the Bartoli route was causing the issues 
we encountered, however their formation was not explicitly confirmed via spectroscopic 
means. This, coupled with the characteristically purple colour of many indole analogues 
was deemed an adequate explanation in this instance. It is likely that attack on the 
deactivated ketone group of xanthone 108 is slower than on the nitro group, further 
highlighting their incompatibility. The ketone group in our xanthone 108 also suffers from 
deactivation through conjugation into the flanking aromatics. This is in part due to the 
contribution of the tautomeric imine form it is able to adopt, which further reduces the 
electrophilicity of the ketone group. Extra stabilisation of this form is conferred by the 
extended conjugation gained over the entirety of the planar molecule, increasing its 
favourability. As further confirmation of the imino contribution, examination of the Infra-red 
spectrum of 108 showed a markedly decreased carbonyl band intensity to that which 
would be expected. 
 
Figure 62. Tautomerism of 3-amino-6-nitro-xanthen-9-one 108 between the keto (left), and the 
imino (right) forms. 
Having experienced a few setbacks in the pursuit of constructing rhodamine cores as a 
result of chemical incompatibility, the literature was again scoured. Interestingly it was 
found that analogous fluorophores could be constructed without the need for the upper 
lactone. This could reduce the number of possible side reactions through removal of the 
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upper carboxylic acid group as well as eliminating the open close equilibrium, which 
contributed to the lack of aniline group nucleophilicity.  
 
Figure 63. Infra-red spectrum of 3-amino-6-nitro-xanthen-9-one, compound 108, weak carbonyl 
band expanded for clarity. 
2.2.5 Simplified Fluorophores 
The specific mechanism controlling the fluorescence in rhodamines and fluoresceins had 
been unclear for a long period, largely ignored with only empirical observations 
contributing to its understanding.162 Published research had shown that the upper carboxyl 
group involved in lactonization was indispensable for fluorescence, as its removal resulted 
in a sharp reduction in fluorescence quantum yield.163 Later on however, it was proven 
that the carboxyl group played no part in the fluorescence properties, it merely acted as a 
steric barrier to force the upper ring to orientate itself orthogonally to the lower xanthene 
system and restrict rotation. In the case of fluorescein 6, this supposed indispensability 
was countered through demonstration via replacement of the upper carboxyl group with a 
methyl group. This produced a new fluorescein analogue coined 2-Me Tokyo Green 115 
(Figure 65), which had a near identical fluorescence quantum yield, absorbance and 
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emission maxima to fluorescein 6. Furthermore, it demonstrated that even the small 
methyl group provided a sufficient rotational steric barrier to induce orthogonality, paving 
the way for the creation of additional analogues.164  
 
Figure 64.  Fluorescein 6, front view (left) and top down view (right). The carboxyl group acts only 
to provide a rotational steric barrier to the top ring system rendering it orthogonal to the lower 
xanthene rings. The carboxyl is therefore not essential for strong fluorescence and may be 
substituted with another sufficiently bulky group. 
The research into Tokyo Greens also revealed that the fluorescence quantum yield of that 
class of fluorophores was directly dependent on the electron density of the upper ring 
system.164 It was shown that as electron density in the upper ring increased, the quantum 
yield decreased down to a point at which essentially no fluorescence was visually 
observable. Fluoresceins and Tokyo Greens were described as directly linked donor-
acceptor systems, in which Photoinduced electron Transfer (PeT) determined their 
quantum efficiency of fluorescence. As electron density in the upper ring increased, so did 
the rate of PeT, progressively quenching fluorescence and reducing quantum yield.164 
This quenching mechanism was in addition to that observed upon acylation of the 
hydroxyl groups, the basis for the on/off fluorescence exploited in fluorescent probes. This 
second quenching mechanism (also observed for NH2 acylation in rhodamines) not only 
reduces the hydroxyl lone pair donation into the main body of the fluorophore, but also 
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locks the molecule into the lactone form, disrupting molecular conjugation. Breaking of 
molecular conjugation in the Tokyo Greens cannot happen in this manner due to lack of 
the upper carboxylic acid group. Therefore the quenching mechanism when acylated is 
due in part to reduction in back donation of hydroxyl lone pairs (NH2 lone pairs in 
rhodamines), sometimes referred to as the push/pull effect. Further quenching is endowed 
though the ability to shed additional energy through the increase in vibrational 
deactivation. This results from the improved vibrational freedom imbued by additional 
lower ring-bound functionality. 
 
2.3 The Singapore Green Fluorophore 
2.3.1 Properties and Synthesis 
Inspection of the literature revealed a further related, but orphan family of fluorophore 
which possessed desirable characteristics. These were both an un-symmetric structure, 
and the lack of troublesome upper carboxylic acid group. This orphan fluorophore was 
coined Singapore Green (SG), and had built on the lessons learned from stripping down 
fluoresceins while maintaining the upper rotational steric barrier. It was a hybrid of 
rhodamine and Tokyo Green, possessing both an NH2 and OMe group, the upper ring 
bore only a methyl group, (Figure 65). The NH2 could act as a handle for recognition 
sequence attachment, while the methyl group masked OH reactivity or could be 
substituted for solid support attachment.165 As these features were both desirable for the 
research, and very little investigation of this class had been undertaken, an excellent 
opportunity had presented itself. A library of novel analogues could be synthesised and 
investigated for the effect that variation of the upper ring had on spectral properties. This 
would indicate whether the same mechanism modulating fluorescence intensity in the 
Tokyo Greens also applied to the Singapore Greens. Accordingly, the most promising 
candidates could then be put forward for next generation probe development. 
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Figure 65. The Singapore Green fluorophore 116 is a structural hybrid of Tokyo Green 115 and 
Rhodamine 110 7, possessing a portion of each structure as shown. 
Pursuit of this route provided a synthetic advantage over the previous, particularly as the 
problematic upper lactone ring need not be installed. Furthermore, this approach could 
eliminate the problem hydrogenation of the lactone benzyl position encountered with 
deprotection of Cbz- groups of LGX precursor 77. Additionally, the carboxyl group side 
reactions encountered during attachment of biomimetic sequences to the NH2 would be 
eliminated. This would be the case whether the biomimetics were attached before the 
fluorophore was fully constructed as was the current strategy, or after.  
Simplification of the Grignard reagents required to install the top ring system to xanthone 
would also be noted, as no protected carboxyl precursor is required. Selective 
functionalisation of the upper ring in any position to produce a single regioisomer would 
also be enabled. This was a considerable advantage over the traditional production 
method for upper ring functionalisation, shown in Figure 66. The SGs could also be 
constructed from the parent xanthones which our synthetic investigations had started 
from. A conveniently smooth progression into their investigation was consequently 
possible at this stage.  
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Figure 66. Condensation of a substituted phthalic anhydride to produce an upper ring substituted 
rhodamine analogue yields a mixture of difficult to separate isomers. A Grignard reaction installing 
the substituted upper ring results in only a single isomer. 
With the adjusted strategy, additional elaboration to the xanthone core was undertaken to 
produce the modified structure from which the fluorophores would be constructed. 
Maintenance of the un-symmetric nature of the core was always important, as well as the 
need for conversion of the nitro group into a compatible functional group to avoid the 
problems previously noted. 
Diazotization of the amine group of 108 followed by quenching in hot water yielded the 
hydroxy derivative 3-hydroxy-6-nitro-xanthen-9-one 117 in near quantitative yield without 
the need for further purification. Alkylation of the hydroxyl group of 117 followed this, 
facilitated by iodomethane. The product 3-methoxy-6-nitro-xanthen-9-one 118 was 
produced efficiently and in excellent yield, again without requiring further purification. 
 
Figure 67. Conversion of 3-amino-6-nitro-xanthen-9-one 108 to 3-methoxy-6-nitro-xanthen-9-one 
118 via diazotisation, hydrolysis and subsequent alkylation. 
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Following alkylation of the hydroxyl group to produce 118, attention was turned to 
providing the handle for attachment of a biomimetic or recognition sequence. Reduction of 
the nitro group of 118 with tin(II)chloride afforded the required amino derivative, 3-amino-
6-methoxy-xanthen-9-one 119 in quantitative yield, yet again without purification. 
With the xanthone 119 which the fluorophores would be constructed from in hand, 
protection of the NH2 group was the undertaken. This was achieved using the acid labile 
trityl group, attached effectively using trityl chloride in 60 minutes, purification by 
precipitation in a large volume of hexane yielded pure product 120. 
 
Figure 68. Conversion of 3-methoxy-6-nitro-xanthen-9-one 118 to 3-amino-6-methoxy-xanthen-9-
one 119 via reduction and subsequent trityl protection to yield 120. 
With the protected xanthone 120 ready, the Grignard addition of 121 followed reproducing 
the orphan fluorophore Singapore Green (SG1, 116), the first step into the investigation of 
this novel class. This part of the synthesis was performed in accordance with the 
published procedure to ensure its applicability.165  
 
Figure 69. Conversion of xanthone 120 to SG1 116 via addition of Grignard reagent 121, followed 
by acidic deprotection and dehydration of intermediate 122. 
Commercially obtained Grignard reagent 121 was introduced into a THF solution of 
protected xanthone 120 at room temperature, then refluxed for 16 hours, TLC examination 
followed. A further portion of the Grignard was then added as starting material 120 was 
still strongly apparent in the TLC, indicating its low reactivity. Further investigation of the 
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TLC revealed a strongly fluorescent high polarity component which appeared after several 
seconds. As none of the reaction products were expected to be so fluorescent at this 
stage, it was reasoned that the silica of the TLC plate had catalysed deprotection and 
dehydration to form the fluorescent SG1 116. Reflux for a further 16 hours followed the 
second Grignard addition. Further TLC analysis revealed that the starting material had 
been more thoroughly consumed at this point, although total consumption had not 
occurred. 
Following quenching and workup, purification was attempted on tertiary alcohol 122. 
Gradient column chromatography using a 0 - 10 % MeOH/DCM mobile phase led to 
significant streaking, converse to that detailed in the literature.165 It was determined that 
deprotection and dehydration were occurring in situ leading to variable rates of elution for 
the same components, confounding purification. It is notable that the literature cites no 
spectroscopic evidence whatsoever for isolation of the tertiary alcohol intermediate, likely 
for the same reason mentioned here.165 Although the trityl group is normally expected to 
survive silica chromatography, in this case a significant increase in conjugation throughout 
the molecule is gained upon dehydration. There is also an increase in steric crowding 
associated with conversion of the trityl protected amine to an imine following dehydration 
(Figure 70). It is conceivable that this increased the acid lability of the trityl group 
sufficiently to allow deprotection on silica, going some way toward explaining this 
observation.  
 
Figure 70. Dehydration of 122 with concurrent imine formation results in decreased bond length 
and increased steric clash between the trityl group and the xanthone rings in 123. 
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After concluding that deprotection and dehydration were occurring on the column and at 
variable points, it was decided that the best course of action would be to fully deprotect 
the crude and purify the final product in one step. This was achieved in the traditional way 
using trifluoroacetic acid in DCM, after which the same purification conditions were 
successful. This confirmed the method to produce the highly fluorescent Singapore 
Green, SG1 116. 
2.3.2 Synthesis of a Novel Singapore Green Library 
With a working method to produce new fluorophores, generation of a selection of novel 
analogues was the next course of action. Several substituted aromatic bromides were 
obtained from which to generate the associated Grignard reagents. Following their 
generation, the protected xanthone would be exposed to form a small library of novel 
SGs.   
The aromatic bromide 2-bromobenzotrifluoride 124 was obtained, its Grignard reagent 
125 generated, and a simple test reaction on cyclohexanone 96 was run to ensure 
applicability. This was met with success in generation of tertiary alcohol 126, the identity 
of which was confirmed spectroscopically. The same conditions were applied to generate 
further Grignard reagents for production of other SGs. 
 
Figure 71. Test reaction to validate method of Grignard reagent generation. 
The second Singapore Green (SG2 127, Figure 73) was generated in a similar manner to 
the first, using Grignard reagent 125 under the same conditions. Two additions of the 
reagent 16 hours apart resulted in incomplete consumption of the starting material even 
under reflux, further confirming the lack of electrophilicity of the parent xanthone. 
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Quenching, workup and trityl deprotection yielded the crude fluorophore which was then 
purified in the same manner as SG1 116. The product isolated was the novel fluorophore 
SG2 127, the first accompaniment to the orphan SG1 116 in this class.  
To improve yields and simplify handling of the precursor, a solid supported strategy was 
adopted. Polymer bound 2-chlorotrityl chloride resin was chosen as the solid support as a 
result of its simplicity of use and applicability to protection of the NH2 group of xanthone 
119. A 2-chlorotrityl chloride resin of 1.6 mmol/g loading, 100 – 200 mesh, 1 % DVB 
crosslinked was used for support.  
Loading of the resin was achieved using a stoichiometric quantity of xanthone 120 with 
respect to resin binding sites. This was performed in the presence of 10 equivalents of 
pyridine base and in accordance with published procedure.160 The binding mixture was 
agitated for 24 hours in freshly silyl protected solid phase glassware, after which the 
binding solution was removed, resin washed with DMF x 5, MeOH x 10 and DCM x 10 
and dried under vacuum. Following this the resin was methanol capped using a 17:2:1 
DCM:MeOH:DIEA mix, agitated for 60 minutes and washed with DCM x 3, DMF x 3, 
MeOH x 3, DCM x 3, vacuum desiccated at 50 oC for 24 hours and stored under dry 
nitrogen until required. Quantification of loading was determined via quantitative NMR 
(qNMR) and performed for each batch of polymer bound xanthone for use in reaction 
stoichiometry.  
Novel fluorophores SG2 – SG9 127 – 134 were produced using the 2-chlorotrityl 
supported xanthone under reflux while agitating. Each of these were subjected to three 
separate Grignard additions of 12 equivalents, the consumed reagent having been 
removed each time a new portion was added. Cleavage from the resin was achieved 
using a 5 % TFA/DCM solution in which the resin was stirred for 20 minutes. The resin  
was then washed three additional times with the cleavage solution and the washings 
combined. Purification was again via column chromatography using a 0 – 10 % 
MeOH/DCM gradient mobile phase. 
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Figure 72. Expansion of aromatic region of 1H-NMR spectrum of fluorophore SG7 147 with 
associated aromatic proton assignments.  
With a small library of novel fluorophores SG1 - 9 in hand, their spectral properties were 
investigated. Fluorescence quantum yield, extinction coefficient and λex/λem were 
determined for each of the Singapore Green fluorophores SG1, 2 – 9, 116, 127 - 134 
Figure 73. 
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Figure 73. Singapore Greens 1 – 9 (SG1, 2 – 9, 116, 127 – 134). N.B. SG1 – 8.TFA, SG9.HCl. 
2.3.3 Spectral Analysis of Singapore Greens 
Quantum yield provided the quotient of photons absorbed to those re-emitted as 
fluorescence. Relative fluorescence quantum yield was measured using fluorescein as the 
standard.166 The equation used for quantum yield determination was as follows: 
Φx = Φst (mx/mst)(ηx2/ηst2) 
Where:  Φx = quantum yield of SG,                                                                                                 
Φst = quantum yield of fluorescein. 
mx = gradient of ∫ fluorescence intensity vs absorbance of SG,                      
mst = gradient of ∫ fluorescence intensity vs absorbance of fluorescein. 
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ηx = refractive index of ethanol (1.361),                                                                                          
ηst = refractive index of 0.1 M NaOH (1.334). 
Molar extinction coefficient was determined using the standard formula: 
A = Ɛcl 
Where: A = Absorbance. 
  Ɛ = Molar extinction coefficient (M-1cm-1). 
  c = concentration (M). 
  l = path length (cm). 
Fluorophore QY Ɛ (M-1cm-1) λex (nm) λem (nm) 
SG1.TFA 116 0.64 46044 492 519 
SG2.HCl 127 0.56 25695 499 526 
SG3.TFA 128 0.63 26450 491 519 
SG4.TFA 129 0.48 44527 492 526 
SG5.TFA 130 0.015 35411 501 527 
SG6.TFA 131 0.39 22822 497 532 
SG7.TFA 132 0.0098 38279 505 525 
SG8.TFA 133 0.56 36186 496 526 
SG9.TFA 134 0.65 17178 498 525 
 
Table 8. Spectral characteristics of the Singapore Green fluorophores SG1 – 9. 
Interestingly, the two di-methyl analogues, SG3 128 and SG6 131 exhibit markedly 
different quantum yields of 0.63 and 0.39 respectively, despite differing only by disposition 
of the methyl groups on the upper ring. This may be as a consequence of the methyl 
groups of SG6 131 being arranged meta to one another. The result of this is that both of 
these groups inductively donate electron density to the same two positions, one of which 
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links the upper ring to the lower xanthene system. As PeT is analogous to an ionisation 
process, and both electron releasing methyl groups donate electron density to this 
junction, its ionisation energy is plausibly lowered. With this effect in mind, it is 
conceivable that ionisation occurs here more easily and so the rate of PeT to the 
xanthene system is increased more substantially than expected, quenching fluorescence 
more significantly. This same effect is not seen in SG3 128 due to the para disposition of 
methyl groups to one another, in this case both oppose each other’s electron donation to 
any specific position on the ring, nullifying the enhancement to PeT when compared to 
SG6 131. 
 
Figure 74. Disposition of methyl groups on SG3 128 oppose each other’s electron donating effect, 
in SG6 131 they work in conjunction to enhance electron density in positions indicated. The result 
is a disproportionate increase in rate of PeT in SG6 131 over SG3 128 with corresponding drop in 
quantum yield, despite having the same relative electron density in the upper ring system.  
Remarkably, there is a huge difference in quantum yield between the mono-methoxy 
substituted SG4 129, and the methyl-methoxy substituted SG5 130, with quantum yields 
of 0.48 and 0.015 respectively. The difference between their upper rings being only a 
mildly electron donating methyl group, which would be predicted to make little difference. 
This result implies there is a threshold electron density which exists for the upper ring. 
Above this threshold, PeT is the dominant depopulator of the excited state, at which point 
fluorescence quantum yield drops off massively. Naturally SG7 132 being di-methoxy 
substituted and consequently more electron rich, places it above the aforementioned PeT 
threshold, so PeT dominates and its quantum yield is negligible at 0.0098. 
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Figure 75. Comparison of SG4 129, SG5 130 and SG7 132 fluorescence quantum yields. A large 
drop is observed between SG4 and SG5 despite only a modest increase in upper ring electron 
density, this is indicative of a threshold above which PeT becomes the dominant process. 
The three most fluorescent of the Singapore Greens, SG1 116, SG8 133, and SG9 134 
also follow suit in the observation that the relative electron densities of their upper rings 
show the expected inverse correlation with quantum yield. The least electron dense CF3 
variant SG9 134 being most fluorescent and the slightly more electron rich naphthyl 
substituted SG8 133 the least of the three, with SG1 116 in between (Figure 76). 
 
Figure 76. Fluorescence quantum yield decreases as upper ring electron density increases. 
Considering these observations, it may be concluded that the same PeT quenching 
mechanism applies to Singapore Greens as it does to Tokyo Greens. This relationship is 
not in direct proportionality to electron density, but contains a threshold after which PeT 
dominates and fluorescence drops off rapidly. Additionally, mesomeric effects appear 
dominant over those observed from inductive effects in terms of upper ring electron 
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density and PeT rate. This dominance of mesomeric over inductive effect is similar to that 
observed in electrophilic aromatic substitution via resonance stabilisation of positive 
charge brought about through PeT ionisation. 
Furthermore, as with the Tokyo Greens we have also demonstrated that removal and 
replacement of the upper carboxyl group with a variety substituents has very little effect on 
the λex/λem. Only very slight variations are noted on these properties associated with 
experimental and equipment-based imperfections. The similarity in λex/λem to fluorescein 
and rhodamine 110 7 is useful, as the same incident radiation source in the form of the 
488 nm argon ion laser is compatible with all of them.  
The measured values for the molar extinction coefficient (ε) appear to show a modest 
correlation to molecular cross-sectional area. The most electron deficient and therefore 
conceivably contracted CF3 analogue SG9 134 produces the lowest value, with the more 
functionalised and conceivably larger analogues eliciting higher values. However, SG1 
116 exhibits the highest extinction coefficient, which is difficult to equate to it possessing a 
larger molecular cross-sectional area than the naphthyl derivative SG8 133, which has a 
lower coefficient. Therefore, the only conclusion that can be drawn is that other steric, 
electronic, solvatochromic or agglomeration effects account for the variations seen, and 
these cannot be sufficiently addressed herein. 
2.3.4 Fluorescence Quenching of Singapore Greens via Acylation 
Having successfully produced a small library of novel Singapore Green fluorophores, 
acylation of some examples was undertaken in order to determine their comparative 
quantum yield and extinction coefficients. The variation in these properties would be the 
basis for fluorescence contrast change in any future probe built upon these fluorophores. 
Acetic anhydride was applied in the presence of pyridine as solvent to initially yield an 
unexpected spirocyclic bis-acylated analogue of SG1 116, named SG1BisAc 135. This 
bis-acyl product decomposed rapidly in the presence of light to form the target compound 
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SG1Ac 136. The molecule was re-synthesised and its photolysis monitored periodically 
via NMR until complete decomposition had occurred. The photochemical nature of 
decomposition was proven conclusively by holding 135 under light free conditions within 
the magnet of a 600 MHz NMR spectrometer for 70 hours at 293 K. The period of 70 
hours was chosen as in normal daylight at 293 K SG1BisAc 135 had fully decomposed to 
SG1Ac 136 with concurrent elimination of acetic acid, observed at around 2.02 ppm. After 
70 hours of darkness in the NMR magnet at a fixed temperature of 293 K no change was 
recorded in the spectrum, proving that the decomposition was indeed light induced. 
 
Figure 77. Acylation of SG1 116 resulted in the spirocyclic bis-acyl analogue SG1BisAc 135 which 
rapidly decomposed in light to furnish the target product SG1Ac 136. 
 
Figure 78. Changes in aromatic region of 1H-NMR spectrum upon decomposition of SG1BisAc 135 
to SG1Ac 136 in light over a 70 hour period. Specific timings marked under each spectrum. 
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Figure 79. Changes in aliphatic region of 1H-NMR spectrum upon decomposition of SG1BisAc 135 
to SG1Ac 136 with CH3 groups colour coded for clarity. Timings marked under each spectrum. 
Acylation of SG5 130 and SG7 132 was undertaken in the same manner as that of SG1 
116, both under the same conditions to efficiently yield the spirocyclic bis-acyl products as 
seen with SG1 116. However, unlike SG1BisAc 135, exposure to light did not induce 
photolysis in either of them, this was evidenced by the fact that after more than a week of 
exposure to daylight no change was seen visually or via NMR. This was in direct contrast 
to that seen with SG1BisAc 135, with all other variables held the same.  
In order to further study the photostability of the two bis-acylates SG5BisAc 137 and 
SG8BisAc 139, the samples were subjected to both soft (365 nm) and hard (254 nm) UV 
irradiation. Both samples were initially exposed to 365 nm irradiation with 1H-NMRs run at 
5 minute intervals up to 60 minutes, throughout this time no change was seen visually or 
via NMR. Following this, both were exposed to 254 nm UV irradiation, again with 
measurements at 5 minute intervals up to 320 minutes. No photolysis was observed under 
these conditions either, with no change seen visually or via NMR spectroscopy. In light of  
the contradictory photo stability observed for the bis-acylates SG5BisAc 137 and 
SG8BisAc 139 when compared to SG1BisAc 135 the implication is that there exists a 
steric barrier to photolysis. Despite the differing electron densities in the upper rings of the 
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other bis-acylates, the most significant difference is the steric properties of the upper 
rings. As SG1BisAc 135 decomposed readily in normal daylight while the two others were 
highly resistant even to prolonged irradiation with hard UV, the only conclusion that can be 
made is that there is a steric barrier. This steric barrier appears to prevent both SG5BisAc 
137 and SG8BisAc 139 from adopting the correct orientation for photolysis to occur, 
rendering them kinetically/orientationally stabilised with respect to photolysis. 
 
Figure 80. Both bis-acylates SG5BisAc 137 and SG8BisAc 139 are highly resistant to photolysis 
under normal lighting and UV irradiation of 365 or 254 nm. 
Having successfully acylated the SG1 116 to form SG1Ac 136, their relative quantum 
yields and extinction coefficients could be measured for comparison with the non-acylated 
equivalent. This would provide a proof of concept measurement as to the effectiveness of 
fluorescence quenching when the fluorophore was bound to a biomimetic or other 
recognition sequence, as it would be in a probe. The value obtained for brightness (Φ x ε) 
and the difference measured would provide the basis for fluorescence contrast change in 
any fluorescent probe utilising this fluorophore. 
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2.3.5 Spectral analysis of Singapore Green Acyls 
Fluorophore QY (Φ) Ɛ (M-1cm-1) Brightness (Φ x ε)  
SG1 116 0.64 46044 29810.35 
SG1Ac 136 0.12 225 27.19874 
 
Table 9. Comparative fluorescence, extinction coefficient and brightness values of SG1 116 and 
SG1Ac 136. 
The brightness differential between SG1 116 and SG1Ac 136 was found to be of excellent 
magnitude, with values of 29810 and 27 respectively. This represents a brightness 
change of 99.909 % or approximately an 1100-fold increase in brightness between the 
acylated and free fluorophore. This contrast change would be sufficient for utilisation in 
future fluorogenic probes and proves the concept and utility this class of fluorophore. 
Furthermore, there is scope for improvement upon this value based on the variation in 
fluorescence quantum yield observed upon modulation of upper ring electron density. 
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2.4 Conclusions 
Optimisation and scale up of the synthesis of the S. aureus probe LGX was successful, 
with a more than fourfold improvement to the isolated yield. This enables its production to 
be further scaled up with an aim to eventually form part of an ultra-fast detection system 
for use in healthcare environments. This could form an effective first line of defence for the 
control of troublesome bacterial strains via accurately targeted antibiotic therapy. A 
previously unencountered synthetic complication in the form of over hydrogenation was 
identified and efficiently circumvented via a modification to the synthetic route. This is of 
particular value as hydrogenation of any benzyl ester could be reversed by DDQ. This 
would have utility in the production of other probes containing protected arginine, should 
the steric conditions be appropriate. This complication highlighted the troublesome nature 
and side reactivity of the upper lactone system in rhodamine prompting a reassessment of 
probe construction order. Investigation of non-symmetric fluorophores which could be 
constructed following peptide attachment further highlighted the need for simplification of 
the synthetic route.  
Building on the lessons learned from the LGX project, an orphan class of fluorophore 
coined Singapore Green was investigated. A small library of nine novel fluorophores 
based on this motif were synthesised and fully characterised. It was also confirmed that 
the upper lactone ring system is not essential for fluorescence, while upper ring electron 
density modulates fluorescence quantum yield though varying PeT-based quenching. It 
was further evidenced that that the correlation between electron density and quantum 
yield is not linear, rather a threshold exists beyond which PeT predominates and quantum 
yield drops significantly. 
The characterisation of this novel group of fluorophores has demonstrated they possess 
good quantum yields and extinction coefficients as well as demonstrating their 
compatibility with existing two-channel fluorescence instruments utilising the argon ion 
laser. Their excellent fluorescent properties, coupled with the ease of synthesis and 
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functionalisation (compared with the rhodamine class) provides considerable scope and 
potential for their utilisation for rapid protease detection systems. This is potentially of 
considerable value in the detection of proteases which are characteristic of a disease 
state or indicate the presence of problem pathogens, in light of the grave and continuing 
problem of antibiotic resistance. 
 
2.5 Future Work 
Having synthesised and scaled up the LGX probe successfully, as well as proven the 
favourable fluorescence properties of the Singapore Green fluorophores, the next logical 
step would be to combine the two. However, before selection of the best Singapore Green 
candidate to move forward with, further investigation in terms of extension of lower 
xanthene ring systems should be undertaken (Figure 81). The same synthetic 
methodology to synthesise the xanthone precursors up may be used to achieve this. This 
modification is likely to reveal useful information as to how their λex/λem may be modulated, 
as other work on analogous structures has demonstrated this elicits a bathochromic shift 
in λex/λem.116  
 
Figure 81. Extension of lower xanthene ring systems on Singapore Green precursors. R1 = CH3, 
C2H5, C3H7 etc. 
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Variation of substituents on the upper and lower ring systems is also likely to give rise to 
changes in quantum yield of florescence as observed in this work, warranting further 
investigation (Figure 82).  
 
Figure 82. Synthesis of Singapore Greens with extended lower xanthene ring systems as well as 
variation of ring substituents R1, R2 and R3 to determine their effects on spectral characteristics. R1 
= CH3, C2H5, C3H7; R2 = CH3, OCH3, CF3; R3 = H, CH3, OCH3, CF3 etc. 
Following this, determination of the new analogues’ full spectral properties including 
fluorescence quantum yield would conclusively determine the best candidate to move 
forward with. This candidate would then form the central core for a next generation 
Staphylococcus aureus probe (Figure 83). 
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Figure 83. The most favourable Singapore Green analogue would be used as the core for a next 
generation S. aureus probe using the proven synthetic route to LGX. 
As the synthesis of LGX has been optimised, and the Singapore Green fluorophores 
simplified relative to rhodamine, construction of the new probe should proceed relatively 
smoothly. Once this has been achieved, biological testing should be undertaken in order 
to allow direct comparison to the LGX probe in terms of sensitivity and selectivity. If these 
test prove favourable, the new probe could be eventually patented and put into production 
as a rapid detection system for S. aureus in healthcare environments. 
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3.1 General Experimental Methods 
3.1.1 Physical Methods 
All 1H-NMR spectra were recorded at either 400 MHz on a Brüker AV400 FT-NMR 
spectrometer equipped with a BB-1H/D Z-GRD probe head (broadband multinuclear with 
autotune) or a 600 MHz Bruker AV600 equipped with a PATXI 1H/D-13C/15N Z-GRD probe. 
13C-NMR spectra were recorded at 100 MHz using the Brüker AV400 or at 125 MHz using 
the Brüker AV600. 19F spectra were obtained at 376 MHz on the Brüker AV400. All NMR 
spectra were recorded using NMR tubes of specification 5 mm o/d, No Z107374, Brüker 
BioSpin AG, Switzerland. NMR spectral measurements were carried out in solution using 
deuterated chloroform, deuterated dichloromethane, deuterated dimethyl sulfoxide, or 
deuterated methanol as the solvent. All NMR signals quoted are in ppm as downfield δ 
chemical shifts from either the internal tetramethylsilane (TMS) standard at δ = 0.00 or 
from the residual CHCl3 resonance at δ = 7.26 ppm, residual DCM resonance at δ = 5.32, 
residual DMSO resonance at δ = 2.50 ppm, or the residual MeOD resonance at δ = 3.31 
ppm. All coupling constants are quoted in Hz. Sample analysis was carried out using 
standard procedure for sweep width optimisation and parameter sets for proton dimension 
in correlation spectra. The final spectra were obtained following standard Fourier 
transform NMR processing for the averaged transients. The data was processed manually 
using TopSpin 3.5 pl7 (c) 2017 Brüker BioSpin. 
TLC analysis was performed using Fluka glass backed silica gel plates 60 F254, 250 μm or 
Merck aluminium backed aluminium oxide 60 F254 and visualised at either 254 or 365 nm 
UV by a UVP UVGL – 58 multiband UV lamp, or using KMnO4, Iodine, Vanillin or 
Ninhydrin stains. Flash column chromatography was performed at ambient temperature 
using high purity Merck 63 - 200 μm silica gel at moderate pressure, or with a Biotage 
Isolera Spektra Four system using Biotage ZIP 40 – 60 μm flash cartridges. 
Gas Chromatography – Mass Spectrometry was performed using a Shimadzu GCMS-
QP2010 SE and undertaken using a 1 ppm – 1 ppb solution of each compound. The 
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samples were introduced into the GC-MS and analysed under standard procedure. 
Chromatograph peaks were then checked for the mass, and then the mass spectral 
fragmentation pattern was cross referenced in silico against the inbuilt fragmentation 
pattern database where applicable.  
Low resolution mass spectra (LR MS): EI (electron impact); ES (electro spray); CI 
(chemical ionisation) and High resolution mass spectra (HR MS) were obtained via 
MEDAC Ltd. in accordance with BS EN ISO 9001:2008 provision for microanalysis 
service. 
Infra-red analysis was performed using either a small quantity of the neat oil or a solid 
powdered sample coated onto the analysis plate of a ThermoScientific Nicolet 869-
142500 iD5 Diamond ATR FT-IR spectrophotometer, or coated onto either a KBr or NaCl 
disc and analysed using a ThermoScientific Nicolet iS5 FT-IR spectrophotometer. 
UV-Vis spectrophotometry was performed using an Agilent Cary 7000 UMS 
spectrophotometer using ultra-pure optically matched, stoppered rectangular Spectrosil 
quartz fluorimeter cells, type 23-Q-10 with a 10 mm path length. A scan rate of 600 
nm/min was employed. 
Fluorescence measurement was performed using an Agilent Cary Eclipse fluorescence 
spectrophotometer using the same ultra-pure optically matched, stoppered rectangular 
Spectrosil quartz fluorimeter cells, type 23-Q-10 with a 10 mm path length. 
3.1.2 Reagents, Solvents and Reaction Conditions 
All chemicals were purchased from commercial vendor Sigma-Aldrich chemicals unless 
otherwise stated, and purchased at the highest possible grade (at least > 95 %) and used 
as received. All anhydrous solvents were also purchased at the highest possible grade 
from commercial vendor Sigma-Aldrich chemicals and obtained in SureSealTM packaging 
and stored under nitrogen at 4 oC. Other solvents were of SLR grade from the same 
vendor. Anhydrous reactions were performed using oven then flame dried glassware 
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under vacuum, and carried out under an anhydrous nitrogen atmosphere. Water refers to 
deionised water, LiCl solutions are saturated and brine is a saturated aqueous solution of 
sodium chloride. Where no reaction temperature is given, reactions were carried out at an 
ambient temperature of 20 oC. Evaporation of solvents was performed on a Büchi RE111 
Rotovapor in conjunction with a Büchi 461 water bath. 
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3.2 Experimental Methods 
Boc-NH-Val-Pro-OMe, 64 
 
 
 
To a solution of Boc-L-Valine-OH 62 (1.00 g, 4.60 mmol) in anhydrous DCM (20 ml) was 
added COMU (2.36 g, 5.52 mmol) and triethylamine (2.79 g, 3.84 ml, 27.6 mmol). The 
resulting solution was then stirred for 30 minutes under a dry nitrogen atmosphere. L-
proline methyl ester 63 (0.76 g, 4.6 mmol) was added to the resulting solution and stirred 
for a further 24 hours. The crude mixture was washed with 1 M aqueous HCl solution (3 x 
10 ml), saturated NaHCO3 solution (3 x 10 ml), water (3 x 10 ml) and brine (2 x 10 ml). 
The organics were then dried over Na2SO4 and concentrated under vacuum. Purification 
was achieved via silica flash chromatography using an ethyl acetate:petroleum ether (40 - 
60) 1:1 mix to yield a white amorphous solid.167 (0.950 g, 63 %, 1:1 ethyl 
acetate:petroleum ether (40 – 60) Rf = 0.3). 
1H-NMR (400 MHz; CDCl3) δ = 0.87 (3H, d, J=6.80 Hz, CH3-7), 0.96 (3H, d, J=6.80 Hz, 
CH3-8), 1.36 (9H, s, CH3-1), 1.94 (4H, m, CH2-11,12), 2.15 (1H, m, CH-6), 3.59 (1H, m, 
CH-10), 3.65 (3H, s, CH3-15), 3.71 (1H, m, CH-10’), 4.21 (1H, dd, J=6.24, 9.43 Hz, CH-
13), 4.46 (1H, dd, J=4.64, 9.23 Hz, CH-5), 5.17 (1H, d, J=9.23 Hz, NH-4). 
13C-NMR (100 MHz; CDCl3) δ = 17.56, 19.38, 25.10, 28.48, 29.17, 31.43, 47.32, 52.33, 
57.02, 58.97, 79.70, 156.07, 171.53, 172.55. 
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Boc-NH-Val-Pro-OH, 76 
 
 
 
To a solution of Boc-Val-Pro-OMe 64 (0.85 g, 2.60 mmol) in THF was added a 1M 
aqueous solution of LiOH (100 ml), the resulting solution was stirred at room temperature 
for 2 hours. Following this the solution was concentrated under vacuum, washed with 1M 
HCl solution (3 x 40 ml) and extracted with ethyl acetate (3 x 30 ml), dried over Na2SO4 
and the solvent removed under vacuum. Purification was achieved via recrystallisation 
from DCM:petroleum ether (40 - 60) to yield a fluffy white solid. (0.590 g, 63 %). 
1H-NMR (400 MHz; CDCl3) δ = 0.93 (3H, d, J=6.80 Hz, CH-7), 0.99 (3H, d, J=6.80 Hz, 
CH-8), 1.42 (9H, s, CH3-1), 2.11 (5H, m, CH-6, CH2-11,12), 3.65 (1H, m, CH-10), 3.80 
(1H, m, CH-10’), 4.27 (1H, dd, J=6.83, 9.27 Hz, CH-13), 4.58 (1H, m, CH-5), 5.29 (1H, d, 
J=9.35 Hz, NH-4). 
13C-NMR (100 MHz; CDCl3) δ = 17.52, 19.22, 24.87, 28.08, 28.31, 31.26, 47.61, 56.94, 
59.32, 79.74, 155.86, 172.92, 173.81. 
LR MS (EI) m/z = 315.2, requires 315.2 [M + H]+. 
HR MS (ES) m/z = 313.2523, requires 313.1760 [M - H]+. 
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Rhodamine-(Arg(Cbz)2-NHBoc)2, 69 
 
 
To a solution of HO-Arg(Cbz)2-NH-Boc 68 (0.81 g, 1.50 mmol) in anhydrous DMF (10 ml) 
under a dry nitrogen atmosphere was added HATU (0.62 g, 1.64 mmol) and DIEA (0.31 g, 
0.42 ml, 2.40 mmol). The resulting solution was stirred for 30 minutes before addition of 
rhodamine 110 (0.250 g, 0.682 mmol). The solution was stirred at room temperature for 
20 hours. Purification was achieved via isocratic silica flash chromatography using ethyl 
acetate:chloroform in a 3:7 ratio as a glassy white amorphous solid. (0.231 g, 25 %, 3:7 
ethyl acetate:CHCl3, Rf = 0.3). 
1H-NMR (400 MHz; CDCl3) δ = 1.43 (18H, s, CH3-39), 1.81 (8H, m, CH2-18, 19), 3.97 (4H, 
m, CH2-20), 4.41 (2H, m, CH-17), 5.13 (8H, m, CH2-25, 31), 5.82 (2H, br s, NH-36), 6.54 
(2H, dd, J=2.12, 8.59 Hz, CH-5, 5b), 6.72 (1H, d, J=8.59 Hz, CH-4), 6.77 (1H, d, J=8.59 
Hz, CH-4b), 7.04 (1H, dd, J=1.40, 7.00 Hz, CH-9), 7.28 (20H, m, CH-27, 28, 29, 33, 34, 
35), 7.46 (2H, s, CH-2, 2b), 7.62 (2H, m, CH-10, 11), 8.01 (1H, dd, J=1.86, 6.42 Hz, CH-
12), 8.78 (2H, br s, NH-15), 9.32 (2H, br s, NH-21), 9.44 (2H, br s, NH-23). 
13C-NMR (100 MHz; CDCl3) δ = 24.93, 28.28, 28.49, 44.12, 54.61, 67.42, 69.25, 80.44, 
82.48, 108.18, 108.24, 114.42, 115.76, 124.04, 125.17, 126.38, 128.16, 128.25, 128.31, 
128.51, 128.65, 128.98, 129.09, 129.86, 134.59, 134.60, 135.17, 136.36, 139.66, 151.55, 
153.41, 155.87, 161.00, 163.60, 169.60, 171.06. 
HR MS (ES) m/z = 1379.5876, requires 1379.5619 [M + H]+. 
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Rhodamine-(Arg(Cbz)2-NH2)2, 75 
 
 
To a solution of Rhodamine-(Arg(Cbz)2-NHBoc)2 69 (0.02 g, 0.0140 mmol) in anhydrous 
DCM (3 ml) under a dry nitrogen atmosphere was added TFA (3 ml) and stirred for 4 
hours at room temperature. The mixture was then washed with 1 M aqueous NaOH (3 x 2 
ml) and the organic layer separated. The aqueous layer was then washed with DCM (3 x 
2 ml) and the organics combined, these were then washed with brine (2 x 2 ml), dried over 
anhydrous Na2SO4 and under vacuum to yield a colourless glassy solid which was used 
immediately for the next reaction step without further purification. (0.015 g, 93 %). 
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Rhodamine-(Arg(Cbz)2-Pro-Val-NHBoc)2, 77 
 
 
To a solution of Boc-Val-Pro-OH 76 (0.028g, 0.0880 mmol) in anhydrous DMF (7 ml) 
under a dry nitrogen atmosphere was added HATU (0.037 g, 0.0960 mmol), the resulting 
mixture was stirred for 10 minutes at room temperature, after which DIEA (0.0 g, 0.512 ml, 
0.296 mmol) was added. The solution was stirred for a further 30 minutes, at which point 
Rhodamine-(Arg(Cbz)2-NH2)2 75 (0.016 g, 0.0520 mmol) was added. The reaction was 
followed by TLC analysis and was found to have ceased after 18 hours. The crude 
reaction mixture was diluted with ethyl acetate (15 ml), washed with saturated NaHCO3 (3 
x 3 ml), saturated LiCl (3 x 3 ml), brine (1 x 2 ml) and dried over anhydrous Na2SO4. 
Solvent was removed under vacuum to yield an off white foamy solid. Purification was 
achieved via preparative silica TLC using 100 % ethyl acetate to yield a clear glassy solid. 
(0.044 g, 47 %, 100 % ethyl acetate, Rf = 0.7). 
1H-NMR (400 MHz; CDCl3) δ = 0.86 (12H, m, CH-46), 1.43 (18H, s, CH3-50), 1.89 (18H, 
m, CH-18, 19, 39, 40, 45), 3.54 (2H, m, CH-41), 3.69 (2H, m, CH-41’), 4.03 (4H, m, CH2-
20), 4.22 (2H, m, CH-44), 4.30 (4H, m, CH-38), 4.50 (2H, m, CH-17), 5.02 (2H, d, J=9.13 
Hz, CH-25), 5.16 (2H, d, J=9.13 Hz, CH-25’), 5.25 (4H, s, CH-31), 6.66 (1H, d, J=7.55 Hz, 
CH-5), 6.67 (1H, d, J=7.55 Hz, CH-5b), 6.99 (1H, m, CH-4), 7.07 (1H, m, CH-4b), 7.09 
(1H, m, CH-9), 7.25 (6H, m, CH-34, 35), 7.37 (10H, m, CH-27, 28, 29), 7.53 (1H, s, NH-
36), 7.54 (1H, s, NH-36b), 7.61 (3H, m, CH-2, 10, 11), 7.75 (1H, s, CH-2b), 8.03 (1H, d, 
J=7.36 Hz, CH-12), 8.83 (2H, m, NH-21), 9.41 (2H, m, NH-23). 
13C-NMR (100 MHz; CDCl3) δ = 14.26, 17.60, 17.65, 19.52, 25.12, 25.32, 28.50, 29.84, 
31.37, 44.14, 47.76, 54.16, 57.29, 57.38, 60.45, 60.57, 67.36, 69.26, 79.82, 82.66, 
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108.30, 114.33, 123.99, 125.18, 126.42, 128.25, 128.30, 128.39, 128.50, 128.62, 128.64, 
128.97, 129.05, 129.83, 134.62, 135.15, 136.34, 140.08, 151.66, 156.00, 161.26, 163.60, 
170.13, 172.12. 
LR MS (EI) m/z = 1772.0, requires 1771.8 [M + H]+. 
HR MS (ES) m/z = 1771.8899 requires 1771.8005 [M + H]+. 
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Rhodamine-(H2)-(Arg-Pro-Val-NHBoc)2, 78 
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Into a solution of Rho-(Arg(Cbz)2-Pro-Val-NHBoc)2 77 (0.032 g, 0.0182 mmol) in 
anhydrous DMF (0.5 ml) and anhydrous methanol (0.5 ml) was added 10 % Pd/C (0.001 
g). The resulting mixture was then stirred under a dry hydrogen atmosphere for 48 h. The 
crude reaction mixture was then concentrated under vacuum, reconstituted in anhydrous 
methanol and filtered through Celite. The filtrate was dried under high vacuum to yield the 
product as an amorphous white solid. (0.024 g, 80 %). 
1H-NMR (600 MHz; CD3OD) δ = 0.99 (12H, m, CH3-34), 1.45 (18H, s, CH3-38), 1.87 (2H, 
m, CH-29’), 2.00 (6H, m, CH-28, CH-29, CH-33), 2.12 (2H, m, CH-28’), 2.28 (4H, m, CH2-
18), 3.24 (4H, m, CH2-20), 3.70 (2H, m, CH-30), 3.93 (2H, m, CH-30’), 4.20 (2H, m, CH-
32), 4.74 (4H, m, CH-17, 27), 6.05 (1H, s, CH-7), 6.70 (1H, d, J=7.80, CH-5), 6.90 (1H, d, 
J=7.80, CH-5b), 7.00 (1H, d, J=7.80, CH-4), 7.02 (1H, d, J=8.50, CH-9), 7.05 (1H, d, 
J=7.80, CH-4b), 7.23 (1H, dd, J=6.91, 8.50, CH-10), 7.25 (1H, dd, J=6.91, 8.50, CH-11), 
7.42 (1H, s, CH-2), 7.44 (1H, s, CH-2b), 7.46 (1H, d, J=8.50, CH-12), 8.17 (2H, s, NH-15), 
8.48 (2H, d, J=7.00, NH-25), 10.11 (2H, d, J=7.70 Hz, NH-24). 
13C-NMR (125 MHz; CD3OD) δ = 17.2, 18.4, 22.3, 24.7, 24.9, 27.3, 28.9, 29.2, 29.4, 30.2, 
35.6, 40.7, 44.1, 48.3, 48.6, 53.7, 58.0, 60.4, 73.3, 76.5, 79.2, 82.7, 107.4, 114.1, 115.6, 
123.7, 124.3, 126.2, 127.0, 134.4, 139.5, 149.5, 154.6, 155.4, 162.2, 169.6, 170.0, 171.1, 
172.2 
LR MS (EI) m/z = 1236.3 (z = 1), requires 1236.7 [M + 2H]+. 
HR MS (ES) m/z = 619.6222 (z = 2), requires 619.3362 [M + 2H]+. 
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LGX; Rhodamine-(Arg-Pro-Val-NHBoc)2, 61 
 
 
 
Into a solution of rhodamine-(H2)-(Arg-Pro-Val-NHBoc)2 78 (0.032 g, 0.0182 mmol) in 
anhydrous methanol (0.5 ml) and anhydrous DMF (0.5 ml) under a dry nitrogen 
atmosphere was added 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (0.033 g, 0.146 
mmol). The resulting mixture was stirred at room temperature for 30 minutes while 
monitoring via TLC analysis. Purification was achieved via MDAP and dried under high 
vacuum to yield the product as an amorphous white solid. (0.022 g, 83 %). 
1H-NMR (600 MHz; CD3OD) δ = 0.99 (12H, m, CH3-34), 1.45 (18H, s, CH3-38), 1.87 (2H, 
m, CH-29), 2.00 (6H, m, CH-28, 29’, 33), 2.12 (2H, m, CH-28’), 2.28 (4H, m, CH2-18), 3.24 
(4H, m, CH2-20), 3.70 (2H, m, CH-30), 3.93 (2H, m, CH-30’), 4.20 (2H, m, CH-32), 4.74 
(4H, m, CH-17, 27), 6.65 (1H, J=7.80, NH-35), 6.75 (1H, d, J=7.80, CH-5), 6.75 (1H, d, 
J=7.80, CH-5b), 7.19 (1H, d, J=7.80, NH-35b), 7.21 (1H, d, J=8.50, CH-9), 7.22 (1H, d, 
J=7.80, CH-4), 7.41 (2H, s, NH-21), 7.73 (1H, dd, J=6.90, 8.50, CH-10), 7.79 (1H, dd, J-
6.90, 8.50, CH-11), 7.82 (1H, s, CH-2), 7.89 (1H, s, CH-2b), 8.05 (1H, d, J=8.50, CH-12), 
8.17 (2H, s, NH-15), 8.48 (2H, d, J=7.00, NH-25), 10.11 (1H, s, NH-24) 10.11 (1H, s, NH-
24b). 
 
13C NMR (125 MHz; CD3OD) δ = 17.2, 18.4, 22.3, 24.7, 24.9, 27.3, 28.9, 29.2, 29.4, 30.2, 
35.6, 40.7, 44.1, 48.3, 48.6, 53.7, 58.0, 60.4, 73.3, 79.2, 82.7, 107.4, 114.1, 115.6, 123.7, 
124.6, 126.2, 128.0, 130.0, 135.4, 140.7, 151.5, 156.7, 157.4, 163.8, 169.8, 171.0, 172.2, 
173.2. (Three additional peaks for C-2b, C-4b and C-5b).  
 
HR MS (EI) m/z = 618.3322 (z = 2), requires 618.3283 [M + 2H]+. 
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3-Nitroxanthen-9-one, 82a 
 
 
 
Two routes: 
Into concentrated sulphuric acid at 0 oC was slowly added concentrated nitric acid with 
stirring to form a 1:1 mixture, this was stirred at 0 oC for 30 minutes, after which xanthone 
(1.50 g, 7.65 mmol) was slowly added. The resulting mixture was stirred at 0 oC for a 
further 40 minutes after which it was poured over ice (500 ml) and stirred until a 
precipitate formed. This was isolated and re-suspended in 20 % Na2CO3 with stirring until 
evolution of CO2 had ceased. The solid was then washed with water (3 x 100 ml) and air 
dried. Purification was achieved via silica flash column chromatography using an Ethyl 
acetate:petroleum ether (40 - 60) gradient of 1:9 to 4:6, yielding a white crystalline solid. 
(0.331 g, 1.377 mmol, 18 %, 3:7 ethyl acetate:petroleum ether (40 – 60) Rf = 0.5). 
To a stirred solution of phenol (18.3 g, 194 mmol) in DMF (200 ml) was added K2CO3 
(26.81 g, 194 mmol). To the resulting solution was added 2-chloro-4-nitro-benzoic acid 
(19.6 g, 97.0 mmol) and copper powder (1.23 g, 19.4 mmol). The mixture was then 
refluxed at 130 oC for 40 hours, cooled to room temperature, poured over concentrated icy 
HCl (600 ml) and stirred until a brown precipitate formed. The pH was adjusted to 1 and 
the solid isolated, washed with excess cold water and air dried. The dry isolated solid was 
added portionwise to concentrated H2SO4 (150 ml) and heated to 80 oC with stirring for 1.5 
hours and cooled to room temperature. The crude mixture was slowly poured over ice 
(500 ml) and stirred until a brown/beige precipitate formed, this was isolated and stirred in 
solution of 20 % Na2CO3 until evolution of CO2 ceased and washed with excess water. 
Purification was achieved via isocratic silica flash column chromatography using ethyl 
acetate:petroleum ether (40 - 60) in a 3:7 ratio yielding a white crystalline solid. (7.95 g, 34 
%, 3:7 ethyl acetate:petroleum ether (40 – 60) Rf = 0.5). 
1H-NMR (400 MHz; d6 - DMSO) δ = 7.54 (1H, ddd, J=0.91, 7.15, 7.98 Hz, CH-8), 7.70 
(1H, dd, J=0.91, 8.56 Hz, CH-10), 7.94 (1H, ddd, J=1.72, 7.15, 8.56 Hz, CH-9), 8.20 (1H, 
dd, J=2.04, 8.73 Hz, CH-2), 8.20 (1H, dd, J=1.72, 7.98 Hz, CH-7), 8.40 (1H, d, J=8.73 Hz, 
CH-3), 8.45 (1H, d, J=2.04 Hz, CH-13). 
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13C-NMR (100 MHz; d6 - DMSO) δ = 114.14, 118.22, 118.23, 121.14, 124.94, 125.06, 
126.05, 128.10, 136.26, 151.04, 155.11, 155.87, 175.24. 
IR (ATR): v = 3092, 1667, 1614, 1575, 1522. 
LR MS (EI) m/z = found 241.0, requires 241.0 [M]+. 
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3-Aminoxanthen-9-one, 82 
 
 
 
To a stirred suspension of 3-nitroxanthen-9-one 82a (0.90 g, 3.70 mmol) in industrial 
methylated spirit (50 ml) was added tin(II) chloride (3.34 g, 14.80 mmol). The resulting 
mixture was heated to reflux for 2 hours, after which TLC analysis confirmed consumption 
of the starting material. The crude mixture was cooled to room temperature, the solvent 
removed under vacuum, saturated aqueous NaHCO3 (30 ml) added and mixture stirred for 
30 minutes. The mixture was then filtered and washed with excess water and dried in air. 
The dry residue was ground to a fine powder and subjected to ultrasonication in 
chloroform several times, the organic extracts were combined, washed with water (3 x 25 
ml), brine (2 x 25 ml) and dried over Na2SO4 to yield the pure product as a yellow/beige 
solid. (0.802 g, 79 %).168 
1H-NMR (400 MHz; d6 - DMSO) δ = 6.41 (2H, s, NH2-14), 6.47 (1H, d, J=2.04 Hz, CH-13), 
6.61 (1H, dd, J=2.04, 8.71 Hz, CH-2), 7.33 (1H, ddd, J=0.81, 7.17, 7.87 Hz, CH-8), 7.46 
(1H, d, J=8.31, 0.81 Hz, CH-10), 7.68 (1H, ddd, J=1.63, 7.17, 8.31 Hz, CH-19), 7.79 (1H, 
d, J=8.71 Hz, CH-3), 8.04 (1H, dd, J=1.63, 7.87 Hz, CH-7). 
13C-NMR (100 MHz; d6 - DMSO) δ = 107.01, 120.27, 122.00, 127.06, 131.02, 133.20, 
135.18, 137.02, 143.61, 164.87, 165.28, 167.55, 183.39. 
LR MS (EI) m/z = found 212.1, requires 212.1 [M + H]+. 
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3'-Aminospiro[isobenzofuran-3,9'-xanthene]-1-one, 85 
 
 
 
 
To a solution of phenol (2.00 g, 21.3 mmol) in anhydrous methansulfonic acid (30 ml) 
under a dry nitrogen atmosphere, were added 3-aminophenol (2.32 g, 21.3 mmol) and 
phthalic anhydride (3.15 g, 21.3 mmol) with vigorous stirring. The mixture was heated to 
140 oC for 48 hours, cooled to room temperature and poured over ice (400 ml). The crude 
mixture was stirred for 30 minutes until a suspension was formed, and its pH was adjusted 
to 8 using a 10 % aqueous NaOH solution. The aqueous phase was filtered, and the 
residue subjected to ultrasonication in DCM (3 x 30 ml) followed by chloroform (3 x 30 ml). 
The organic extracts were combined and washed with 10 % aqueous NaOH solution (3 x 
50 ml), brine (2 x 25 ml), dried over Na2SO4, the solvent was then removed under 
vacuum. Purification was achieved via successive dry loaded isocratic flash column 
chromatography, using a mobile phase of 1.5:98.5 methanol:DCM followed by 1:99 to 
yield a deep red fluffy solid. (0.103 g, 13 %, 1:99 methanol:DCM Rf = 0.3). 
1H-NMR (400 MHz; CD2Cl2) δ = 4.00 (2H, s, NH2-21), 6.38 (1H, dd, J=2.28, 8.55 Hz, CH-
2), 6.55 (1H, d, J=2.28 Hz, CH-13), 6.56 (1H, d, J=8.55 Hz, CH-3), 6.77 (1H, dd, J=1.47, 
7.91 Hz, CH-10), 7.02 (1H, ddd, J=0.97, 7.17, 7.91 Hz, CH-9), 7.17 (1H, d, J=7.47 Hz, 
CH15), 7.27 (1H, dd, J=0.97, 8.42 Hz, CH-7), 7.40 (1H, ddd, J=1.47, 7.17, 8.42 Hz, CH-
8), 7.63 (1H, ddd, J=1.02, 7.41, 7.47 Hz, CH-16), 7.69 (1H, ddd, J=1.25, 7.41, 7.51 Hz, 
CH-17), 7.99 (1H, d, J=7.51 Hz, CH-18). 
13C-NMR (100 MHz; CD2Cl2) δ = 101.04, 111.51, 116.99, 119.38, 123.41, 123.89, 124.78, 
127.05, 127.96, 129.07, 129.65, 130.43, 134.96, 139.55, 143.43, 149.27, 151.43, 152.45, 
153.17, 155.55. 
HR MS (ES) m/z = 316.0976, requires 316.0968 [M + H]+. 
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3'-Amino-6'-iodo-spiro[isobenzofuran-3,9'-xanthene]-1-one, 89 
 
 
 
 
To a solution of 3-aminophenol (4.00 g, 36.7 mmol) in anhydrous methanesulfonic acid 
(35 ml) under a dry nitrogen atmosphere, were added 3-iodophenol (8.06 g, 36.65 mmol) 
and phthalic anhydride (5.42 g, 36.7 mmol) with vigorous stirring. The resulting 
suspension was heated to 140 oC for 40 hours and cooled to room temperature. The 
crude mixture was then poured over ice (300 ml) and stirred until a brown suspension 
formed, the pH was then adjusted to 7 using 10 % aqueous NaOH solution. The crude 
mixture was extracted with DCM (3 x 50 ml), the organics combined and washed with 10 
% aqueous NaOH solution (3 x 50 ml), brine (2 x 25 ml), dried over Na2SO4 and 
concentrated to yield a crude brown solid. Purification was achieved via dry loaded flash 
column chromatography using a gradient of 3:7 ethyl acetate:petroleum ether (40 - 60) to 
1:1, followed by standard isocratic flash column chromatography using 3:97 
methanol:DCM to yield the product as a fluffy pink solid.169 (1.136 g, 7 %, 3:97 
methanol:DCM Rf = 0.3). 
1H-NMR (400 MHz; d6 - DMSO) δ = 5.67 (2H, s, NH2-21), 6.36 (1H, dd, J=2.04, 8.55 Hz, 
CH-2), 6.39 (1H, d, J=8.55 Hz, CH-3), 6.45 (1H, d, J=2.04 Hz, CH-13), 6.50 (1H, d, J=8.31 
Hz, CH-7), 7.28 (1H, dd, J=0.90, 7.62 Hz, CH-15), 7.42 (1H, dd, J=1.72, 8.31 Hz, CH-8), 
7.72 (1H, ddd, J=0.90, 7.45, 7.56 Hz, CH-17), 7.76 (1H, d, J=1.72 Hz, CH-10), 7.79 (1H, 
ddd, J=0.87, 7.45, 7.62 Hz, CH-16), 7.99 (1H, dd, J= 0.87, 7.56 Hz, CH-18). 
13C-NMR (100 MHz; d6 - DMSO) δ = 82.64, 96.06, 99.05, 104.68, 111.50, 119.07, 123.91, 
124.58, 125.33, 125.97, 128.37, 129.44, 130.08, 132.42, 135.54, 151.24, 151.40, 151.49, 
152.12, 168.49. 
HR MS (ES) m/z = 441.9946, requires 441.9935 [M + H]+. 
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1-Oxaspiro[4.5]decan-2-one, 97 
 
 
 
Into a stirred solution of SmI2 (0.13 M, 20 ml, 2.64 mmol) in dry THF under a dry nitrogen 
atmosphere was added a solution of cyclohexanone (0.10 g, 0.11 ml, 1.06 mmol), ethyl 
acrylate (0.11 g, 0.11 ml, 1.06 mmol) and s-BuOH (0.08 g, 0.10 ml, 1.06 mmol) in dry THF 
drop-wise. The resulting solution was stirred at room temperature for 20 h. The reaction 
mixture was dried in vacuo, taken up into DCM and washed with 1M HCl x 2, dried over 
Na2SO4 and purified via flash column chromatography in 1:3 ethyl acetate:petroleum ether 
(40 - 60) to yield a colourless oil. (0.108 g, 66 %, 1:3 ethyl acetate:petroleum ether (40 – 
60) Rf = 0.5). 
1H NMR (400 MHz; CDCl3) δ = 1.32 - 1.61 (m, 6H, CH2-6, 7, 8) 1.64 - 1.73 (m, 2H, CH2-9) 
1.73 - 1.82 (m, 2H, CH2-5) 1.99 (t, J=8.34 Hz, 2H, CH2-3) 2.57 (t, J=8.34 Hz, 2H, CH2-2) 
13C NMR (100 MHz; CDCl3) δ = 22.53, 24.87, 28.54, 32.79, 36.85, 86.34, 176.74.  
IT (ATR): v = 2933, 2860, 1762. 
HR MS (ES) m/z = 155.0994, requires 155.1063 [M + H]+. 
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N’,N’-dimethylbenzohydrazide, 100 
 
 
 
To a vigorously stirred biphasic mixture of diethyl ether (40 ml), 10 % aqueous NaOH 
solution (20 ml) and dimethylhydrazine (2.57 g, 3.25 ml, 42.7 mmol) at 0 oC, benzoyl 
chloride (6.00 g, 4.95 ml, 42.7 mmol) was slowly added over 20 minutes, the solution was 
maintained at 0 oC for 1 hour. The resulting solution was followed via TLC analysis for a 
further 5 hours, after which the starting material had been consumed. The crude mixture 
was separated, and the aqueous layer washed with diethyl ether (3 x 30 ml), the organics 
were combined and washed with 10 % aqueous NaOH solution. The organics were dried 
over Na2SO4, and the solvent removed under vacuum. Purification was achieved via 
trituration in in petroleum ether (40 - 60) followed by recrystallisation from petroleum ether 
(40 - 60):ethyl acetate, to yield lustrous rod shaped crystals.170 (4.830 g, 70 %). 
1H-NMR (400 MHz; CDCl3) δ = 2.66 (6H, s, CH3-7), 7.09 (1H, br s, NH-6), 7.37 (2H, m, 
CH-3), 7.45 (1H, m, CH-1), 7.71 (2H, m, CH-2). 
13C-NMR (100 MHz; CDCl3) δ = 47.49, 126.99, 128.43, 131.45, 133.65, 165.65. 
LR MS (EI) m/z = 187.1, requires 187.1 [M + Na]+. 
HR MS (ES) m/z = 164.0955, requires 164.0950 [M]+. 
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N-benzoyl-N',N'-dimethylbenzohydrazide, 101 
 
 
 
To a vigorously stirred biphasic mixture of diethyl ether (40 ml), 10 % aqueous NaOH 
solution (20 ml) and dimethylhydrazine (2.57 g, 3.25 ml, 42.7 mmol), benzoyl chloride 
(6.00 g, 4.95 ml, 42.7 mmol) was slowly added over 20 minutes, the solution was 
maintained at 0 oC for 1 hour. The resulting solution was followed via TLC analysis for a 
further 5 hours, after which the starting material had been consumed. The crude mixture 
was separated, and the aqueous layer washed with diethyl ether (3 x 30 ml), the organics 
were combined and washed with 10 % aqueous NaOH solution. The organics were dried 
over Na2SO4, and the solvent removed under vacuum. Purification was achieved via 
trituration in in petroleum ether (40 - 60) followed by recrystallisation from petroleum ether 
(40 - 60):ethyl acetate, to yield large diamond shaped crystals.171 (1.374 g, 12 %). 
1H-NMR (400 MHz; CDCl3) δ = 2.94 (6H, s, CH3-7), 7.39 (4H, m, CH-2), 7.49 (2H, m, CH-
1), 7.70 (4H, m, CH-3). 
13C-NMR (100 MHz; CDCl3) δ = 44.04, 128.25, 128.54, 132.05, 135.15, 173.56. 
LR MS (EI) m/z = 269.2, requires 269.1 [M + H]+. 
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3H-spiro[2-benzofuran-1-1’-cyclohexan]-3-one, 103 
 
 
 
To a solution of s-BuLi (1.40 M, 0.25 ml, 3.05 mmol) at -78 oC in anhydrous THF (10 ml) 
under a dry nitrogen atmosphere was added N’,N’-dimethylbenzohydrazide 100 (0.20 g, 
1.22 mmol) and TMEDA (0.14 g, 0.18 ml, 2.44 mmol). Cyclohexanone (0.24 g, 0.25 ml, 
2.44 mmol, 0.8 eq) was then added dropwise; the resulting solution was stirred at -78 oC 
for a further 4 hours before further stirring at room temperature for 16 hours. The reaction 
as then quenched with cold water, the water layer separated, washed with DCM (3 x 5 
ml), the organics combined and washed with brine (2 x 3 ml), dried over anhydrous Na-
2SO4 and concentrated under vacuum. Purification was achieved via silica flash column 
chromatography using 1:4 ethyl acetate:petroleum ether (40 - 60) to yield a fragrant 
colourless oil. (0.061 g, 0.302 mmol, 25 %, 1:4 ethyl acetate:petroleum ether (40 - 60) Rf = 
0.4). 
1H NMR (400 MHz; CDCl3) δ = 1.67 - 1.78 (4H, m, CH2-9, 13) 1.78 - 1.92 (6H, m, CH2-10, 
11, 12) 7.38 (1H, d, J=7.65 Hz, CH-6) 7.48 (1H, m, CH-4) 7.63 (1H, m, CH-5) 7.84 (1H, d, 
J=7.65 Hz, CH-3).  
13C NMR (100 MHz; CDCl3) δ = 22.22, 24.62, 36.24, 86.87, 120.89, 125.38, 125.66, 
128.83, 133.83, 154.81, 170.01.  
IR (ATR): v = 3052, 2934, 2861, 1746, 1614, 1600. 
HR MS (ES) m/z = 202.0987, requires 202.0993 [M]+. 
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Spiro[isobenzofuran-3,9'-xanthene]-1-one, 104 
 
 
 
To a solution of N’,N’-dimethylbenzohydrazide 100 (0.200 g, 1.22 mmol) in anhydrous 
THF (5 ml) at -78 oC under a dry nitrogen atmosphere containing TMEDA (0.14 g, 1.22 
mmol), was slowly added a 1.40 M solution of s-BuLi in THF (2.18 ml, 3.05 mmol). The 
solution was stirred at -78 oC for 1 hour, after which a solution of xanthone in THF (5 ml, 
0.24 g, 1.22 mmol) was added dropwise. The reaction mixture was maintained at -78 oC 
for 1 further hour, after which was warmed to room temperature and stirred for 4 hours. 
The crude mixture was quenched with water (10 ml) and the organic layer washed with 
DCM (3 x 10 ml), the organics combined, washed with water (3 x 10 ml) dried over 
Na2SO4 and the solvent removed under vacuum. The crude was reconstituted in THF (20 
ml) and acidified with 6 M aqueous HCl solution (10 ml) and let stand for 12 hours, after 
which the pure product had crystallised out of solution as needle like crystals. These were 
isolated, washed with diethyl ether (3 x 5 ml) and dried under vacuum. (0.059 g, 16 %). 
1H-NMR (400 MHz; CD2Cl2) δ = 6.85 (2H, dd, J=1.58, 8.00 Hz, CH-13), 7.06 (2H, ddd, 
J=1.21, 7.11, 8.00 Hz, CH-1, 9), 7.16 (1H, m, CH-15), 7.33 (2H, dd, J=1.21, 8.33 Hz. CH-
3, 7), 7.44 (2H, ddd, J=1.58, 7.11, 8.33 Hz, CH-2, 8), 7.65 (2H, ddd, J=1.27, 7.39, 7.39 
Hz, CH-17), 7.69 (1H, ddd, J=1.47, 7.39, 7.39 Hz, CH-16), 8.02 (1H, m, CH-18). 
13C NMR (100 MHz; CD2Cl2) δ = 82.66, 117.69, 119.57, 124.26, 124.37, 125.57, 126.69, 
128.46, 130.44, 131.26, 135.76, 151.70, 153.95, 169.71.  
IR (ATR): v = 3055, 3043, 1765, 1605, 1573. 
HR MS (ES) m/z = found 301.0870, requires 301.0865 [M + H]+. 
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3-Amino-6-nitro-xanthen-9-one, 108 
 
 
 
To a stirred suspension of 3-acetamidophenol (18.10 g, 120 mmol) in anhydrous DMF 
(200 ml) under a dry nitrogen atmosphere, was added anhydrous K2CO3 (16.60 g, 120 
mmol), 2-chloro-4-nitrobenzoic acid and copper powder (0.40 g, 6.00 mmol). The resulting 
mixture was heated to 130 oC for 16 hours, then cooled to room temperature. The crude 
mixture was quenched by pouring over 500 ml of iced 5 M HCl solution and adjusted to 
pH 1 via further HCl addition. The mixture was stirred until a pale brown solid had 
precipitated, the solid was then isolated, washed with cold water and dried in air. The solid 
was then slowly dissolved in concentrated H2SO4 (100 ml) and heated to 80 oC for 1 hour 
with stirring. After cooling to room temperature, the mixture was poured over ice (300 ml) 
and stirred until a brown solid formed, the solid was isolated and stirred with 20 % w/v 
Na2CO3 until evolution of CO2 ceased. The crude product was washed with water and 
dried under vacuum. Purification was achieved via successive reverse recrystallisation 
and decantation using ethyl acetate:petroleum ether (40 - 60) 1:1 to pure ethyl acetate. 
The pure product was isolated as a bright yellow powder. (9.220 g, 30 %, 1:1 ethyl 
acetate:petroleum ether (40 – 60) Rf = 0.2). 
1H-NMR (400 MHz; d6 - DMSO) δ = 6.56 (1H, d, J=2.04 Hz, CH-13), 6.70 (2H, s, NH2-14), 
6.71 (1H, dd, J=2.04, 8.79 Hz, CH-2), 7.87 (1H, d, J=8.79 Hz, CH-3), 8.14 (1H, dd, 
J=2.14, 8.65 Hz, CH-8), 8.31 (1H, d, J=8.65 Hz, CH-7), 8.34 (1H, d, J=2.14 Hz, CH-10). 
13C-NMR (100 MHz; d6 - DMSO) δ = 97.33, 110.67, 113.15, 113.49, 117.76, 125.69, 
127.60, 127.71, 150.23, 154.81, 156.46, 158.32, 172.38. 
IR (ATR): v = 3479, 3345, 3223, 3105, 1646, 1630, 1608, 1573, 1543. 
LR MS (EI) m/z = found 257.1, requires 257.1 [M + H]+. 
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3-Hydroxy-6-nitro-xanthen-9-one, 117 
 
 
 
To a stirred solution of 3-amino-6-nitro-xanthen-9-one 108 (1.48 g, 5.78 mmol) in a 
mixture of concentrated H2SO4 (30 ml) and water (15 ml) at 0 oC, a solution of NaNO2 
(1.20 g, 17.3 mmol) in water (10 ml) was added dropwise. The mixture was stirred for 1 
hour at 0 oC, then poured into boiling water (1000 ml) and held at 90 oC for a 1 hour. The 
reaction was cooled to room temperature, the solid isolated, washed with excess cold 
water and dried under vacuum to yield the pure product as a light brown powder. (1.283 g, 
86 %). 
1H-NMR (400 MHz; d6 - DMSO) δ = 6.88 (1H, d, J=2.20 Hz, CH-13), 6.94 (1H, dd, J=2.20, 
8.75 Hz, CH-2), 8.03 (1H, d, J=8.75 Hz, CH-3), 8.15 (1H, dd, J=2.16, 8.67 Hz, CH-8), 8.33 
(1H, d, J=8.67 Hz, CH-7), 8.36 (1H, d, J=2.16 Hz, CH-10), 11.12 (1H, s, OH-14). 
13C-NMR (100 MHz; d6 - DMSO) δ = 102.16, 113.77, 113.92, 114.85, 118.05, 125.13, 
127.85, 128.11, 150.57, 154.98, 157.85, 164.65, 173.63. 
IR (ATR): v = 3074 br, 1649, 1607, 1565, 1528.  
LR MS (EI) m/z = found 256.0, requires 256.0 [M - H]+. 
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3-Methoxy-6-nitro-xanthen-9-one, 118 
 
 
 
To a suspension of 3-hydroxy-6-nitro-xanthen-9-one 117 (1.28 g, 4.98 mmol) in 
anhydrous DMF (30 ml) under a dry nitrogen atmosphere, was added anhydrous K2CO3 
(1.38 g, 9.98 mmol). The suspension was stirred for 20 minutes, after which iodomethane 
(0.850 g, 5.99 mmol) was added dropwise. The resulting mixture was stirred at room 
temperature for 18 hours, after which TLC analysis showed complete disappearance of 
starting material. The crude reaction mixture was diluted with chloroform (30 ml), filtered, 
the residue washed several times with chloroform and the organic extracts combined. The 
organic extracts were washed with saturated aqueous LiCl solution (3 x 50 ml), and the 
LiCl layers back extracted with chloroform. The organics were combined, washed with 
saturated aqueous NaHCO3 (3 x 50 ml), water (2 x 50 ml) and brine (2 x 50 ml). The 
washing process was repeated until the organic layer was clean via TLC, after which it 
was dried over Na2SO4 followed by vacuum, to yield a beige powder. (1.086 g, 80 %). 
1H-NMR (400 MHz; d6 - DMSO) δ = 3.98 (3H, s, CH3-14), 6.95 (1H, d, J=2.36 Hz, CH-13), 
7.02 (1H, dd, J=2.36, 8.91 Hz, CH-2), 8.18 (1H, dd, J=2.12, 8.67 Hz, CH-8), 8.27 (1H, d, 
J=8.91 Hz, CH-3), 8.36 (1H, dd, J=0.32, 2.12 Hz, CH-10), 8.50 (1H, dd, J=0.32, 8.67 Hz, 
CH-7). 
13C-NMR (100 MHz; d6 - DMSO) δ = 56.27, 100.69, 113.79, 114.36, 114.95, 118.28, 
125.17, 127.73, 127.96, 150.75, 155.09, 157.92, 165.51, 173.91.  
IR (ATR): v = 3104, 1668, 1615, 1575, 1524. 
LR MS (EI) m/z = found 271.0, requires 271.1 [M]+. 
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3-Amino-6-methoxy-xanthen-9-one, 119 
 
 
 
To a stirred suspension of 3-methoxy-6-nitro-xanthen-9-one 118 (1.09 g, 4.00 mmol) in 
absolute ethanol (30 ml), was added tin(II) chloride (2.43 g, 12.8 mmol). The resulting 
mixture was heated to reflux for 20 hours, after which TLC analysis showed complete 
consumption of the starting material. The crude mixture was cooled to room temperature, 
the ethanol was removed under vacuum, quenched with saturated aqueous NaHCO3 (50 
ml) and stirred for 30 minutes. The crude solid was isolated and washed with water (3 x 
30 ml), then air dried for 12 hours. The resulting solid was ground into a fine powder, 
suspended in acetone, subjected to ultrasonication, filtered and the acetone filtrate 
retained. The residue was repeatedly subjected to this process until the acetone filtrate 
became colourless. The organic extracts were combined and dried under vacuum to yield 
a shiny fluorescent yellow solid requiring no further purification. (0.941 g, 98 %). 
1H-NMR (400 MHz; d6 - DMSO) δ = 3.90 (3H, s, CH315), 6.34 (2H, s, NH2-14), 6.51 (1H, 
d, J=2.05 Hz, CH-13), 6.64 (1H, dd, J=2.05, 8.65 Hz, CH-2), 6.95 (1H, dd, J=2.40, 8.80 
Hz, CH-8), 7.03 (1H, d, J=2.40 Hz, CH-10), 7.82 (1H, d, J=8.65 Hz, CH-3), 8.00 (1H, d, 
J=8.80 Hz, CH-7). 
13C-NMR (100 MHz; d6 - DMSO) δ = 55.95, 97.53, 100.44, 110.66, 112.16, 112.55, 
115.20, 127.16, 127.35, 155.34, 157.17, 158.02, 163.90, 173.26. 
IR (ATR): v = 3373, 3336, 3216, 1649, 1596. 
LR MS (EI) m/z = 229.1, requires 229.1 [M]+. 
 
 
 
 
 
6
11
7
10
8
9
4
12
5
O
2
1
3
13
O
NH2
14
O
CH3
15
Chapter 3 - Experimental 
 
149 
 
3-Methoxy-6-(tritylamino)xanthen-9-one, 120 
 
 
 
To a solution of 3-amino-6-methoxy-xanthen-9-one 119 (0.94 g, 3.90 mmol) in anhydrous 
DCM (60 ml), was added triethylamine (1.58 g, 2.18 ml, 15.6 mmol) followed by trityl 
chloride (2.17 g, 7.80 mmol). The reaction was stirred at room temperature while 
monitoring via TLC analysis, complete consumption of the starting material was noted 
after 1 hour. The crude reaction mixture was then diluted with water (50 ml), the aqueous 
portion separated and successively washed with DCM (3 x 50 ml). The organics were 
then combined, washed with water (3 x 50 ml), brine (2 x 50 ml), dried over anhydrous 
Na2SO4 and the solvent removed under vacuum. Purification was achieved via dissolution 
in DCM and subsequent precipitation in excess vigorously stirred n-hexane. The product 
was isolated, washed several times with 10:1 to 20:1 n-hexane:ethyl acetate and dried 
under vacuum to yield a very light yellow powder. (1.523 g, 81 %). 
1H-NMR (400 MHz; CDCl3) δ = 3.85 (3H, s, CH3-15), 5.66 (2H, s, NH-14), 6.07 (1H, d, 
J=2.26 Hz, CH-13), 6.54 (1H, dd, J=2.26, 8.77 Hz, CH-2), 6.69 (1H, d, J=2.44 Hz, CH-10), 
6.84 (1H, dd, J=2.44, 8.87 Hz, CH-8), 7.94 (1H, d, J=8.77 Hz, CH-3), 8.14 (1H, d, J=8.87 
Hz, CH-7). 
13C-NMR (100 MHz; CDCl3) δ = 55.82, 71.92, 100.22, 101.45, 112.53, 113.16, 114.03, 
116.09, 127.09, 127.47, 128.03, 128.41, 129.21, 144.45, 151.93, 157.62, 157.92, 164.30, 
175.40. 
IR (ATR): v = 3316, 1601, 1520. 
HR MS (ES) m/z = found 484.1925, requires 484.1913 [M + H]+. 
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2-Chlorotrityl resin bound methoxyaminoxanthone, 3-Methoxy-6-
(tritylamino)xanthen-9-one 119p 
 
 
 
The 2-chlorotrityl chloride resin (2.60 g, 4.16 mmol trityl sites) was swelled in anhydrous 
DCM (50 ml) under a nitrogen atmosphere for 30 minutes, the solvent was removed and 
the resin rinsed with anhydrous DCM (2 x 10 ml). The resin was then dried under a stream 
of nitrogen, after which a pyridine (3.29 g, 41.6 mmol, 3.36 ml) and a solution of 3-
methoxy-6-(tritylamino)xanthen-9-one (1.00 g, 4.16 mmol) in anhydrous DCM/DMF (50 
ml/10 ml) was added. The resulting suspension was agitated for 36 hours, after which the 
solution was removed under positive nitrogen pressure. The crude resin was washed with 
anhydrous DMF (5 x 30 ml), anhydrous methanol (10 x 20 ml) and anhydrous DCM (10 x 
20 ml), then dried under a nitrogen stream. 
A solution of DCM:Methanol:DIEA (34 ml:4 ml:2 ml) was then added to the resin under a 
dry nitrogen atmosphere and the resulting suspension was agitated for 1 hour at room 
temperature. The capping solution was then removed under positive nitrogen pressure 
and washed with DCM (3 x 20 ml), DMF (3 x 20 ml), methanol (3 x 20 ml) and DCM (3 x 
20 ml), dried under a nitrogen stream and vacuum desiccated at 50 oC for 48 h, then 
stored under nitrogen. 
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SG1.TFA; 6-Methoxy-9-(o-tolyl)xanthen-3-iminium trifluoroacetate, 116 
 
 
 
Under a dry nitrogen atmosphere, a stirred 2 M solution of o-tolylmagnesium bromide 
(2.58 ml, 1.03 mmol) was diluted to 0.5 M with anhydrous THF (7.73 ml). Into this was 
added a 0.1 M solution of 3-methoxy-6-(tritylamino)xanthen-9-one 120 (0.50 g, 1.03 
mmol) dropwise at room temperature. The solution was then heated to 60 oC and stirred 
for 16 h, after which an additional portion of o-tolylmagnesium bromide (1.03 ml, 2.06 
mmol) was slowly added and maintained at 60 oC for a further 16 h while following with 
TLC analysis. The reaction was then quenched with water (20 ml), then acidified to pH 7 
via slow addition of cold aqueous 1 M HCl. The solution was extracted with diethyl ether 
(3 x 15 ml) and ethyl acetate (1 x 15 ml). The organics were combined, washed with water 
(2 x 15 ml) and brine (1 x 15 ml), dried over anhydrous Na2SO4 and concentrated under 
vacuum. 
The crude product was reconstituted in DCM (14 ml), to which water (4 ml) and 
trifluoroacetic acid (2 ml) were added with stirring at room temperature. The mixture was 
stirred for 30 minutes after which water (10 ml) was added, and the organic layer 
separated. The organics were washed with saturated NaHCO3 (2 x 10 ml), water (1 x 10 
ml) and brine (1 x 10 ml), then dried over anhydrous Na2SO4 and concentrated under 
vacuum. Purification was achieved via flash column chromatography using a gradient 
elution of 0 – 10 % methanol:DCM, to yield the product as a foamy red solid. (0.025 g, 7.7 
%, 1:99 methanol:DCM Rf = 0.1). 
Manual Grignard preparation 
Into a flask containing magnesium turnings (0.13 g, 5.15 mmol) under a dry nitrogen 
atmosphere was added anhydrous diethyl ether (7.7 ml). Into this was added a solution 1-
bromo-2-methyl benzene (0.88 g, 5.15 mmol, 0.89 ml) in anhydrous THF (2.6 ml) 
dropwise, with stirring and heating to mild reflux. Upon Grignard initiation, heating was 
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removed and the remaining bromide continued to be added dropwise with stirring to 
maintain a mild reflux until all bromide was added. The mixture was stirred for a further 1h 
at which point a solution of 3-methoxy-6-(tritylamino)xanthen-9-one 120 (0.50 g, 1.03 
mmol) in anhydrous THF (10 ml) was added dropwise over 30 minutes, followed by 
heating to 60 oC. The mixture was maintained at 60 oC for 16 hours and followed by TLC 
analysis, after which a second portion of Grignard reagent was added, prepared in the 
same manner as before using magnesium (0.13 g, 5.15 mmol) and bromo-2-methyl 
benzene (1.04 g, 2.06 mmol, 1.03 ml) in anhydrous THF (4 ml). Following addition, the 
mixture was stirred for a further 18 h at 60 oC and followed by TLC analysis. After 36 h the 
reaction was quenched with water (10 ml), stirred for 30 min and slowly acidified to pH 7 
with cold aqueous 1M HCl. Subsequently the solution was extracted with diethyl ether (3 x 
10 ml) and ethyl acetate (1 x 10 ml), the organics combined and washed with water (2 x 
10 ml) and brine (1 x 10ml), then dried over anhydrous Na2SO4 and concentrated under 
vacuum. 
The crude product was reconstituted in DCM (14 ml), to which water (4 ml) and 
trifluoroacetic acid (2 ml) were added with stirring at room temperature. The mixture was 
stirred for 30 minutes after which water (10 ml) was added, and the organic layer 
separated. The organics were washed with saturated NaHCO3 (2 x 10 ml), water (1 x 10 
ml) and brine (1 x 10 ml), then dried over anhydrous Na2SO4 and concentrated under 
vacuum. Purification was achieved via flash column chromatography using a gradient 
elution of 0 – 10 % methanol:DCM, to yield the product as a foamy red solid. (0.035 g, 
10.9 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; MeOD) δ = 2.05 (3H, s, CH3-22), 4.08 (3H, s, CH3-21), 7.00 (1H, d, 
J=1.92 Hz, CH-13), 7.07 (1H, dd, J=1.92, 9.36 Hz, CH-2), 7.17 (1H, dd, J=2.34, 9.12 Hz, 
CH-8), 7.28 (1H, d, J=7.50 Hz CH-15), 7.31 (1H, d, J=9.36 Hz, CH-5), 7.34 (1H, d, J=9.12 
Hz, CH-7), 7.45 (1H, d, J=2.34 Hz, CH-10), 7.49 (1H, dd, J=7.50, 7.50 Hz, CH-16), 7.54 
(1H, d, J=7.68 Hz, CH-18), 7.60 (1H, dd, J=7.50, 7.50 Hz, CH-17), 8.72 (2H, br d, J=56.89 
Hz, NH2-20). 
13C-NMR (150 MHz; MeOD) δ = 19.66, 57.57, 98.56, 98.63, 101.55, 116.65, 118.29, 
121.31, 121.38, 127.37, 130.07, 131.63, 131.98, 132.27, 132.71, 134.34, 137.21, 158.49, 
161.51, 161.73, 164.19, 164.30, 169.67. 
19F-NMR (376 MHz; MeOD) δ = -76.77. 
IR (ATR): v = 2917 br, 1645, 1596, 1549. 
HR MS (ES) m/z = found 316.1341, calculated 316.1338 [M]+. 
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1-[2-(Trifluoromethyl)phenyl]cyclohexan-1-ol, 126 
 
 
 
Into a flask containing magnesium turnings (0.14 g, 5.56 mmol) under a dry nitrogen 
atmosphere was added anhydrous THF (8 ml). Into this was added 2-
bromobenzotrifluoride (1.00 g, 0.61 ml, 4.44 mmol) dropwise with stirring, while 
simultaneously heating to mild reflux. Upon Grignard initiation, the bromide continued to 
be added to maintain a mild reflux until addition completed, after which the resulting 
mixture was stirred for an additional 20 minutes. A cyclohexanone (0.22 g, 2.22 mmol, 
0.23 ml) solution in anhydrous THF (1 ml) was then added dropwise and stirred for 18h at 
room temperature and monitored via TLC analysis. The reaction was acidified to pH 6 with 
5 % aqueous HCl. The solution was then extracted with diethyl ether (2 x 5 ml) and ethyl 
acetate (1 x 5 ml) and the organics combined. The organics were then washed with water 
(1 x 5 ml) and brine (1 x 5ml) dried over Na2SO4 and concentrated under vacuum. 
Purification was achieved via flash column chromatography using gradient elution 0:1 - 
3:7 EtOAc:petroleum ether (40 - 60) to yield a fragrant colourless oil (0.215 g, 40 %, 1:3 
ethyl acetate:petroleum ether (40 - 60) Rf = 0.3). 
1H NMR (400 MHz, CD2Cl2)  δ  = 1.31 (1H, br s, OH-14), 1.65 (2H, m, CH2-11), 1.83 (8H, 
m, CH2-9, 10, 12, 13), 7.35 (1H, m, CH-4), 7.52 (1H, m, CH-5), 7.61 (1H, dd, J=0.73, 8.02 
Hz, CH-6), 7.77 (1H, dd, J=0.88, 7.96 Hz, CH-3). 
13C NMR (100 MHz, CD2Cl2) δ = 22.31, 25.77, 39.46, 39.48, 74.84, 124.30, 127.02, 
127.07, 128.28, 128.40, 129.73, 131.96, 131.97. 
IT (ATR): v = 3612, 2931, 2858, 1604, 1577. 
HR MS (ES) m/z = 244.1084, requires 244.1075 [M]+. 
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SG2.HCl; 6-Methoxy-9-[2-(trifluoromethyl)phenyl]xanthen-3-iminium hydrochloride, 
127 
 
 
 
Into a flask containing magnesium turnings (0.16 g, 6.51 mmol) under a dry nitrogen 
atmosphere was added anhydrous THF (6 ml). Into this, a solution of 2-
bromobenzotrifluoride (1.47 g, 6.51 mmol, 0.89 ml) in anhydrous THF (4 ml) was added 
dropwise, with stirring and heating to mild reflux. Upon Grignard initiation, heating was 
removed and the remaining bromide continued to be added dropwise with stirring to 
maintain a mild reflux until all was added. The mixture was then stirred for a further 1 h at 
which point a solution of 3-methoxy-6-(tritylamino)xanthen-9-one 120 (0.45 g, 0.930 
mmol) in anhydrous THF was added dropwise over 30 minutes, followed by heating to 60 
oC. The mixture was maintained at 60 oC for 18 h and followed by TLC analysis. After the 
initial 18h a second portion of Grignard reagent was added, prepared in the same manner 
as before using magnesium (0.11 g, 4.65 mmol) and 2-bromobenzotrifluoride (1.05 g, 4.65 
mmol, 0.63 ml) in anhydrous THF (4 ml). Following addition, the mixture was stirred for a 
further 18h at 60 oC and followed by TLC analysis. After 36 h the reaction was quenched 
with water (10 ml), stirred for 30 min and slowly acidified to pH 7 with cold aqueous 1 M 
HCl. Subsequently the solution was extracted with diethyl ether (3 x 10 ml) and ethyl 
acetate (1 x 10 ml), the organics combined and washed with water (2 x 10 ml) and brine 
(1 x 10ml), then dried over anhydrous Na2SO4 and concentrated under vacuum. 
The crude product was reconstituted in THF (30 ml), to which 6 M aqueous HCl (30 ml) 
was added. The solution was stirred and followed by TLC analysis and after 1h the 
deprotection was deemed complete. Saturated NaHCO3 solution (30 ml) was then added 
to the resulting mixture with stirring until CO2 evolution ceased. The mixture was basified 
to pH 7 with 10 % aqueous NaOH. The mixture was then extracted with DCM (5 x 20 ml), 
the organics washed with water (3 x 10 ml) and brine (1 x 20 ml), then dried over 
anhydrous Na2SO4 and concentrated under vacuum. Purification was achieved via flash 
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column chromatography using a gradient elution 0 – 10 % Methanol:DCM to yield a fluffy 
red solid. (0.050 g, 13.2 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; MeOD) δ = 4.08 (3H, s, CH3-21), 7.00 (1H, d, J=2.04 Hz, CH-13), 
7.07 (1H, dd, J=2.04, 9.36 Hz, CH-2), 7.16 (1H, dd, J=2.40, 9.12 Hz, CH-8), 7.23 (2H, d, 
J=9.36 Hz, CH-3), 7.24 (1H, d, J=9.12 Hz, CH-7), 7.47 (1H, d, J=2.40 Hz, CH-10), 7.55 
(1H, m, CH15), 7.93 (2H, m, CH-16,17), 8.07 (1H, m, CH-18). 
13C-NMR (150 MHz; MeOD) δ = 57.62, 98.57, 101.42, 117.00, 118.25, 118.80, 121.49, 
128.15, 129.99, 130.19, 131.24, 132.02, 132.20, 132.34, 133.92, 134.49, 158.13, 158.19, 
161.29, 164.45, 169.72. 
19F-NMR (376 MHz; MeOD) δ = -60.12 (CF3) 
IR (ATR): v = 3400 br, 1649, 1451. 
HR MS (ES) m/z = found 370.1053, calculated 370.1055 [M]+. 
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SG3.TFA; 9-(2,5-Dimethylphenyl)-6-methoxy-xanthen-3-iminium trifluoroacetate, 128 
 
 
 
Into a flask containing magnesium turnings (0.23 g, 9.49 mmol) under a dry nitrogen 
atmosphere was added anhydrous THF (4 ml). Into this a solution of 2-bromo-1,4-dimethyl 
benzene (1.69 g, 9.11 mmol, 1.26 ml) in anhydrous THF (4 ml) was added dropwise, with 
stirring and heating to mild reflux. Upon Grignard initiation, heating was removed and the 
remaining bromide continued to be added dropwise over 30 minutes with stirring to 
maintain a mild reflux until all bromide was added, the reaction was then stirred for a 
further 1 h at room temperature. The 2-chlorotrityl chloride resin bound 3-methoxy-6-
(tritylamino)xanthen-9-one 119p (0.27 mg/mg loading by qNMR, 0.69 g resin, 0.18 g 
loading, 0.759 mmol) was swelled in anhydrous THF (10 ml) for 30 minutes prior to use, 
the solvent was then removed, after which the Grignard reagent was added and heated to 
60 oC. The reaction was agitated and maintained at 60 oC for 24 h while following via TLC 
analysis. After the initial 16 h the reaction solvent was removed and a second portion of 
Grignard reagent was added (12 equivalents), prepared in the same manner as before. 
Again, this was agitated at 60 oC for a further 16 h, after which the reaction mixture was 
removed and a third portion of Grignard (12 equivalents) was added as before and 
agitated at 60 oC for 16 h. Following this, the reaction mixture was cooled to room 
temperature, removed, and the resin washed with DMF (5 x 10 ml), methanol (10 x 10 ml), 
DCM (10 x 10 ml) and diethyl ether (5 x 10 ml), then dried under a stream of nitrogen and 
vacuum desiccated. 
The resin was then stirred in a 5 % trifluoroacetic acid solution in DCM (1 ml/20 ml) for 20 
minutes, the solution was removed, retained and the resin further washed with 5 % 
trifluoroacetic acid in DCM (3 x 20 ml). The extracts were combined and concentrated 
under vacuum. Purification was achieved via flash column chromatography using a 
gradient elution of 0 – 10 % methanol:DCM, to yield a red foam. (0.061 g, 18.1 %, 1:99 
methanol:DCM Rf = 0.1). 
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1H-NMR (600 MHz; CD2Cl2) δ = 1.96 (3H, s, CH3-22), 2.39 (3H, s, CH3-23), 4.01 (3H, s, 
CH3-21), 6.98 (1H, br s, CH-15), 7.00 (1H, dd, J=2.46, 9.06 Hz, CH-8), 7.14 (1H, br s, CH-
13), 7.15 (1H, dd, J=1.80, 9.06 Hz, CH-2), 7.21 (1H, d, J=2.46 Hz, CH-10), 7.23 (1H, d, 
J=9.06 Hz, CH-3), 7.27 (1H, d, J=9.06 Hz, CH-7), 7.33 (2H, m, CH-17,18), 8.93 (2H, br d, 
J=240.23 Hz, NH2-20). 
13C-NMR (150 MHz; CD2Cl2) δ = 19.31, 21.02, 57.26, 57.56, 98.70, 100.53, 100.73, 
115.85, 117.56, 117.65, 121.05, 129.59, 131.16, 131.39, 131.58, 131.65, 133.17, 133.58, 
136.51, 157.45, 160.23, 161.22, 162.56, 168.39. 
19F-NMR (376 MHz; CD2Cl2) δ = -75.93. 
IR (ATR): v = 3313 br, 3069 br, 1644, 1597, 1544. 
HR MS (ES) m/z = found 330.1507, calculated 330.1494 [M]+. 
 
All subsequent Grignard reactions were performed using the same solid supported 
procedure, their stoichiometries for preparation of the Grignard reagent are quoted. The 
crude product was also cleaved from the resins using the same method. 
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SG4.TFA; 6-Methoxy-9-(2-methoxyphenyl)xanthen-3-iminium trifluoroacetate, 129 
 
 
 
2-Bromoanisole (2.33 g, 12.4 mmol, 1.55 ml), magnesium turnings (0.32 g, 13.0 mmol) x 3 
portions. 
2-chlorotritylchloride resin bound 3-methoxy-6-(tritylamino)xanthen-9-one 119p (0.27 
mg/mg loading by qNMR, 0.94 g resin, 0.25 g loading, 1.04 mmol). 
Purification achieved via flash column chromatography using gradient elution 2 – 10 % 
methanol:DCM to yield a foamy red solid. (0.67 g, 14.5 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; CD2Cl2) δ = 3.70 (3H, s, CH-22), 4.01 (3H, s, CH-21), 6.99 (1H, dd, 
J=2.46, 9.12 Hz, CH-8), 7.17 (1H, d, J=2.46 Hz, CH-10), 7.17 (1H, br d, J=8.40 Hz, CH-
18), 7.20 (2H, m, CH-15, 16), 7.30 (1H, d, J=1.83 Hz, CH-13), 7.30 (1H, d, J=9.39 Hz, 
CH-3), 7.35 (1H, dd, J=1.83, 9.39 Hz, CH-2), 7.36 (1H, d, J=9.12 Hz, CH-7), 7.63 (1H, m, 
CH-17), 9.33 (2H, br d, J=156.75 Hz, NH2-20). 
13C-NMR (150 MHz; CD2Cl2) δ = 56.05, 57.05, 98.55, 100.34, 112.01, 115.83, 116.61, 
118.13, 120.70, 121.20, 121.41, 131.03, 131.46, 132.60, 133.43, 156.93, 157.04, 157.09, 
159.95, 163.17, 167.42. 
19F-NMR (376 MHz; CD2Cl2) δ = -75.52. 
IR (ATR): v = 3012 br, 1644, 1598, 1546. 
HR MS (ES) m/z = found 332.1291, calculated 332.1287 [M]+. 
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SG5.TFA; 6-Methoxy-9-(2-methoxy-5-methyl-phenyl)xanthen-3-iminium 
trifluoroacetate, 130 
 
 
 
2-Bromo-4-methylanisole (2.65 g, 13.2 mmol, 1.91 ml), magnesium turnings (0.33 g, 13.7 
mmol) x 3 portions. 
2-chlorotritylchloride resin bound 3-methoxy-6-(tritylamino)xanthen-9-one 119p (0.27 
mg/mg loading by qNMR, 1.00 g resin, 0.26 g loading, 1.10 mmol). 
Purification achieved via flash column chromatography using gradient elution 2 – 10 % 
methanol:DCM to yield a foamy red solid. (0.158 g, 32.3 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; CD2Cl2) δ = 2.37 (3H, s, CH3-23), 3.66 (3H, s, CH3-22), 4.02 (3H, s, 
CH3-21), 6.99 (2H, m, CH-13, 15), 7.02 (1H, dd, J=2.45, 9.04 Hz, CH-8), 7.06 (2H, m, CH-
3, 17), 7.20 (1H, d, J=2.45 Hz, CH-10), 7.37 (1H, d, J=9.42 Hz, CH-18), 7.41 (1H, d, 
J=9.04 Hz, CH-7), 7.42 (1H, dd, J=2.15, 9.18 Hz, CH-2), 8.58 (2H, br d, J=94.34 Hz, NH2-
20). 
13C-NMR (150 MHz; CD2Cl2) δ = 20.47, 56.06, 57.10, 98.12, 100.31, 111.97, 115.95, 
116.94, 117.85, 120.27, 120.67, 130.91, 131.25, 131.78, 133.06, 133.91, 154.95, 157.12, 
158.35, 160.28, 162.81, 167.80. 
19F-NMR (376 MHz; CD2Cl2) δ = -75.97. 
IR (ATR): v = 3080 br, 1678, 1644, 1599, 1544. 
HR MS (ES) m/z = found 346.1455, calculated 346.1443[M]+. 
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SG6.TFA; 9-(2,4-Dimethylphenyl)-6-methoxy-xanthen-3-iminium trifluoroacetate, 131 
 
 
 
1-bromo-2,4-dimethylbenzene (1.84 g, 9.94 mmol, 1.34 ml), magnesium turnings (0.25 g, 
10.4 mmol) x 3 portions. 
2-chlorotritylchloride resin bound 3-methoxy-6-(tritylamino)xanthen-9-one 119p (0.30 
mg/mg loading by qNMR, 0.67 g resin, 0.20 g xanthone, 0.829 mmol). 
Purification achieved via flash column chromatography using gradient elution 2 – 10 % 
methanol:DCM to yield a foamy red solid. (0.135 g, 36.7 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; CD2Cl2) δ = 1.98 (3H, s, CH3-22), 2.47 (3H, s, CH3-23), 4.07 (3H, s, 
CH3-21), 6.99 (1H, br s, CH-13), 7.07 (1H, d, J=7.68 Hz, CH-15), 7.11 (1H, dd, J=2.46, 
9.27 Hz, CH-8), 7.25 (1H, br d, J=7.68 Hz, CH-16), 7.29 (1H, d, J=9.48 Hz, CH-3), 7.29 
(1H, br s, CH-18), 7.37 (1H, d, J=2.46 Hz, CH-10), 7.40 (1H, d, J=9.27 Hz, CH-7), 7.69 
(1H, d, J=9.48 Hz, CH-2), 11.45 (2H, br s, NH2-20). 
13C-NMR (150 MHz; CD2Cl2) δ = 24.53, 26.21, 62.67, 106.42, 122.02, 123.64, 124.22, 
125.19, 132.84, 134.44, 135.03, 137.34, 137.52, 137.63, 142.06, 145.13, 147.17, 161.28, 
163.73, 164.43, 168.88, 175.38. 
19F-NMR (376 MHz; CD2Cl2) δ = -75.88. 
IR (ATR): v = 3066 br, 1688, 1595, 1548. 
HR MS (ES) m/z= found 364.1097, calculated= 364.1104 [M – H + Cl]+. 
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SG7.TFA; 9-(2,4-Dimethoxyphenyl)-6-methoxy-xanthen-3-iminium trifluoroacetate, 
132 
 
 
 
1-bromo-2,4-dimethoxy benzene (2.16 g, 9.95 mmol, 1.43 ml), magnesium turnings (0.25 
g, 10.4 mmol) x 3 portions. 
2-chlorotritylchloride resin bound 3-methoxy-6-(tritylamino)xanthen-9-one 119p (0.21 
mg/mg loading by qNMR, 0.96 g resin, 0.20 g xanthone loading, 0.829 mmol). 
Purification achieved via flash column chromatography using gradient elution 2 – 10 % 
methanol:DCM to yield a foamy red solid. (0.68 g, 17.3 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; CD2Cl2) δ = 3.68 (3H, s, CH3-22), 3.93 (3H, s, CH3-23), 4.01 (1H, s, 
CH3-21), 6.71 (1H, d, J=2.22 Hz, CH-18), 6.74 (1H, dd, J=2.22, 8.34 Hz, CH-16), 6.96 
(1H, d, J=1.83 Hz, CH-13), 7.03 (1H, dd, J=2.46, 9.18 Hz, CH-8), 7.05 (1H, dd, J=1.83, 
9.36 Hz, CH-2), 7.12 (1H, d, J=8.34 Hz, CH-15), 7.18 (1H, d, J=2.46 Hz, CH-10), 7.42 
(1H, d, J=9.36 Hz, CH-3), 7.46 (1H, d, J=9.18 Hz, CH-7), 8.41 (2H, br d, J=61.33, NH2-
20). 
13C-NMR (150 MHz; CD2Cl2) δ = 55.61, 55.71, 56.67, 97.63, 97.70, 99.01, 99.87, 105.42, 
112.51, 115.80, 117.61, 119.99, 131.52, 131.77, 133.60, 156.76, 158.05, 159.89, 162.16, 
162.27, 163.45, 167.36. 
IR (ATR): v = 2919 br, 2850, 1693, 1665, 1598, 1543. 
HR MS (ES) m/z = found 362.1387, calculated 362.1392 [M]+. 
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SG8.TFA; 6-Methoxy-9-(1-naphthyl)xanthen-3-iminium trifluoroacetate, 133 
 
 
 
1-bromonaphthalene (1.80 g, 8.70 mmol, 1.22 ml), magnesium turnings (0.22 g, 9.06 
mmol) x 3 portions. 
2-chlorotritylchloride resin bound 3-methoxy-6-(tritylamino)xanthen-9-one 119p (0.21 
mg/mg loading by qNMR, 0.84 g resin, 0.18 g xanthone, 0.725 mmol). 
Purification achieved via flash column chromatography using gradient elution 2 – 10 % 
methanol:DCM to yield a foamy red solid. (0.45 g, 13.3 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; CD2Cl2) δ = 4.02 (3H, s, CH3-25), 6.92 (1H, dd, J=2.46, 9.18 Hz, CH-
8), 6.98 (1H, dd, J=2.07, 9.42 Hz, CH-2), 7.10 (1H, d, J=2.07 Hz, CH-13), 7.17 (1H, d, 
J=9.42 Hz, CH-3), 7.18 (1H, d, J=9.18 Hz, CH-7), 7.26 (2H, m, CH-10, 19), 7.40 (1H, ddd, 
J=1.34, 6.93, 8.36 Hz, CH-20), 7.47 (1H, dd, J=1.05, 7.01 Hz, CH-15), 7.58 (1H, ddd, 
J=1.14, 6.93, 8.34 Hz, CH-21), 7.71 (1H, dd, J=8.31, 7.01 Hz, CH-16), 8.04 (1H, d, J=8.34 
Hz, CH-22), 8.16 (1H, d, J=8.31 Hz, CH-17), 8.77 (1H, d, J=215.03 Hz, NH2-24). 
13C-NMR (150 MHz; CD2Cl2) δ = 57.18, 98.46, 100.57, 116.34, 117.16, 118.53, 121.16, 
125.36, 125.51, 127.39, 128.02, 128.19, 129.12, 129.45, 131.19, 131.69, 131.77, 133.61, 
133.86, 157.10, 158.81, 160.16, 163.10, 168.08. 
IR (ATR): v = 3064 br, 1674, 1643, 1595, 1545. 
HR MS (ES) m/z = found 352.1353, requires 352.1338 [M]+. 
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SG9.TFA; 6-Methoxy-9-[2-(trifluoromethyl)phenyl]xanthen-3-iminium 
trifluoroacetate, 134 
 
 
 
Under a dry nitrogen atmosphere, Amberlyst A21 basic resin (0.50 g) was washed with a 
5:1 DCM/methanol mixture (2 x 10 ml), followed by DCM (5 x 10 ml), methanol (5 x 10 ml) 
and an addition DCM wash (5 x 10 ml). The resin was then dried under a stream of 
nitrogen followed by high vacuum. SG2.HCl 127 (0.01 g, 0.0296 mmol) was then 
reconstituted into DCM/methanol solution of 5:1 (20 ml), to which the clean dry Amberlyst 
A21 resin was then added and stirred for 20 h. The resin was filtered off and washed 
several times with the reaction solution. The washings were combined, the solvent 
removed under high vacuum and stored under nitrogen. The dry compound was 
reconstituted in a 10 % trifluoroacetic acid solution in DCM and stirred under nitrogen for 
24 h, the solvent was then removed under high vacuum for several days, to yield a deep 
red solid. (0.012 g, 0.0248 mmol, 84 %, 1:99 methanol:DCM Rf = 0.1). 
1H-NMR (600 MHz; MeOD) δ = 4.08 (3H, s, CH3-21), 6.99 (1H, d, J=2.04 Hz, CH-13), 
7.05 (1H, dd, J=2.04, 9.42 Hz, CH-2), 7.16 (1H, dd, J=2.40, 9.42 Hz, CH-8), 7.23 (1H, d, 
J=9.42 Hz, CH-3), 7.24 (1H, d, J=9.42 Hz, CH-7), 7.47 (1H, d, J=2.40 Hz, CH-10), 7.54 
(1H, m, CH-15), 7.92 (2H, m, CH-16, 17), 8.07 (1H, m, CH-18). 
13C-NMR (150 MHz; MeOD) δ = 57.60, 98.55, 101.42, 117.02, 118.26, 118.81, 121.48, 
128.15, 130.01, 130.22, 131.27, 132.03, 132.19, 132.35, 133.91, 134.51, 158.14, 158.21, 
161.31, 164.46, 169.72. 
19F-NMR (376 MHz; CD2Cl2) δ = -59.17, -76.23. 
HR MS (ES) m/z = found 370.1060, requires 370.1055 [M]+. 
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SG1BisAc; [3-Acetamido-6-methoxy-9-(o-tolyl)xanthen-9-yl] acetate, 135 
 
 
 
Into a stirred solution of SG1.TFA 116 (0.01 g, 0.0230 mmol) in anhydrous pyridine under 
a dry nitrogen atmosphere, acetic anhydride (0.01 g, 0.115 mmol, 0.01 ml) was added 
dropwise. The resulting solution was stirred at room temperature for 16 h while monitoring 
via TLC analysis, and then evaporated to dryness under high vacuum at 40 oC. The crude 
mixture was reconstituted in DCM (10 ml), washed with 0.5 M aqueous HCl solution (3 x 5 
ml), saturated NaHCO3 (2 x 5 ml), brine (1 x 10 ml), dried over anhydrous Na2SO4 and 
finally evaporated to dryness under high vacuum. Purification was achieved via flash 
column chromatography using a gradient elution of 0 - 5 % methanol:DCM to yield an 
orange solid. (0.007 g, 73 %, 1:9 methanol:DCM Rf = 0.4). 
1H-NMR (600 MHz; CD2Cl2) δ = 1.43 (3H, s, CH3-21), 2.14 (3H, s, CH3-26), 2.73 (3H, s, 
CH3-24), 3.82 (3H, s, CH3-25), 6.59 (1H, dd, J=2.52, 8.70 Hz, CH-8), 6.67 (1H, d, J=2.52 
Hz, CH-10), 6.85 (1H, d, J=8.70 Hz, CH-7), 6.89 (1H, d, J=8.46 Hz, CH-3), 6.92 (1H, dd, 
J=1.95, 8.46 Hz, CH-2), 6.95 (1H, dd, J=7.41, 0.78 Hz, CH-18), 7.18 (1H, ddd, J=7.41, 
7.41, 1.38 Hz, CH-17), 7.26 (1H, br s, NH-23), 7.33 (1H, ddd, J=7.92, 7.41, 0.78 Hz, CH-
16), 7.63 (1H, d, J=1.95 Hz, CH-13), 8.28 (1H, dd, J=1.38, 7.92 Hz, CH-15). 
13C-NMR HSQC (150 MHz; CD2Cl2) δ = 131.76, 130.03, 129.60, 127.32, 125.10, 114.58, 
114.58, 111.08, 99.50, 55.40, 49.18, 24.52, 20.08. 
HR MS (ES) m/z = found 358.1442, requires 358.1443 [M – OAc]+. 
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SG1Ac; N-[6-methoxy-9-(o-tolyl)xanthen-3-ylidene]acetamide, 136 
 
 
 
[3-Acetamido-6-methoxy-9-(o-tolyl)xanthen-9-yl] acetate 135 was exposed to sunlight over 
70 h at 20 oC to induce photolysis to form the elimination product SG1Ac 136 as an 
orange brown solid. (0.006 g, 100 %). 
1H-NMR (600 MHz; CD2Cl2) δ = 2.46 (3H, s, CH3-23), 3.41 (3H, s, CH3-21), 4.15 (3H, s, 
CH3-22), 7.23 (1H, dd, J=1.26, 7.56 Hz, CH-15), 7.25 (1H, dd, J=2.34, 9.24 Hz, CH-8), 
7.44 (1H, d, J=2.34 Hz, CH-10), 7.49 (1H, ddd, J=0.78, 7.56, 7.65 Hz, CH-16), 7.52 (1H, 
dd, J=7.65, 0.78 Hz, CH-18), 7.58 (1H, d, J=9.24 Hz, CH-7), 7.59 (1H, d, J=9.42 Hz, CH-
3), 7.62 (1H, ddd, J=1.26, 7.65, 7.65 Hz, CH-17), 8.56 (1H, d, J= 9.42 Hz, CH-2), 9.02 
(1H, d, J=1.10Hz, CH-13). 
13C-NMR HSQC (150 MHz; CD2Cl2) δ = 131.89, 131.23, 131.10, 128.80, 126.30, 120.35, 
99.89, 57.66, 25.13, 19.67. 
HR MS (ES) m/z = found 358.1446, requires 358.1443 [M]+. 
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SG5BisAc; [3-Acetamido-6-methoxyl-9-(2-methoxy-5-methyl-phenyl)xanthen-9-yl] 
acetate, 137 
 
 
 
Into a stirred solution of SG5.TFA 130 (0.042 g, 0.0910 mmol) in anhydrous pyridine 
under a dry nitrogen atmosphere, acetic anhydride (0.047 g, 0.457 mmol, 0.044 ml) was 
added dropwise. The resulting solution was stirred at room temperature for 16 h while 
monitoring via TLC analysis, after which an additional portion of acetic anhydride (0.141 g, 
1.37 mmol,  0.132 ml) was added dropwise. After an additional 4 h the reaction mixture 
was evaporated to dryness under high vacuum at 40 oC. The crude mixture was 
reconstituted in DCM (10 ml), washed with 0.5 M aqueous HCl solution (3 x 5 ml), 
saturated NaHCO3 (2 x 5 ml), brine (1 x 10 ml), dried over anhydrous Na2SO4 and finally 
evaporated to dryness under high vacuum. Purification was achieved via flash column 
chromatography using a gradient elution of 0 - 5 % methanol:DCM to yield an deep 
orange solid. (0.010 g, 25 %, 1:9 methanol:DCM Rf = 0.4). 
1H-NMR (600 MHz; CD2Cl2) δ = 2.13 (3H, s, CH3-21), 2.39 (3H, s, CH3-27), 2.79 (3H, s, 
CH324), 3.11 (3H, s, CH3-23), 3.80 (3H, s, CH3-25), 6.55 (1H, dd, J=2.55, 8.58 Hz, CH3-8), 
6.57 (1H, d, J=8.22 Hz, CH-18), 6.65 (1H, d, J=2.55 Hz, CH-10), 6.91 (1H, dd, J=1.89, 
8.46 Hz, CH-2), 6.95 (1H, d, J=8.58 Hz, CH-7), 6.99 (1H, d, J=8.46 Hz, CH-3), 7.02 (1H, 
dd, J=2.28, 8.22 Hz, CH-17), 7.30 (1H, s, NH-22), 7.54 (1H, d, J=1.89 Hz, CH-13), 7.93 
(1H, d, J=2.28 Hz, CH-15). 
13C-NMR (150 MHz; CD2Cl2) δ = 21.08, 24.83, 49.98, 55.75, 56.30, 73.10, 99.98, 106.36, 
110.38, 113.53, 114.34, 115.71, 119.44, 126.17, 128.89, 129.01, 129.33, 129.87, 137.42, 
138.68, 152.91, 153.45, 154.29, 160.27, 168.56. 
IR (ATR): v = 3300, 2934, 2834, 1668, 1612, 1586, 1536. 
HR MS (ES) m/z = found 388.1553, requires 388.1549 [M – OAc]+. 
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SG8BisAc; [3-Acetamido-6-methoxy-9-(naphthyl)xanthen-9-yl] acetate, 139 
 
 
 
Into a stirred solution of SG8.TFA 133 (0.079 g, 0.170 mmol) in anhydrous pyridine under 
a dry nitrogen atmosphere, acetic anhydride (0.868 g, 8.50 mmol, 0.803 ml) was added 
dropwise. The resulting solution was stirred at room temperature for 14 h while monitoring 
via TLC analysis, after which it was evaporated to dryness under high vacuum at 40 oC. 
The crude mixture was reconstituted in DCM (10 ml), washed with 0.5 M aqueous HCl 
solution (3 x 5 ml), saturated NaHCO3 (2 x 5 ml), brine (1 x 10 ml), dried over anhydrous 
Na2SO4 and finally evaporated to dryness under high vacuum. Purification was achieved 
via flash column chromatography using a gradient elution of 0 - 5 % methanol:DCM to 
yield a deep orange solid. (0.014 g, 18 %, 1:9 methanol:DCM Rf = 0.4). 
1H-NMR (600 MHz; CD2Cl2) δ = 2.12 (3H, s, CH3-25), 2.80 (3H, s, CH3-4), 3.80 (3H, s, 
CH3-29), 6.50 (1H, dd, J=2.55, 8.70 Hz, CH-8), 6.77 (1H, d, J=2.55 Hz, CH-10), 6.79 (1H, 
dd, J=2.04, 8.46 Hz, CH-2), 6.82 (1H, d, J=8.70 Hz, CH-7), 6.84 (1H, d, J=8.46 Hz, CH-3), 
7.00 (1H, ddd, J=1.55, 6.84, 8.69 Hz, CH-20), 7.20 (1H, m, CH-19), 7.23 (1H, ddd, 
J=1.11, 8.04, 6.84 Hz, CH-21), 7.32 (1H, s, NH-26), 7.62 (1H, dd, J=7.41, 8.10 Hz, CH-
16), 7.77 (2H, m, CH-22, 13), 7.84 (1H, d, J=8.10 Hz, CH-17), 8.52 (1H, dd, J=0.69, 7.41 
Hz, CH-15). 
13C-NMR (150 MHz; CD2Cl2) δ = 24.83, 49.51, 55.82, 74.65, 100.33, 106.69, 111.41, 
115.06, 115.64, 119.16, 125.00, 125.02, 125.05, 125.18, 125.63, 129.13, 129.25, 129.82, 
130.24, 130.27, 135.04, 139.42, 141.44, 152.48, 153.06, 160.89, 168.66, 168.68.  
IR (ATR): v = 3306, 3051, 2932, 1725, 1671, 1611, 1584, 1537. 
HR MS (ES) m/z = found 394.1444, requires 394.1443 [M + H – OAc]+. 
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5.1 Excitation vs Emission Maxima for Singapore Greens 
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5.2 Plots for Fluorescence Quantum Yield Determinations of Singapore Greens 
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SG1 QY = 0.647431877 
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SG2 QY = 0.561098083 
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SG3 QY = 0.63144219 
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SG5 Ɛ = 35411 M-1cm-1 
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SG6 Ɛ = 22822 M-1cm-1 
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SG7 Ɛ = 38279 M-1cm-1 
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SG8 Ɛ = 36186 M-1cm-1 
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SG9 Ɛ = 17178 M-1cm-1 
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SG1Ac QY = 0.120883283 
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